Interferon gene expression in virus-induced human B-lymphoblastoid cells by Shuttleworth, John
University of Warwick institutional repository: http://go.warwick.ac.uk/wrap
A Thesis Submitted for the Degree of PhD at the University of Warwick
http://go.warwick.ac.uk/wrap/3702
This thesis is made available online and is protected by original copyright.
Please scroll down to view the document itself.
Please refer to the repository record for this item for information to help you to
cite it. Our policy information is available from the repository home page.
INTERFERON GENE EXPRESSION IN VIRUS- 
INDUCED HDMAN B-LYM FHOBLASTOID CELLS 
by 
JOHN SHUTTL VORTH 
submitted for the degree of Doctor of Philosophy 
Department of Biological sciences 
University of Warwick 
November, 1982. 
CONTAINS 
PULLOUTS 
to Isabel, for her endless patience and support 
SUDITARY 
Virus infection of human cells induces the transient expression 
of interferon- oc and interferon-/3 " This thesis presents the results 
of investigations into the expression of these interferons in the human 
B-lymphobastoid cell line, Namalwa, following induction by Sendai virus. 
Quantitative and qualitative changes in the synthesis of these 
interferon mRfTAs and proteins were investigated in order to determine 
how interferon gene expression is controlled. Interferon mRNA was assayed 
both by translation in Xenonus oocytes and by hybridization with cloned 
interferon cDTNA. Interferon was measured both by bioassay and by immano- 
radiometric assay using a monoclonal antibody to interferon-4. In 
addition the effects of various treatment which perturb the normal control 
of inte:? feron production have been assessed. 
Sendai virus infection of Namalvra cells resulted in the coordinate 
induction and regulation of both interferon+i and interferon f3 synthesis. 
Although significant amounts of interferon-/3 were present, the cells 
did not produce any functional interferon /3 protein. It was concluded 
that the interferon ß PRIMA in these cells was inactive. 
Production of interferon was shown to be increased by incubating 
cells at reduced temperatures following induction. It was concluded that 
the normal inactivation and degradation of interferon nRTA which occurs 
during the shut-off of interferon production was inhibited at the lower 
temperature. This resulted in increased interferon production over a 
prolonged period. 
Treatment of cells with butyrate or 5'-bromodeoxyuridine before 
induction caused a dose-dependant increase in the rate of interferon mITTA 
and interferon synthesis. These treatments appear to coordinately affect 
the control of both interferon-o< and interferon-/3 gene expression, 
since no differences could be detected in the characteristics of interferon 
or interferon mRNA produced by treated and untreated cells. The effect 
of these treatments was relatively specific, since polyacrylamide gel 
electrophoresis of proteins from butyrate- and 5'-bromodeoxyuridine- 
treated cells failed to detect any changes which were comprable to or 
could account for the effect on interferon synthesis. 
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SECTION 1 INTRODUCTION 
Section 1.1 Regulation of eukaryotic gene expression 
Studies on the regulation of gene expression in eukaryotic cells 
have in recent years indicated that a complex array of regulatory 
mechanisms are involved in controlling the expression of genetic 
information and in determining the structural and functional phenotype 
of a cell. This complexity reflects the variety of situations in 
which different genes are required to be expressed, for example 
during differentiation and specialisation, in response to physiological 
stimuli (for example hormones) or during normal cell growth. The 
interferon (IFN) genes are a group of inducible structural. _(; otein. 
coding) genes which are expressed in cells exposed to a number of 
stimuli, such as virus infection. This thesis presents the results 
of studies on the expression of these genes in a cultured human cell 
line. Before describing the IFN genes and their expression it would 
be useful to briefly consider current ideas about the regulation of 
eukaryotic structural gene expression in order to provide a framework 
for later discussion. 
Regulation of gene expression can broadly be considered to 
involve all these processes which quantitatively or qualitatively 
cause variation in gene activity and gene products. With few 
exceptions (see below) the molecular basis of the events which 
cause this variation is not known. However studies on the structure 
of individual viral and cellular genes and the transcription and 
processing of their mRNAs have indicated that in eukaryotes gene 
expression is regulated at a variety of levels (reviewed by Brown, 
1981; Darnell, 1982), unlike prokaryotes where control occurs 
exclusively at the level of transcription initiation and termination 
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(Miller and Reznikoff, 1978). Fig. 1 shows a schematic 
representation of the events leading from gene-mRNA-protein. The 
levels at which control can occur have been divided into four 
categories for the purpose of discussion, these are a) transcriptional, 
involving the interaction of RNA polymerase with DNA, b) post- 
i 
transcriptional, including formation of mRNA from hn, RNA transcripts 
and its stability in the cytoplasm, c) translational, involving the 
utilisation of mRNA in the polyribosomes and d) post-translational 
in which the modification and turnover of protein are controlled. The 
processes occurring at each level need not themselves be regulatory 
since they are in most cases constitutive and therefore only mediate 
the variation in gene expression. This section is intended to describe 
these potential control points and to discuss information supporting 
their involvement in-the regulation of gene expression. 
a) Transcriptional control 
Control at the transcriptional level involves those mechanisms 
which direct the transcription of RNA from the DNA template. Information 
about these mechanisms has been derived by three different approaches; 
i) studies on gene structure, ii) studies on the organisation of 
chromatin and iii) measurements of the transcriptional activity 
of genes. The important facts to emerge from these studies are 
summarised below. 
i) Gene structure 
The benefits to be gained from an understanding of the primary 
structure of individual genes are self evident. A sufficient number 
of structural genes have now been isolated and sequenced to arrive at 
what could be considered a consensus polymerase II transcription unit. 
Fig. 2 describes the essential features of such a unit encoding a 
single mRNA and protein. 
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FIG. 2. The structural features of an MIA nolymerase II transcription unit. 
The positional information which is required to select accurate 
transcription is provided in most genes by a conserved 8-10 nucleotide 
sequence known as the Goldberg-Hogness box (Goldberg, 1979), in which 
the sequence T-A-T-A usually occurs. Transcription is initiated at a 
site located 25-30 nucleotides downstream (in a 3' direction) from 
the Goldberg-Hogness box (Grosschedl and Birnstiel, 1980). Transcription 
then proceeds through protein coding and non-coding regions of the 
gene and terminates in some 3' region which has yet to be described. 
Increases and decreases in the rate of transcription of a gene are 
thought to be mediated by varying the efficiency with which RNA 
polymerase II interacts with the selector and initiator sequences 
described above. In vitro, site directed mutagenesis of cloned 
genomic DNA and its transcription in surrogate in vivo systems such 
as Xenovus oocyte nuclei have indicated sequences further upstream 
from the Goldberg-Hogness box which are important in modulating the 
rate of transcription in several genes, including the sea urchin 
H2A 
histone genes and the Herpes tK gene (Grosschedl and Birnstiel, 1980; 
Li 
McKnight and Kingsbury, 1982). No clear indication of the role of 
such 5' sequences has yet been discovered, but it has been proposed 
that they may be involved in DNA-protein interactions which alter 
the efficiency of RNA polymerase II binding and initiation of 
transcription (McKnight and Kingsbury, 1982). The identity and 
functional role of these transcriptional signals are being investigated 
by the techniques of gene transfer. Cloned DNA containing protein 
coding genes and their flanking regions have been introduced into 
heterologous cells by calcium co-precipitation (Wigler et al., 1979) 
and shown to carry all the information required for regulated expression. 
For example, hormonal regulation of the rat oc2p globulin gene (Kurtz, 
1981) and the human growth hormone gene (Robbins et al., 1982) has 
been demonstrated in transformed mouse cells. The first real indication 
that transcription may indeed be modulated by protein-DNA interactions 
has been provided by the glucocorticoid responsive murine mammary 
tumour virus genes. Activated glucocorticoid receptor protein binds 
selectively in vitro to a cloned fragment of murine mammary tumour 
virus DNA (Payvar et al., 1981; Ucker et al., 1982). However at 
present little is known about the transcriptional signals required 
for activation of genes during development and differentiation. 
Logically certain aspects of gene structure/organisation must be 
involved in the regulation and coordination of transcription of 
genes such as the highly reiterated histone genes (Hentschel and 
Bi. rnstiel, 1981) and the globin gene clusters (Efstratiadis et al., 
1980). 
ii) The structure of active chromatin 
There is now a considerable amount of evidence to suggest that 
the structure of chromatin from actively transcribed genes is 
different to that from non-transcribed regions of the genome. 
5 
All eukaryotic DNA exists in association with histones and other 
chromosomal proteins which serve not only to package the DNA and 
maintain higher orders of chromatin structure but also to regulate 
the accessibility of genes to transcriptional apparatus. The 
majority of the DNA in the nucleus is in the form of highly condensed 
chromatin and is transcriptionally inactive. However it has been 
-found that active genes are preferentially sensitive to nuclease 
digestion, suggesting that the DNAA present in a more relaxed chromatin 
structure (Weintraub and Groudine, 1976). Following the original 
observation that the globin genes in erythrocyte nuclei are preferentially 
degraded by pancreatic DNase I, the observation has been extended 
to numerous other transcriptionally active genes (reviewed by Weisbrod 
1982a). In addition limited DNase I digestion has identified 
hypersensitive regions located at or near the 5' end of active genes 
which possibly represent the regions involved in regulating and 
initiating transcription (reviewed by Elgin, 1981). 
Several mechanisms appear to contribute to the changes in higher 
order chromatin structure which accompany gene activation. Modification 
of the DNA itself, in the form of methylation of cytosine residues, 
is thought to be associated with inactive/condensed chromatin, and 
indeed there is a degree of correlation between undermethylation, 
DNase I sensitivity and in vivo and in vitro transcription of some i ýý 
genes (Ehrlich and Wang, 1981; Weisbrod, 1982a). Modification of 
chromosomal proteins is also observed in transcriptionally active 
chromatin, for example acetylation of core histones, 
(histoneä 
H2A, H2B. 9 H3 and-H4 which are associated with nucleobomes) 
and 
phosphorylation of histone- Hl, accompagy decondensation _of_. chromatin 
(see below and Weisbr6d,. l982a). In addition certain non-histone 
proteins such as HMG 14 and HMG 17 are preferentially associated with 
such domains and thought to be involved in events which ! acilitatA 
transcription (Weisbrod, 1982b). However, DTdase I sensitivity, 
6 
undermethylation and modification of chromosomal protein, although 
characteristic of active chromatin, only indicate the potential for 
transcription. The primary events which elicit these changes in 
chromatin structure and regulate its transcriptional capacity are not 
known. 
iii) Measurements of transcriptional activity 
Examples of apparent transcriptional control, resulting in increases 
or decreases in cytoplasmic mRNA, have been reported for numerous 
eukaryotic genes. However, steady-state levels of a mRNA can also 
be influenced by changes in its. nuclear and cytoplasmic stability, 
therefore evidence of transcriptional control requires direct 
measurements of the rate of transcription. This can be estimated by 
measuring the incorporation of radioactive precursors into nascent 
nuclear RNA corresponding to a specific mRNA. Using such measurements, 
transcriptional control has been demonstrated for several genes. 
For example, stimulation of egg white protein production in the 
chicken oviduct by oestrogen (McKnight and Palmiter, 1978), glucocorticoid 
regulation of the mouse metallothionein gene (Hagar and Palmiter, 1981) 
and the switch from embryonic to adult globin gene expression in chick 
embryo erythoblasts (Weintraub et al., 1981). In addition the 
expression of several mouse liver specific mRNAs (ranging in abundance 
from 100- 10,000 copies/cell) appeared to be controlled at the 
transcriptional level (Dermann et al., 1981). Transcriptional control 
is therefore frequently used to regulate the expression of a wide 
range of genes. 
b) Post-transcriptional control 
i) RNA processing 
The utilization of primary RNA transcripts 
(or hn RNA) is 
7 
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dependant on successful processing to form mature mRNA and its 
export from the nucleus. The sequence of events which convert 
hnRNA into mRNA are summarised in Fig. 1. The first of these events 
is the addition of a "cap" or 7-methylguanosine (m7G) residue to the 
5' terminus via a series of intermediate reactions(Perry, 1981). 
Most, if not all RNA polymerase II transcripts are modified in this 
way. The post-transcriptional addition of a poly(A) segment to the 
3' end is a more selective process, only 25% of capped molecules 
being polyadenylated. This involves endonucleolytic cleavage and 
addition of 150-200 adenylate residues at a site indicated (at least 
partly) by an A-A-U-A-A-A sequence located within the 3' untranslated 
region of the transcript (see Fig. 2). Histone mRNAs are the only 
mRNAs known not to undergo polyadenylation (Darnell, 1982). 
The protein coding regions (exons) of most eukaryotic genes are 
interrupted by non-coding sequences or introns, as indicated in 
Fig. 2. To date, the only genes known to lack introns are histone 
genes (Hentschel and Birnstiel, 1981) and the human IFN-c<and IFN ,3 
genes (see below). The removal of these intervening sequences or 
splicing is required to form functional mRNA with a continuous coding 
sequence. Following this final processing step the capped, polyadenylated 
and spliced mRNA leaves the nucleus. 
The "decision" to process or discard a specific transcript 
provides an obvious control point by regulating the cytoplasmic 
mRNA levels and hence the expression of a gene. Such control must 
occur since the segQence complexity of nuclear, hnRNA is 10-20 
times greater than that of cytoplasmic mRNA (Darnell, 1982). This 
difference cannot be accounted for by intron loss during processing, 
therefore a large proportion of primary transcripts must be 
degraded. Similar conclusions were drawn by comparing the fate of 
capped hnRNA molecules in Chinese hamster ovary cells 
(Salditt- 
8 
Ceorgieff and Darnell, 1982). Only 25-50% of primary transcript 
sequences were found in stable polyadenylated mRNA in the cytoplasm. 
One example where differential processing could be involved in 
regulating gene expression is the growth stimulation of dihydrofolate 
reductase levels in methotrexate-resistant mouse cells (Leys and 
Kellems, 1981). It was found that the appearance of mRNA in the 
cytoplasm was dependant not on increased transcription but increased 
stability of transcripts in the nucleus. 
ii) Control of mRNA stability 
Very little is known about the control of mRNA stability in the 
cytoplasm. The mechanisms and structural features which control and 
determine the half-life of a mRNA remain obscure, although it is 
possible that the cap structure and poly(A) tail could function to 
prevent (or delay) exonuclease degradation of the molecule. It is 
clear that different mRNAs can have widely different stabilities 
in the same cell, for example the mRNA population of HeLa cells can 
be divided into two components based on the kinetics of their decay 
(following 3H-uridine labelling). Both components decay exponentially, 
one with a half-life of around 4h or less, the other with a half-life 
greater than 24h (Lewin, 1980). What distinguishes each stability 
class is not clear, but it would appear that lower abundance mRNAs 
are closely associated with the less stable population. One 
consequence of a rapid decay rate would be that the cytoplasmic 
levels of a mRNA could be rapidly adjusted once its synthesis had 
stopped and its presence was no longer required. However the 
physiological significance of this variety in mRNA stability will 
only be explained by comparing the half-lives of specific mRNAs 
for 
proteins of known function. 
Changes in the stability of a specific mRNA provide an additional 
9 
means of regulating cytoplasmic mRNA levels to meet the requirements 
of a cell. Several examples of variations in the half-life of a mRNA 
have been reported, these usually accompanying changes in the rate of 
b. 
its transcription. The accumulation of casein mRNA following prolactin 
stimulation of breast tissue is caused by a combination of increased 
transcription and mRNA stability. (Guyette et al., 1979). In 
contrast, the suppression of oc- fetoprotein production in newborn 
rats by glucocorticoids results from decreased transcription and 
mRNA stability (Fu Chui et al., 1981). 
c) Translational control 
It has been recognised for a long time that mRNA present in 
the cytoplasm need not necessarily be involved in translation, the 
most striking example being provided by amphibian oocytes. For instance, 
more than 90% of the mRNA pool of Xenopus oocytes is not present in 
polyribosomes (Rosbach and Ford, 1974)" It would appear that a large 
proportion of this inactive mRNA is present in a "masked" untrqnslatable 
form in mRNP particles, and can be activated during maturation or 
after fertilisation. Similar gross changes in translation of mRNA 
populations occur during the heat shock response and after virus 
cells 
infection of culturedn(Darnell, 1982) which result in a general 
reduction of total protein synthesis. 
d) Post-translational control 
The function or biological activity of a protein is often 
dependant on post-translational modification, such as glycosylation, 
phosphorylation, and proteolytic cleavage, each of which could provide 
10 
a control point influencing the expression of a functional gene 
product. Processing of the polyprotein precursor known as pro- 
opiomelanocortin in the brain and pituitary is one example of a 
post-translational event known to perform a regulatory function 
(Herbert and Uhler, 1982). This large precursor polypeptide is 
cleaved at different points to produce either adrenocorticotropin, 
melanocyte stimulating hormones and lipotropin in the anterior 
pituitary, or endorphins in the intermediate lobe. This differential 
processing therefore performs a regulatory function, qualitatively 
determining the expression of'peptide hormones. 
e) Modulation of gene expression by drugs and metabolic inhibiters 
Numerous indirect approaches have been used to investigate 
the regulation of gene expression, some of which involve the addition 
of agents which perturb normal cellular processes. One strategy, 
which is of particular relevance to the. study of IFN gene expression 
is the use of inhibitors to block RNA and protein synthesis. The 
information that has been obtained about IFN production using this 
approach is discussed further in section 1.2. An alternative strategy 
employs agents which appear to selectively modulate the expression 
of specific gene products. The short chain fatty acid butyrate and 
the halogenated pyrimidine 5'-bromodeoxyuridine (BrdUrd) have also 
been used to study IFN production (see section 1.3) therefore it 
would be useful to review the effects of these agents on gene 
expression in general. 
i) The effects of butyrate on gene expression. 
Low concentrations of butyrate have a varied and well 
documented 
effect on the expression of many differentiated and specialised cell 
proteins (reviewed by Prasad and Sinha, 1976). For example, 
butyrate 
increases the synthesis of human chorionic gonadotrophin and follicle 
stimulating hormone by HeLa cells (Ghosh and Cox, 1976; 1977), 
prostaglandin synthase activity in mastocytoma cells (Koshihara et al., 
1981) and induces differentiation and haemoglobin accumulation in 
murine erytholeukemic cells (Leder and Leder, 1975). In contrast, 
butyrate inhibits steroid induction of chicken egg white proteins 
(McKnight et al., 1980) and glucocorticoid-induced tyrosine amino 
transferase in hepatoma tissue cultures (Tichonicky et al., 1981). 
The biochemical effects of butyrate are often accompanied by alterations 
in cell morphology (Simmons et al., 1975) and butyrate-treatment has 
been shown to cause reversion of the transformed phenotype of murine 
sarcoma virus-infected cells ( Via at el., 1980 ). 
It has been assumed that the effects of butyrate on gene expression 
are a reflection of altered patterns of transcription although direct 
evidence has not always been obtained. The butyrate-induced biochemical 
and morphological alterations in HeLa cells are blocked by inhibitors 
of RNA and protein synthesis (Simmons et al., 1975; Fishman et al., 
1975)" Similarly butyrate-treated murine erytholeukemic cells and 
chick myoblasts accumulate new unique-sequence RNA transcripts and 
proteins (Reeves and Cserjesi, 1979; Fishman et al., 1980; Mintz 
et al., 1981). It would appear that butyrate acts by potentiating 
or initiating events which lead to these alterations in transcription 
and gene expression. This suggestion is based on studies of the effect 
of butyrate on chromatin structure and cell cycle progression. Butyrate 
effectively inhibits DNA synthesis and arrests cells in late G1 phase, 
close to the GI/S boundary (Hagopian et al., 1977; Fallon and Cox, 
1979; D'Anna et al., 1980). Concomitantly butyrate also induces 
massive hyperacetylation of core histones, in particular H3 and H4, and 
also causes dephosphorylation of H1 and H2A (Vidali et al., 1978; 
Sealy and Chalkley, 1978; D'Anna et al., 1980). It is not clear 
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whether the effects of butyrate on cell cycle progression are a 
cause or a consequence of these histone modifications; H1 phosphorylation 
in particular is required for the 02 to M transition and also for entry 
into S phase. However it is known that butyrate inhibits the enzyme 
histone deacetylase in vitro (Vidali et al., 1978). By weakening 
electrostatic DNA-histone interactions, these changes in histone 
modification would be expected to favour chromatin dispersal and 
DNA accessibility, potentiating its template functions. In fact 
acetylation 
rapid, sequential, /deacetylation in contiguous arrays of nucleosomes 
has been proposed to perform part of a surveillance mechanism during 
normal cell growth, allowing access for DNA repair and regulatory 
proteins (Perry and Chalky, 1982). 
Direct evidence of changes in chromatin structure has been 
provided by comparing the DN ase I sensitivity of chromatin from 
butyrate-treated and untreated cells (Vidali et al., 1978). Chromatin 
from butyrate-treated cells was more sensitive to nuclease digestion 
(a property of transcriptionallly competent or active chromatin, see 
above), which is consistent with the idea that butyrate increases or 
potentiates transcription. Although there appears to be some 
correlation between histone hyperacetylation, increased DNase I 
sensitivity and increased RNA synthesis (Davie and Candido, 1980; 
Dobson and Ingram, 1980), histone modification Per se is not sufficient 
to allow gene activation and transcription (Weisbrod, 1982a). In 
addition, whereas butyrate-induced histone acetylation and inhibition 
of DNA synthesis occur rapidly, and are maximal within 6-12h, changes 
in gene expression occur over a longer time scale of 24h or more. 
Therefore the effects of butyrate on gene expression must also involve 
other mechanisms which have yet to be identified. 
ii) The effects of BrdUrd on gene expression 
Incorporation of the thymidine analogue BrdUrd into cellular DNA 
13 
affects the expression of differentiated functions in a variety of 
cells. Treatment of cells with low concentrations of BrdUrd increases 
the synthesis of various enzymes and proteins such as glucose-6- 
phosphate dehydrogenase and prolactin in rat pituitary tumour cells 
(Bick and Soffer 1976; Biswas et al., 1977). BrdUrd and other 
halogenated pyrimidines also induce endogenous RNA and DNA tumour 
viruses (Besmer et al., 1975; Hampar et al., 1972). In constrast, 
BrdUrd inhibits differentiation in rat exocrine pancreas and DMSO 
induced murine erytholeukemic cells (Walther et al., 1974; Ashman and 
Davidson, 1980). All of these effects are reversed or prevented by 
the addition of thymidine which blocks incorporation of the analogue 
into DNA. However some of the effects of BrdUrd do not appear to 
depend upon its incorporation into DNA, for example the suppression of 
pigmentation in hamster melanoma cells (Davidson and Kaufman, 1977). 
This suppression can be reversed by the addition of deoxycytidine without 
reducing the amount of BrdUrd substituted into DNA. High concentrations 
of BrdUrd are known to inhibit the enzyme ribonucleotide reductase, 
therefore it could be that this effect of BrdUrd is due to its 
cy toxicity. However suppression of melanin synthesis in BrdUrd- 
treated murine melanoma cells has been shown to be accompanied by 
new mRNA and protein synthesis and is therefore not purely an- 
inhibitory effect (Price, 1976). 
The mode of action of BrdUrd is not understood, although its 
substitution into DNA is known to increase the thermostability of 
chromatin and the binding affinities of chromosomal proteins 
(Lapeyre and Bekhor, 1974; Gordon et al., 1976; Schwartz, 1977). 
It has therefore been suggested that BrdUrd affects transcription by 
altering chromatin structure and perturbing the regulatory functions 
of chromosomal proteins. BrdUrd incorporation would be expected to 
promote chromatin condensation and antagonise the effects of agents 
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such as butyrate and DMSO which relax chromatin structure and 
are potent inducers of differentiation. This could account for 
some of the inhibitory effects of BrdUrd. However, as with butyrate, 
gross perturbation of chromatin structure is an unlikely explanation 
for the selective effects which these agents have on gene expression. 
Both agents undoubtedly affect the other cellular functions which 
could equally be involved in mediating their effects; firstly the 
butyrate-induced alterations in chromatin structure are not the 
direct cause of changes in gene expression and secondly, BrdUrd can 
affect transcription without being incorporated into DNA. Nonetheless 
butyrate and BrdUrd are useful tools for modulating gene expression 
and their use in studying the regulation of IFN synthesis is discussed 
below. 
f) Summary 
It would appear that control of transcription provides the most 
frequent (and fundamental) means of regulating eukaryotic gene 
expression. At present however, information is limited to a small 
fraction of the genes which are being expressed by a cell. A typical 
animal cell contains greater than 105 mRNA molecules (Davidson and 
Britten, 1979). Genes coding for abundant mRNAs such as globin and 
ovalbumin, which are present at more than 104 mRNA molecules/cell, 
have until recently been the major source of information about control 
of gene expression. Although genes coding for moderately abundant 
mRNAs (represented by a few hundred mRNA molecules/cell) have now 
been shown to be transcriptionally controlled (Dermann et al., 
1981), the expression of genes represented by low abundance mRNAs 
(only 1 to several copies/cell) has not been investigated. One 
possible exception to this is the dihydrofolate reductase gene whose 
expression became accessible to study only after a 500-fold 
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amplification of gene copy number by methotrexate (Leys and Keliens, 
1981). The finding that the dihydrofolate reductase gene was controlled 
post-transcriptionally leads to the speculation that other genes are 
controlled in this way. Indeed the significant difference between 
mRNA and hnRNA sequence complexity would suggest that a large number 
of genes are transcribed but not expressed. Therefore regulation of 
gene expression at levels other than transcription may play a more 
important role than appears at present. 
To conclude, there is considerable scope for study of eukaryotic 
gene expression. Only by comparing the control of expression of a 
variety of genes, which are expressed in different cell-types and 
different circumstances, can a representative view of eukaryotic 
regulation be obtained. 
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Section 1.2 IFN gene expression. 
a) Preamble 
Interferon (IFN) is the collective name given to a group of 
functionally related proteins which are produced by cells in response 
to a variety of (seemingly unrelated) stimuli. These stimuli include 
viruses, natural and synthetic polynucleotides and, in the case of 
cells from the immune system, mitogens and specific antigens. Binding 
of IFN to responsive cells induces resistance to virus infection 
(the antiviral state) and also initiates a number of alterations in 
cell structure and function. 
The IFNs produced by different combinations of inducer and 
cell-type are antigenically distinct. At present human and mouse 
IFNs are classified on the basis of their antigenic specificities 
(Committee on interferon nomenclature, 1980) into three main types, 
these; being i) IFN-w(formerly called type I or leukocyte IFN) which 
is the major product induced in leukocytes by virus infection, 
2) IFN-f3 (formerly called type I or fibroblast IFN) which is 
produced predo. minantly by virus infected fibroblasts, and 3) IFN- Y 
(originally type II or immune IFN) which is induced in lymphocytes 
by mitogen or antigen stimulation (reviewed by Stewart, 1979; 
Epstein, 1981). 
Although cells may produce predominantly one type of IFN, often 
small quantities of another IFN type are also induced. Thus IFN 
induced in fibroblasts by NDV infection contains not only IFN-13 but 
also up to 20% IFN-oc(Hayes et al., 1979)" Similarly, virus induced 
human B-lymphoblastoid cells, the subject of this thesis, are reported 
to produce a mixture of both IFN- "and IFN fl(Havell et al., 1977). 
It is unlikely (but as yet not proven) that IFN- 
öis present in 
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virus induced IFN mixtures since the inducers and kinetics of 
induction of IFN- Ware very different to those of IFN-a(and IFN p 
(reviewed by Epstein, 1981). In addition, the gene coding for 
human IFN- ' is structurally unrelated to the human IFN-o&and IFN 19 
genes which themselves show significant homology in both coding and 
flanking regions (Gray and Goeddell, 1982). It would appear that 
despite showing similar biological properties, the control of 
induction and expression of IFN-ý and the IFN-o(/IFN-/3family are 
completely different. For these reasons this introduction will be 
restricted to the human IFN-oc. and IFN /3 gene family. Before 
discussing these genes and their expression, it would be useful to 
briefly consider some of the biological and physicochemical properties 
of human IFN-cc and IFN 13 to put into context the information in the 
remainder of this section. 
The purification and characterisation of human IFNs from virus 
induced cells has clearly indicated that cells produce extremely 
small quantities of IFN. For example, only 1 ug of IFN-o(was 
obtained by induction of leukocytes from 2 litres of human blood. 
(Rubenstein et al., 1979). Such purified preparations of IFN-al and 
IFN f3 have been found to have very high specific activities, in the 
order of 2x 108 units/mg of protein (Rubenstein et al., 1979; Zoom 
et al., 1979; Knight, 1976), where 1 unit is defined as the quantity 
of IFN which reduces virus replication by 50% in a specified assay. 
IFN-ocand IFN-/3 activities have been found to be resistant to low 
pH conditions and (to varying extent) SDS and reducing agents such 
as /3- mercaptoethanol. This has allowed their characterisation by 
polyacrylamide gel electrophoresis. IFN-c<preparations show 
considerable size heterogeneity composed of molecules with apparent 
molecular weights ranging from 15,000-22,000 (Reviewed by Stewart, 
1979). This heterogeneity was originally attributed to varying degrees 
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of glycosylation or post-translational modification. However, it 
is now clear, from gene cloning and amino acid sequencing (see 
below), that human IFN-o(is composed of a family of structurally 
related proteins, all of which are equivalent in size and apparently 
non-glycosylated. The heterogeneity seen on polyacrylamide gels 
must presumably be artifactual. Surprisingly though, electrophoresis 
indicated differences in the composition of IFN-o(preparations from 
human leukocytes and lymphoblastoid cells (Pickering et al., 1980). 
To accommodate these (as yet undefined) differences, IFN-o(mixtures 
are also described by their cell-type of origin (lymphoblastoid, 
Ly; leukocyte, Le. Interferon committee on nomenclature, 1980). 
IFN 13 is more homogeneous in size than IFN-oc, with an apparent 
molecular weight of 20,000 on polyacrylamide gels (Knight et al., 
1980). This is consistent with the fact that only a single human 
IFN-/3 gene and protein have been found (see below). 
Human IFN- . and IFN 15 can be distinguished not only by their 
antigenic specificity but also by their biological activity in cells 
from another species. IFNs in general are species-specific in their 
action, and indeed human IFN . has virtually undetectable cross- 
species activity. IF2%'- « however, shows significant antiviral and 
growth inhibitory activity in bovinet murine, and feline cell 
lines (reviewed by Stewart, 1979)" 
The diversity of biological effects which have been attributed 
to purified IFN, An vivo and in vitro, suggest that it may play 
an important regulatory role. A detailed account of the range of 
effects and mechanism of action of IFN would be inappropriate here. 
However, from the point of view of defining the context in which 
IFN is normally expressed, the proposed regulatory functions of IFN 
can be summarised as follows. i) IFN has been shown to inhibit 
virus replication, inhibit normal and transformed cell growth, 
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cause changes in cell surface properties and cellular morphology, 
inhibit antibody production, and enhance surface antigen expression 
and natural killer cell recruitment (reviewed by Taylor-Papadimitriou, 
1980). In an attempt to rationalise these varied effects it has 
been proposed that IFN acts as an effector molecule which is 
involved in host-defence mechanisms and immunologic surveillance. 
Thus IFN would be produced in response to a number of antigenic 
stimuli (for example viruses) and el icits a number of responses 
which limit or remove the foreign antigen. 
ii) It has also been suggested that the growth inhibitory effect of 
IFN might be involved in the regulation of cell growth and differentiation. 
This is based largely on indirect evidence indicating that mechanisms 
involved in mediating the biological effects of IFN (reviewed by 
Baglioni, 1979; Lengyel, 1981; 1982) may also be involved in 
controlling cell growth during normal proliferation or differentiation 
(Stark et al., 1979; Kimchi et al., 1981). It is proposed that IFN 
is released by cells upon reaching confluence or at the onset of 
differentiation, preventing further cell divisions. 
Consequently, at present no clear definition of the role of IFN 
can be made. Consideration of the control of IFN gene expression is 
therefore restricted largely to a description of model in vitro 
systems.. Recently our knowledge of the IFNs has been considerably 
advanced by the cloning of the human IFN genes. The remainder of 
this section reviews our current understanding of the human IFN-e{ 
and IFN /3 genes and the regulation of their expression in vitro. 
b) The human IFN- c( and IFN- genes and their expression 
The cloning of multiple IFN genes from human cDNA and genomic 
DNA, using recombinant DNA techniques, has indicated that IFN- w' and 
IFN /3 belong to a family of proteins whose genes are structurally 
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related. IFN-o(consists of a family of 15 or more genes, a large 
number of which are known to be expressed. Only a single more 
distantly related IFN 13 gene 
6. 
has been positively identified so far. 
The human IFN-o(family 
Cloned cDNA sequences compl. eo»entary to human IFN-o(mRNA were 
first isolated by two independant groups from cDNA libraries prepared 
from leukocytes and a myeloblastoid cell line, both of which are 
predominantly IFN- ( producers (Nagata et al., 1980a; Goeddell et al., 
1980a). It was not long before it became apparent that these cDNA 
libraries contained several IFN-o(related sequences. Restriction 
enzyme analysis and nucleotide sequencing indicated that at least 
8 distinct IFN. (cDNAs were present in the library from the myeloblastoid 
cell line, these were classified as Le IFN-A to Le IFN-H by the 
group concerned (Goeddell et al., 1981). The nucleotide and- 
predicted amino acid sequences indicated that these IFNs were closely 
related. Homology at the nucleotide level varied from 84-94% in the 
coding regions of the genes. This complexity of the IFN-o(family was 
confirmed when no less than 8 IFN- « related genes, classified as 
IFN-ccl to IFN- c(8, were detected in a gene bank constructed from 
human chromosomal DNA (Nagata et al., 1980b). Most of these genomic 
sequences have been correlated with the cDNA sequences (Goeddell et 
al., 1981), although small differences in sequence suggest that many 
may be in fact allelic varients. This means that the different 
nomenclature of the two groups can be partly reconciled (see Table 
1). To date 13 non-allelic human IFN-°c genes have been positively 
identified, together with 9 allelic varients and 6 pseudogenes 
which show varying degrees of homology to the potentially 
functional 
IFN-clgenes sequence (Weissmann et al., 1982; Brack et al., 1982, 
Lawn et al., 1981b). In addition further weakly 
hybridising but as 
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Table I. The nomenclature used to describe the closely related IFN-o< 
genes, correlated on the basis of nucleotide sequence data 
( reproduced from Weigsmann et al., 1982 ). 
not correlated 
IFN- a1 =' I i-D 
IFN-« 2= IFN-A 
a) IRR-« 3 = IRR-F 
IFN-ac 5= IFN-G 
IMI-« 6v ITN-K 
IIII-C( 7 IFN-J 
IFN-ý. 8 IFi1-B 
IFN-. t 4 IFN-C 
IIII-I 
= means identical '= means allelic or very similar 
a) this designation was assigned to the protein sequence of 
Zoon et al., 1980, only IFN-F has been sequenced. 
yet uncharacterised sequences have been reported. Several of the DNA 
segments carrying IFN- c related sequences overlap, indicating that 
at least 3 strongly hybridizing and 3 weakly hybridizing genes are 
linked. This suggests that the IFN- « genes may be clustered (Brack 
et al., 1982), and since all of the IFN- ° genes have been located 
on chromosome 9 using hybridization of specific probes with genomic 
DNA from mouse-human cell hybrids carrying human chromosome 9 this 
may be the case (Owerbach et al. t 1981). 
All of the IFN- c(gene sequences, with the exception of IFN- a2 
(LeIFN-A) contain a 567 nucleotide coding sequence. By aligning the 
predicted amino acid sequences with NH2-terminal sequences from 
mature IFN- ° (Le) and (Ly) (Zoon et al., 1980; Allen and Fantes, 
1980; Levy et al., 1980) it was shown that this could code for a 
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putative preIFN consisting of 166 amino acids with a 23 amino acid 
signal sequence characteristic of most secretory proteins (Mantei 
et al., 1980; Goeddell et al., 1980a). Cleavage of the signal 
peptide would give rise to a mature IFN with a calculated molecular 
weight of 19,390 which agrees closely with the size of purified 
IFN- d(Ly) estimated from polyacrylamide gel analysis (Allen and 
Fantes, 1980). 
One surprising feature of the IFN- o( genes is that they contain 
no introns. Comparison of cDNA and genomic sequences and R-loop 
mapping showed that neither the coding or flanking regions possess 
intervening sequences (Nagata et al., 1980b; Lawn et al., 1981b; 
Brack et al., 1982). Other features of the IFN genes resemble those 
described for other structural genes. Sequence motifs resembling 
the consensus Goldberg-Hogness transcription signal (Goldberg, 1979) 
are found approximately 30 nucleotides upstream from the mRNA cap site. 
The protein coding sequence is preceded by a 70 nucleotide 5' non- 
coding region (Nagata et al., 1980b) and followed by 242-442 
nucleotides of 3'untranslated sequence (Goeddell et al., 1981). 
At least 10 of the 13 authentic, non-allelic IFN-a(genes are 
-- , potentially functional and probably expressed in cells since they 
produce active IFN when translated in E. cola (Nagata et al., 1980b), 
or are represented in cDNA libraries (Goedell., et al., 1981). 
Several investigators have reported heterogeneity of IFNmRNA in 
cellular poly(A)+RNA from induced Namalwa (lymphoblastoid) cells 
which could partly be accounted for by the multiplicity of IFN 
genes (Berger et al., 1980; Sagar et al., 1981; Sehgal et al., 
1981a, 1981b). Most of the IFN- a mRNA was around 1.3Kb in size, 
the predicted size for a mature poly (A) tailed mRNA transcribed 
from the genes described above. However larger transcripts from 
23 
1.8-3.5 Kb in size were detected in both lymphoblastoid cells and 
leukocytes which did not hybridize with any of the IFN-a genes already 
cloned, even though they were translated into proteins characterised 
as IFN- by biological activity and neutralisation by anti-IFN-c< 
sera. The significance of these transcripts will not be established 
until they have been fully characterised. 
There is now a large amount of evidence indicating that cells 
do produce a mixture of IFN-°cproteins, apart from the potentially 
artifactual data obtained from polyacrylamide gel electrophoresis. 
The NH2-terminal amino acid sequence of one of several leukocyte 
IFN- -X components resolved by reverse flow high performance liquid 
chromatography (Rubenstein et al., 1979; Levy et al., 1980) has 
close homology with the predicted NH2-terminal sequence of cloned 
IFN-°42. Similar data (Zoon et al., 1980) shows homology between 
the major component of Namalwa (lymphoblastoid) IFN-oeand cloned 
IFN-o(3. At least 5 distinct, related polypeptides have been 
distinguished in Namalwa IFN- c by sequencing of tryptic and 
chymotryptic peptides (Allen and Fantes, 1980). Two of these show 
homology to, and have the same amino acid deletion at positions 44, 
as IFN-ßc2. There are also similarities between the remaining 3 
components and IFN- a 1, although additional species may be involved. 
This clearly demonstrates expression of multiple IFN-o(species, but 
also suggests that different cell-types (and inducers) may 
preferentially express different mixtures of IFN-o<proteins, an 
idea supported by the frequency of IFNcDNA species found in libraries 
from different cell types (Nagata et al., 1980b; Goeddell et al., 1981). 
It seems unlikely that any of these IFN-o(proteins are glycosylated 
since no sequence of the type Asn-X-(Ser or Thr), which is required 
for N-glycosidic linkage, occurred in any of the tryptic or 
chymotryptic peptides prepared from Namalwa IFN- a 
(Allen and Fantes, 
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1980). Furthermore this IFN had a very low amino sugar content, 
althoughneither observation eliminates the possibility of 0-linked 
glycosylation or glycosylation of minor components. 
The biological and physicochemical properties of several of 
the cloned IFN- a gene products expressed in E coli have been 
compared with natural HuIFN- cK(Le) and have been shown to share all 
of the characteristics attributed to IFN- a. Cloned IFN-o(induced 
virus resistance in_vivo. and in vitro, inhibited cell proliferation, 
modulated various immune responses, was neutralised by anti-IFN-O 
and was stable at pH2 (Goeddell et al., 
1980a; Massuci et al., 1980). Another significant finding was 
that the individual cloned IFN-ecspecies differed in their anti- 
viral activity in various heterologous cells (Streuli et al., 1981; 
Weck et al., 1981). 
The high heterospecific activity of IFN- a species, particularly 
in bovine cells varied over an order of magnitude. This behaviour 
was predicted by the characterisation of polyacrylamide gel fractions 
of natural IFN- « mixtures when it was found that the fastest migrating 
components of IFN- « (Le) were significantly more active in bovine 
cells than in human cells (Stewart II et al., 1975). In fact cloned 
IFN- « 1, the species with the highest ratio of activity in bovine 
compared to human cells, comigrated with the leading edge of IFN-cc 
(Le) in polyacrylamide gel and had a similar molecular weight 
(18-19,000) and chemical properties (Stewart II., 1980). In 
conclusion it can be said that the multiplicity of human IFN-°c 
genes is reflected in, and confirmed by, the expression of a 
family of IFN-o(proteins. The E. c_synthesised cloned proteins 
have all of the structural, physiochemical and biological 
properties of natural IFN- oc. 
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The human IFN-/3 gene 
The cloning of IFN-/3 cDNA from cDNA libraries prepared from 
poly(rI). poly(rC)-induced fibroblasts was reported by several 
independent groups shortly after the first isolation of IFN- a 
cDNA clones (Taniguchi et al., 1980a; Goeddell et al., 1980b; 
Derynck et al., 1980; Houghton et al., 1980). Comparison of its 
coding sequence with that of IFN-o(1 showed that in fact IFN-ocand 
IFN-13 were structurally related (Taniguchi et al., 1980b), with 
approximately 45% homology at the nucleotide level and 29% at the 
amino acid level. This indicated that IFN genes were most probably 
derived from a common ancestor. 
Direct restriction analysis of the human genome using this IFN-/3 
cDNA revealed that only a single IFN /3 gene was present (Tavernier 
et al., 1981). The cloned IFN-113 gene resembled IFN-t<genes in several 
of its structural features. Firstly, neither the coding or 
untranslated sequences contained introns (Degrave et al., 1981). 
Secondly, the coding region gave a predicted pre-IFN /3 protein 187 
amino acids in length which when aligned with NH2-terminal sequence 
data for mature IFN-/3 , indicated that the IFN-/3 protein was 166 amino 
acids in length, the remaining 21 amino acids forming the signal 
sequence (Knight et al., 1980; Derynck et al., 1980). Therefore the 
mature IFN-y3 polypeptide is of the same size (approximately 19,000) as 
IFN- oc. However unlike IFN- a, IFN is most probably a glycoprotein, 
as was previously suggested (Tan et al., 1979), since its predicted 
amino acid sequence includes at least one Asp-X - 
(Ser or Thr) 
N-glycosidic linkage site. The predicted amino acid sequence from all 
of the IFN-/3 cDNA and genomic clones and the published NH2-terminal 
sequence of fibroblast produced IFN /3 were all in close agreement, 
which strongly suggested that only a single IFN-ß was present in 
the 
human genome. A second IFN-/J cDNA was thought to have been isolated 
from 
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a mRNA which apparently showed IFN mRNA activity (Weissenbach et al., 
1980). ThisrcDNA did not hybridize with the existing IFN 13 cDNA, 
and no further characterisation has been reported. Other groups have 
failed to detect the mRNA used to construct this cDNA (Content et al., 
1982). 
Further similarities between IFN /fand IFN- al genes occur in 
their 5' flanking regions. In addition to the Goldberg-Hogness box 
at position -31 other consensus sequences appear further upstream 
from the cap-site (Degrave et al., 1981). Two of these motifs are 
similar to those found in other genes and one in particular occurs 
only in inducible genes (Benoist et al., 1980). The significance of 
these sequences for expression of IFN genes will obviously require 
further investigation. However, if such 5' flanking sequences are 
involved in regulating transcription then IFN- a and IFN 13 genes would 
conceivably show homologies in those regions since they respond to 
the same inducer (see part C below). The IFN /3 gene as with the IFN-a 
gene family, is located on chromosome 9 (Meager et al., 1979a; Owerbach 
et al., 1981), although it is not known how closely the genes are 
organised. 
. Further evidence that only a single IFN gene is present and 
expressed in human cells is provided by reports that IFN 13 mRNA 
consists of a discrete population of molecules around 1.1 Kb in 
size (Raj and Pitha; Gross et al., 1982). However it has been 
suggested that no less than 5 IFN /3 mRNAs can be detected under 
certain circumstances (Sehgal et al., 1981a). Two size classes of 
IFN 13 mRNA were found in poly(rI). poly (rC) induced fibroblasts 
(Sehgal and Sagar, 1980). Although the IFN activity translated from 
both classes of mRNA was neutralised by anti-IFN 
/3 serum, the larger 
transcripts did not cross-hybridize with the established IFN /3 sequence. 
Further investigation using somatic-cell hybrid analysis located 4 
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of the 5 putative IFN-ý3 genes to human chromosomes 2,5 and 9 (Sehgal 
et al., 1981a). These assignments are interesting since originally 
chromosomes 2 and 5 were implicated as being required for human IFN 
production (Tan et al., 1974). These results are perplexing since 
as with the large IFN-oCtranscripts (Sehgal et al., 1981b) it is 
difficult to reconcile the fact that these additional genes appear 
to show little sequence homology, while their proteins share antigenic 
characteristics with authentic IFN _. This could only be accounted 
for by the presence of structurally unrelated genes (or perhaps 
related genes with introns) which code for proteins with structural 
features similar to IFN-"c and IFN . If this is the case then their 
classification as IFN-off and IFN-13 is debatable. 
To conclude, IFN-ocand IFN -/3 form a structurally related multigene 
family which codes for a group of proteins which share many biological 
and physicochemical properties. 
c) The regulation of human IFN-ocand IFN /3 gene expression 
The study of IFN-o( and IFN /3 gene expression in cultured human 
cells has shown that IFN synthesis is tightly regulated. Virus 
induction of cells results in a brief period of de novo IFN synthesis 
usually lasting only a few hours. This is followed by the rapid 
decline and shut-off of IFN synthesis. It would appear that the 
IFN genes are available for transcription (in the presence of inducer) 
in most cell-lines, although the IFN- a and IFN -yC genes are differentially 
expressed in different cell-lines and with different inducers. There 
is some evidence to suggest that the mouse IFN genes are in a non- 
inducible or non-transcribable state in mouse teratocarcinoma cells 
and early mouse embryo tissues (Burke et al., 1978; 
Barlow, 1981). 
Virus infection failed to induce IFN synthesis in these cells. However, 
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similar information is not available for human cells. 
Constitutive or "spontaneous" IFN production has been described 
in several lymphoblastoid cell-lines (Adams et al., 1975; Pickering 
et al., 1980). Although a number of these lines carry Epstein-Barr 
virus (EBV), no correlation was found between expression of EBV antigens 
and constitutive IFN production (Tovey et al., 1977; see also section 
1.3). The IFN was neutralised by anti-IFN-« but did not show the 
characteristic size heterogeneity of induced IFN-a mixtures (Pickering 
et al., 1980). These cell lines respond normally to induction by 
producing increased levels of, IFN, therefore the normal induction- 
regulation mechanisms are functional. Constitutive IFN synthesis 
could be an indication of "leaky" regulatory mutants or the presence 
of unidentified inducing stimuli. Alternatively, perhaps some or all 
cells constitutively express low levels of IFN as suggested by the 
"Basal-level IFN hypothesis" (see below). 
Induction of IFN synthesis 
Information about the inducer and mechanism of induction of 
IFN- a and IFN ,3 synthesis remains almost anecdotal, belying the fact 
that over 20 years of intensive research has been directed towards 
describing these aspects of the IFN system. One of the problems has 
been the diversity of stimuli which initiate IFN synthesis, no 
common inducer or sequence of events can be identified. 
visas 
Reprsentatives.. of every major^family can induce IFN in human 
cells (Stewart II, 1979). These include single-stranded RNA, double- 
stranded RNA and DNA viruses. The effectiveness of individual viruses 
can vary depending on the strain of virus and the cell-type, 
however 
several viruses have emerged as being particularly good 
inducers 
of IFN synthesis in a variety of cell-types, notably paramyxoviruses 
such as Newcastle disease virus (NDV) and Sendai virus 
(Ho et al., 1970; 
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Gresser, 1961). In describing a virus as an inducer of IFN synthesis 
it should be remembered that any one of the events involved in its 
replication is potentially capable of providing the stimulus although 
adsorption, penetration and uncoating can be eliminated since 
infectious viral RNA alone is sufficient to induce IFN. The intrinsic 
ability of any of the remaining events to initiate IFN synthesis can 
be masked by the effects of virus replication on cellular macromolecular 
synthesis. Consideration such as these have made it difficult to 
define the nature of the proximate inducer of IFN synthesis. 
Several synthetic inducers have been used to study the induction 
of IFN synthesis. By far the best (and most extensively studied) 
is the double-stranded polynucleotide, polyriboinosinic acid, 
polyribocytodylic acid or poly(rI). poly(rC). (Field et al., 1968). 
The discovery that it induces IFN synthesis prompted suggestions 
that double-stranded RNA was in fact the proximate inducer, since 
many viruses form double-stranded RNA during replication. Unfortunately 
research into the structural requirements of such a molecule for IFN 
induction failed to confirm a unique role for double-stranded RNA. 
For example, certain double-stranded polynucleotides were inactive, 
while single-stranded non-replicating viruses and poly(rI) could induce 
IFN (Torrence et al., 1975; Dianzani et al., 1974; Thang et al., 1977). 
Consequently no universal model can be proposed for the structure of 
the molecule which "triggers" IFN synthesis. 
The induction mechanism 
The initial interaction of the inducer with cells is followed by 
a lag period before the appearance of IFNmRNA or IFN. This lag or 
induction phase can vary depending on the combination of cell-type 
and inducer. For example human diploid fibroblasts 
induced by 
poly(rI). poly(rC) show a short 1-2h lag but NDV 
induction results 
in an 8h lag before the IFN production phase 
(Mozes and Vilcek, 1975). 
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The induction mechanism can therefore be considered to include all 
of the events which occur between the primary inducer-cell interaction 
and the eventual transcription and synthesis of IFNmRNA, and most 
likely consists of a sequential multi-step process. 
Numerous mechanisms have been proposed to explain the events 
which give rise to IFN synthesis, but basically only three hypotheses 
can be considered to retain some credibility: 
i) "The double-stranded RNA hypothesis" is an attempt to describe a 
unifying mechanism whereby double-stranded RNA, in the form of virus 
replicative intermediate or synthetic polynucleotides, triggers a 
sequence of events which initiate IFN synthesis. Indeed several lines 
of evidence indicate that early virus functions are required. For 
example IN-inactivation of NDV first causes loss of infectivity, then 
at higher doses, loss of polymerase activity. The capacity to induce 
IFN was destroyed in parallel with the loss of polymerase activity, 
suggesting that viral RNA synthesis and the formation of double-stranded 
replicative intermediates was required (Meager et al., 1972). 
Unfortunately, there is an equal amount of evidence arguing against 
the involvement of double-stranded RNA, for example the induction of 
IFN synthesis by single-stranded viral and synthetic RNA (see above). 
The wealth of evidence for and against this hypothesis is reviewed 
extensively by Stewart, (1979), 
ii) "The repressor-depletion hypothesis" was formulated to explain 
the observation that cycloheximide and other reversible inhibitors 
of macromolecular synthesis could induce IFN synthesis (Tan and 
Berthold, 1977). The ability of the inducer to initiate IFN synthesis 
was suggested to be due to inhibition of synthesis of a short-half life 
repressor molecule which normally repressed IFN gene activity. Indeed, 
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many viruses and double-stranded RNA do depress cellular macro molecular 
synthesis but conversely several effective inducers do not. 
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iii) "The basal-level IFN hypothesis" is related to the repressor 
depletion hypothesis and suggests that the repressor is in fact IFN 
which is synthesised constitutively at a low level. Evidence in 
support of this idea comes from the surprising observation that IFN 
is bound selectively to both poly(rI) and poly(rU) immobilized on 
columns (De Maeyer-Guignard et al., 1977). The selective binding of 
basal-levels of IFN by virus input RNA replicative intermediates or 
synthetic polynucleotides would then remove the repression from the 
IFN genes. Further support for this hypothesis has not been put 
forward. 
In-, conclusion there is no all inclusive explanation to account 
for the variety of information on IFN induction. Whatever the 
mechanism, induction causes the increased synthesis of both IFNmRNA 
and IFN9 since various studies have shown that synthesis of IFN can be 
prevented by addition of actinomycin D (an irreversible inhibitor of 
DNA dependant RNA polymerases) during the induction phase or by 
addition of cycloheximide (which inhibits protein synthesis) during 
the production phase. The requirement for RNA synthesis was taken 
as an indication that induction results in the derepression of the 
IFN genes. Although this assumption is probably correct, to date 
there is no direct evidence that induction causes an increase in 
transcription as opposed to an increase in IFNmRNA processing. 
The control of IFN production 
In most cells the induction phase is followed 
by the appearance 
and rapid accumulation of IFN. After a relatively short period the 
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rate of IFN synthesis reaches a maximum then rapidly declines to 
undetectable levels. This shut-off of IFN synthesis occurs even 
in the continued presence of inducer. By far the most intensively 
studied model is the production of IFN 
/3 by poly(rI). poly(rC) induced 
fibroblasts, in which IFN production is first detected (in the medium) 
within lh of induction, peaks at 2.5-3h and is shut-off by 6-8h 
(Sehgal et al., 1977). 
Investigations into the regulation of IFN production have made 
use of the effects of inhibitors of RNA and protein synthesis on the 
normal production of IFNmRNA and IFN in poly(rI). poly(rC) induced 
fibroblasts. Inhibition of RNA synthesis by actinomycin D indicated 
that IFNmRNA synthesis commenced shortly before the appearance of 
IFN and was complete by around 3h after induction, judged by the 
effect of the inhibitor-on amounts of IFN produced (Sehgal et al., 
1976; 1977). This suggested that IFN production was controlled at 
the transcriptional (or mRNA processing) level since IFNmRNA synthesis 
after 3h either did not occur or was not required. However, various 
combinations of reversible inhibitors of macromolecular synthesis, 
when added before the shut-off, prolonged IFN synthesis and resulted 
in a paradoxical increase or "superinduction" of IFN synthesis (Vilcek 
and Havell, 1973; Sehgal and Tamm, 1976; Sehgal et al., 1976). Such 
observations have led to the suggestion that a post-transcriptional 
control mechanism, affecting IFNmRNA stability is also involved 
in controlling IFN production. 
i) "Superinduction"of IFN synthesis 
A typical "superinduction" protocol involves poly(rI. poly(rC) 
induction in the presence of cycloheximide. At 4h after induction 
(when IFNmRNA synthesis is complete) RNA synthesis is irreversibly 
inhibited by actinomycin D. then at 5h the cycloheximide block is 
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continues for up to 4 days. 
To investigate the phenomenon poly(A)+RNA from poly(rI). poly(rC) 
induced and "superinduced" cells was extracted at various times after 
induction. The relative amounts of IFNmRNA in these RNA samples was 
estimated by microinjection into Xenopus oocytes and assay of translated 
IFN activity (Sehgal et al., 1977; Cavalieri et al., 1977a). In 
cells induced by poly(rI). poly(rC), translatable IFNmRNA accumulated 
to a maximum by around 2-3h after induction then rapidly decayed with 
an apparent half-life of 18 mins. "Superinduced" cells showed a 
similar accumulation of IFNmRNA, however its functional stability was 
increased, showing an apparent half-life of around 68 mins. The 
increased stability of IFNmRNA was proposed to be the cause of the 
increased production of IFN. 
Although there is some evidence to suggest that "superinduction" 
can alter the period of transcription and the amounts of IFNmRNA 
synthesised, the-rate of accumulation of IFNmRNA is not altered 
(Cavelieri et al., 1977). Increased IFNmRNA stability alone is 
sufficient to explain the increased IFN production, in which case 
"superinduction" should more properly be called "superproduction" 
since the effect is on production rather than induction of IFN 
synthesis. 
ii) The post-transcriptional repressor hypothesis 
Metabolic inhibiters have been observed to produce similar 
effects on the synthesis of a number of other inducible proteins, 
such as steroid induced tyrosine amino transferase. By analogy 
it was suggested that a McAuslan-Tomkins type translational repressor 
(McAuslan, 1963; Tomkins et al., 1972) was involved in the inactivation 
of cytoplasmic IFNmRNA and shut-off of IFN synthesis. All of the 
evidence is consistent with the hypothesis that a repressor mRNA 
34 
and protein, with a short half-life of around 3-4h, is co-ordinately 
induced with IFN and responsible for inactivating IFNmRNA. Firstly, 
both protein and RNA synthesis is required for termination of IFN 
synthesis. Secondly, when RNA and protein synthesis is inhibited 
during the shut-off of IFN synthesis, the decline in IFNmRNA levels 
continues at the same rate for 3-4h then proceeds at a slower rate. 
Thirdly, when RNA synthesis is partially and reversibly inhibited 
by DRB from the time of inductionlincreased IFN production occurs 
after removal of inhibitor despite the fact that IFNmRNA synthesis 
is reduced (Vilcek and Havell, 1973; Sehgal and Tamm, 1976; Sehgal 
et al., 1976). It has been argued that the inactivation of IFNmRNA 
is selective, since its degradation during the shut-off of IFN 
synthesis is not accompanied by a change in the stability of total 
poly(A)+mRNA in the cells (Sehgal and Gupta, 1980 ). Similarly 
i't; was shown that increased IFN 
production in inhibiter-treated cells could not be accounted for 
by reduced - mRNA competition due to the depletion of short half- 
life mRNA (Sehgal and Tamm, 1976). 
Unfortunately "superinduction" has not been demonstrated in 
virus induced cells. This could be due to an effect of the inhibitors 
on virus replication or the formation of the proximate inducer. 
Alternatively, it could be that the induction or regulation of 
IFN production is different in poly(rI). poly(rC) and in virus 
induced cells. If this were the case the validity of poly(rI). 
poly(rC) induced IFN synthesis as a model for studying IFN production 
is questionable. This point is discussed further in section 4. 
To conclude, the "superinduction" of IFN synthesis is consistent 
with the hypothesis that the synthesis of a post-transcriptional repressor 
molecule is reduced in inhibitor-treated cells, resulting in increased 
mRNA stability and a delay in the shut-off of IFN production. 
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However, direct evidence for the specificity of the repressor will rest 
on identification of the molecular mechanisms involved in controlling 
IFNmRNA stability. 
0 
Other observations relating to the control of IFN production 
Two other phenomena which are relevant to a discussion of the 
regulation of IFN synthesis involve the effect of IFN itself on IFN 
production and the responsiveness of cells to induction following 
the shut-off of IFN production. 
i) "Priming" 
Treatment of cells with IFN, or "priming", before induction 
has several effects on the induction and regulation of IFN synthesis. 
These effects have been characterised mostly in mouse cells and can 
be summarised as follows. 1) "Primed" cells produce increased 
amounts of IFN when induced by viruses or poly(rI). poly(rC). 
2) "priming" shortens the lag phase in virus induced cells (but 
not poly(rI). poly(rC) induced cells). 3) The inducer-cell interaction 
appears to be affected since "primed" mouse cells no longer require 
DEAE-dextran treatment to respond to poly(rI). poly(rC). (Stewartll 
1979). "Priming" develops rapidly, within lh of treatment with 
IFN, and does not require protein synthesis. It therefore differs 
from many other IFN induced effects, such as the antiviral state, 
which involve new protein synthesis and require several hours to 
establish. 
There is no clear explanations for the "priming" effect, 
especially as there is conflicting information about the effect on 
IFNmRNA synthesis. In NDV-induced mouse cells "priming" does not 
alter the amount of IFNmRNA synthesised or its rate of synthesis 
and degradation, although both IFNmRNA and IFN appeared 2-4h earlier 
36 
than in "unprimed cells" (Abreu et al., 1979; Content et al., 1980). 
It was therefore suggested that "priming" increased the efficiency of 
IFNmRNA translation. However increased amounts of IFNmRNA are found 
in primed-poly(rI). poly(rC)-induced mouse cells (Fujita et al., 1979) 
and also in primed-poly (rI). poly(rC)-induced human fibroblasts 
(Sehgal and Gupta, 1980). Although it is tempting to speculate that 
"priming" has a functional role, the mechanism of its effect on the 
induction and regulation of IFN synthesis remain unknown. 
ii) The hyporesponsive or refractory state. 
The induction, production and shut-off of IFN synthesis is 
followed (in most cells) by a hyporesonsive period, lasting several 
days, during which time the cells are refractory to a secondary 
induction of IFN synthesis (Stewart, 1979). It is unlikely that 
IFN itself is the direct cause since there is no correlation between 
and 
hyporesponsiveness ý the persistance of IFN mediated effects such as 
the antiviral state. It has been suggested that the hypothetical 
post-transcriptional repressor which is responsible for IFNmRNA 
inactivation persists after the shut-off of IFN synthesis and 
prevents translation of IFN from a secondary induction. Support 
for this idea will require identification of the repressor and its 
period of synthesis. 
Differential expression of human IFN-e(and IFN- genes 
Very little is known about the coordination of IFN-o(and IFN 
gene expression. Both types of IFN gene appear to be available for 
transcription and respond to the same inducer, yet in different cell- 
types and with different inducers either IFN-IX or IFN 
- are 
preferentially expressed. For example, 80-90% of the IFN activity 
produced by the Namalwa lymphoblastoid cell line was characterised 
antigenically as IFN- o(, the remainder as IFN-ß 
(Havell et al., 1977)" 
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The composition of IFN produced by human fibroblasts varies depending 
on the inducer. After poly(rI). poly(rC) induction only IFN -/3 activity 
can be detected, whereas NDV induction results in a mixture of 
approximately 80cä IFN -/13 and 20% IFN-o((Hayes et al., 1979). It is 
: likely that this differential expression is controlled at the 
level of transcription or RNA processing since the IFNmRNA present 
in these cells qualitatively (and possibly quantitatively) reflects 
the type of IFN they express. Thus NDV or Sendai virus induced 
lymphoblastoid cells contain both IFN-o(and IFN f3 mRNA, determined 
both by translation and characterisation of IFN activity in oocytes and 
by nucleic acid hybridization (Cavalieri et al., 1977b; Sagar et al., 
1981; Gross et al., 1981; 1982). The quantitation of translated 
IFN activity showed that the relative proportions of UN-ac and IFN 
mRNA were similar to the IFN-oCand IFN-113 activity expressed by FS24 
cells (Pang et al., 1980) Similarly poly (. rI). poly(rC) induced 
fibroblasts contain only IFN 13 mRNA (Cavalieri et al., 1977b; Raj 
and Pitha, 1981; Sehgal and Sagar, 1980). However, cytoplasmic 
stability could be involved in regulating IFNmRNA levels. 
The obvious implication from these observations is that cell 
phenotype determines which IFN is predominantly expressed, however the 
functional significance of this is not known. 
d) Expression of human IFN genes in heterologous cells 
The introduction of human IFN genes into a heterologous cell 
environment has provided some interesting information about the 
induction and regulation of IFN synthesis. Two experimental approaches 
have been used: 
i) Human-mouse somatic cell hybrids have been constructed. 
The hybrid cells phenotypically resemble the mouse parent because 
of the preferential loss of human chromosomes and retention of mouse 
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chromosomes. Provided that human chromosome 9 is retained these 
hybrid cells can be induced by NDV to produce both human and mouse 
IFNs which can be distinguished by their target cell specificity. 
It was found that the control of human IFN production conformed 
to the dominant mouse parental phenotype. For example the kinetics 
of IFN production are different in each of the parent cells, however 
human IFN production in the hybrid cells was regulated with the 
same kinetics of the mouse parent (Meager et al., 1979b; Graves and 
Meaner 1980). Likewise human IFN production in the hybrid cells 
was no longer "superinducable". However, only human IFN / was 
expressed regardless of whether human fibroblasts (predominantly 
IFN-/3 producers) or human leukocytes (predominantly IFN-ooproducers) 
were fused with the mouse cells (Meager et al., 1979b; Slate and 
Ruddle, 1979). The reasons for this are not apparent. However, 
since the kinetics of IFN production (both human and mouse) were 
e 
dtermined by the dominant mouse phenotype, the induction and 
regulation of IFN production did not primarily involve species- 
specific mechanisms, although human genes other than the IFN genes 
could be utilised. 
ii) The transfer of cloned human IFN genes into mouse cells will 
potentially provide more information about the mechanisms of 
induction and regulation. DNA containing either the human IFN-oil 
or IFN 19 gene coding and flanking regions has been introduced into 
mouse L tk cells by calcium phosphate coprecipitation (Mantei and 
Weissmann, 1982; Ohno and Taniguchi, 1982; Hauser et al., 1982). 
Both of these genes can be induced by NDV and are expressed in 
parallel with mouse IFN, apparently in agreement with the somatic-cell 
hybrid results discussed above. The only evidence for expression of 
the IFN-o(1 gene was the presence of low levels of human IFN-ocl 
i1el 
transcripts induced cells and no human IFN- al activity could be 
A 
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detected. Whether this meant that no IFN- «l was translated or simply 
that synthesis was below the limits of detection is not clear. Because 
of the high cross-reactivity, of human IFN- « with mouse cells it would 
be difficult to distinguish small amounts of activity in the presence 
of mouse IFN. The failure to detect human IFN-olsynthesis in cell 
hybrids and transformed cells could therefore be due either to 
restricted transcription or translation. 
Site directed mutagenesis of cloned genomic IFN DNA and expression 
in surrogate systems such as this will potentially be able to identify 
those regions of the IFN genes which are involved in induction and 
regulation of transcription. These experiments have already provided 
indirect evidence suggesting that induction does in fact increase 
transcription of the IFN genes rather than increase the processing 
and stability of constitutively produced transcripts. Transfer of the 
human IFN- ocl gene into mouse cells resulted in constitutive expression 
of low levels of IFN- o(l transcripts which showed incorrect initiation 
upstream from the normal .' mRNA cap site 
(Mantei and Weissmann 1982). 
NDV induction resulted in a significant increase in correctly initiated 
human IFN-oll mRNA while the level of incorrectly initiated transcripts 
remained the same. It was argued that since the level of incorrectly 
initiated transcripts did not change, IFNmRNA stability was not 
altered during induction and that increased transcription of the 
IFN genes produces the correctly initiated mRNA. This would obviously 
depend on two assumptions; firstly, that correct 5' termini are not 
involved in determining mRNA processing and stability, and secondly 
that the correctly and incorrectly initiated constitutive 
transcripts 
are produced in the same cells. 
e)ý Summary 
It should be clear from the previous sections 
that studies on 
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the regulation of IFN gene expression have provided more questions 
than answers. Although the cloning and characterisation of the 
human IFN-ocand IFN 13 genes has increased our understanding of the 
nature andproperties of this structurally and functionally related 
family of proteins, considerable gaps remain. The mechanisms controlling 
the transcription of these IFN genes and the synthesis, stability and 
translation of their mRNA remain obscure. Expression of the IFN-Cl 
and IFN-/3 genes appearsto be regulated at the transpriptional level 
and control of IFNmRNA stability in the cytoplasm has also been 
implicated in the shut-off of IFN synthesis. 
The availability of an extremely sensitive bioassay and monoclonal 
antibodies for IFN protein, and also cloned DNA probes, overcomes 
many of the disadvantages associated with studying the expression of 
moderately abundant mRNA and protein. No comparable system has yet 
been described, therefore apart from the intrinsic interest, the 
expression of IFN genes in cultured human cells is potentially a 
useful model for studying the expression of eukaryotic genes. 
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Section 1.3 IFN production by Sendai virus-induced Namalwa 
cells: a system for studying the control of 
human UN-oc an. d IFN-/3 gene expression 
Human IFN-o(and IFN 13 production, purification and characterisation 
has essentially involved only three systems: 1) Poly(rI), poly(rC)- 
induced fibroblasts such as the FS-4 line (Havell and Vilcek, 1972), 
2) Sendai virus-induced peripheral blood leukocytes prepared from 
"buffy coats" (Cantell and Hirvonen, 1977) and 3) Sendai virus- 
induced lymphoblastoid cells such as the Namalwa cell line (Strander 
et al., 1975). These systems were chosen either because of their 
convenience or high yields of IFN, both important considerations for 
obtaining large quantities of pure IFN for experimental use. Much of 
the information obtained from these systems has been considered in 
section 1.2; from which it will be apparent that each has several 
important differemces. From the point of view of choosing a system 
to study the regulation of gene expression the following points 
were considered. 
i) IFN-/3 production in poly (rI). poly(rC) induced and "superinduced" 
fibroblasts has been well characterised, and provides the basis for 
most current ideas about the regulation of IFN synthesis. Apart from 
the questionable validity of using an artificial inducer such as 
poly(rI). poly(rC), IFN production in other cell-lines, including 
IFN-e and IFN 13 producers, should be investigated in order to expand 
ideas about the regulation of gene expression. 
ii) Human leukocytes could provide an alternative system to study 
IFN-o(production. However they have several disadvantages. Firstly, 
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they are inconvenient to obtain in large quantities and cannot be 
readily established in culture. Secondly, they consist of a mixed 
population of cells. Therefore leukocytes do not provide a homogeneous, 
reproducable system even though they may be closer to the in vivo 
situation to which all information must eventually be related. 
iii) Lymphoblastoid cell lines, such as Namalwa, provide an attractive 
alternative. They can be grown in culture indefinitely and produce 
high yields of IFN (both IFN- a and IFN /3 ). Furthermore, IFN synthesis 
can be modulated by the use of agents such as butyrate and BrdUrd (see 
section 1.1). For these reasons Sendai virus-induced Namalwa cells 
were chosen to study the control of IFN gene expression. The 
remainder of this section considers some of the characteristics of 
this system and the question it provides. 
Namalwa cells 
Rlamalwa cells are an Epstein-Barr virus (EBV) transformed, human 
B-lymphoblastoid cell line which was derived from a patient with 
Burkitts lymphoma (Klein et al., 1972). The value of Namalwa cells 
as a source of human IFN was realised when they we1e shown to produce 
high levels of IFN after induction by Sendai virus (Strander et al., 
1975)" Various B-lymphoblastoid cell lines, established either 
from patients with EBV-related diseases (such as Burkitt's lymphoma 
and nasopharyngeal carcinoma) or by in vitro transformation of 
leukocytes with EBV, have been examined for IFN production. While 
most of these cell lines could be induced to produce IFN, the ability 
to produce high yields of IFN was not a general property 
(Stranden 
et al., 1975; Christofins et al., 1981). 
IFN production in these transformed cells does not appear to be 
affected by the resident EBV DNA. All EBV transformed cell-lines 
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express Epstein-Barr nuclear antigen, but the expression of other 
virus coded products such as early antigen (EA) and virus capsid 
antigen (VCA) is normally repressed. These markers can be induced 
in some latently infected B-lymphoblastoid lines by halogenated 
pyrimidines, butyrate and the tumour promoter phorbol myristate acetate 
(Saeraundsen et al., 1980; Klein and Vilcek, 1980). No relationship 
was found between the induction of EBV markers and the production 
of IFN. In any case, Namalwa cells only carry 2 incomplete copies of 
the EBV genome, and neither EA or VCA can be detected before or after 
treatment with butyrate or BrdUrd (Pritchett et al., 1976; Tovey et al., 
1977; Klein and Vilcek, 1980). 
Namalwa and several other lymphoblastoid cell-lines have been 
reported to produce IFN constitutively when cultured at high densities 
of around 107 cells/ml (Adams et al., 1975; Tovey et al., 1977. 
see also section 1.2). Other groups have failed to detect constitutive 
IFN synthesis in exponentially growing Namalwa cells (Pickering et al., 
1980; fRossier and Weideli, 1982). Whether this reflects differences 
in culture conditions or drift in the properties of different Namalwa 
stocks is not clear. However it is clear that normal regulatory 
mechanisms are functional, since virus induction results in a transient 
increase in IFN production in all Namalwa cells. 
Sendai virus 
Several viruses have been shown to induce IFN synthesis in 
Namalwa cells, but paramyxoviruses such as Sendai virus are 
particularly effective (Strander et al., 1975" see also section 1.2). 
Sendai virus is a non-segmented, negative-stranded RNA virus. Its 
5x 106 molecular weight genome codes for 5 structural polypeptides 
(Scheid and Choppin, 1974) with the following functions. 1) The 
virus RNA polymerase complex (p), 2) the haemagglutination/ 
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neuraminidase glycoprotein (HN), 3) the precursor fusion glycoprotein 
Fo which is processed to(F), 4) the nucleocapsid subunit (NP) and 
5) the membrane protein (M).. HN and F are both associated with the 
surface of the virion and are involved in binding and entry into 
the host cell. 
A characteristic feature of Sendai virus replication is the 
generation of defective interfering (DI) particles which contain 
incomplete genomes. Preparations of chicken egg-grown Sendai virus, 
which have a high proportion of DI particles, are routinely used 
to induce IFN production. It has been found that the effectiveness of 
Sendai virus preparations as IFN inducers in Namalwa cells depends on 
the ratio of DI to infective particles (Johnston, 1981). Standard 
virus alone was a poor inducer and DI particles were ineffective. 
Therefore DI particles are responsible for the effectiveness of 
Sendai virus as an IFN inducer, possibly by causing the accumulation of 
replicative intermediate which provide the putative double-stranded 
RNA inducer molecule (see section 1.2). 
The control of IFN Production in Namalwa cells 
The-kinetics of IFN production in Sendai induced Naxnalwa cells 
have already been well characterised. IFN production is first detected 
2-3h after induction and is complete by around 14-16h (Zoon et al., 
1978; Baker et al., 1979; Morser et al., 1979; Johnston, 1980). 
IFNmRNA measured by translation of IFN activity from RNA microinjected 
into Xenopus oocytes, is first detectable in cells 2-3h after induction, 
rapidly accumulates to a maximum by around 9h then declines to 
undetectable levels by around 15h (Morser et al., 1979; 1980). IFN 
production in Namalwa cells therefore resembles that found in 
poly(rI). poly(rC) induced fibroblasts (see section 1.2). In both 
cases IFNmRNA is undetectable in non-induced cells, and induction 
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causes a rapid increase in IFNmRNA and IFN synthesis which is followed 
shortly by the inactivation of IFNmRNA and shut-off of IFN production. 
However, there are several differences which prevent a direct 
comparison between the two systems. The timing and type of IFN 
induced is different in each cell-type. In addition Namalwa cells 
respond poorly to poly(rI). poly(rC) inductions, little or no IFN 
being produced(Vervliet - Volckaert et al., 1980; Johnston, 1980). 
Only one report has indicated that poly(rI). poly(rC) can effectively 
induce IFN synthesis in Namalwa cells (Rossier and Weideli, 1982). The 
reasons for the failure to induce IFN are not known, however differences 
in the binding, release and degradation of poly(rI). poly(rC) suggest 
that its interaction with lymphoblastoid and fibroblast cells is 
different (Vervliet - Vockaert et al., 1980). 
In. addition, IFN production by virus-induced Namalwa cells 
cannot be increased by "superinduction" schedules analogous to those 
described for poly(rI). poly(rc) induced fibroblasts (Zoon et al., 
1978; Morser et al., 1979). To what extent this is due to cell-type 
or inducer remains to be established (see section 1.2). 
Although Namalwa cells cannot be "superinduced", IFN production 
can be increased by treating cells with a variety of agents which 
are known to affect specialised protein synthesis in a number of 
cell-lines. Agents which increase IFN production include butyrate 
(Adolf and Swetly, 1979a; Johnston, 1980), dimethylsulphoxide (Adolf 
and Swetly, 1979a), 5'-bromodeoxyuridine or BrdUrd (Tovey et al., 
1977), glucocorticoids (Adolf and Swetly, 1979b) and the tumour 
promoter phorbolmyristate acetate (Adolf and Swetly, 1980). Two 
of these agents, butyrate and BrdUrd (see section 1.1), have been used 
to investigate the control of IFN production in Namalwa cells. 
Modulation of IFN production by butyrate and BrdUrd 
Treatment of Namalwa cells with butyrate before induction with 
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Sendai virus has been reported to increase IFN production by up to 
30-fold (Adolf and Swetly., 1979; Johnston, 1980) The effect is time 
and concentration dependant,, reaching a maximum when cells are induced 
after 48h of treatment with 1mM butyrate (Baker et al., 1980). Treatment 
also causes many of the other effects described in other cultures, 
including inhibition of DNA synthesis and cell division and 
hyperacetylation of histones H3 and H4 (Baker et al., 1980). In 
addition a partial (60-80%) inhibition of RNA and protein synthesis 
is observed. No changes in cell morphology occur, but cells become 
smaller and are arrested in the G1 phase of the cell cycle. All of 
these effects are fully reversed within 48h of removal of butyrate. 
The increase in IFN production cannot be caused directly by the 
changes in DNA synthesis, cell cycle progression and histone 
acetylation since these occur more rapidly and are complete after 
only 24-36h of treatment with butyrate. 
A similar (up to 32-fold) increase in IFN production has been 
reported when Namaiwa cells are treated with BrdUrd before induction 
(Tovey et al., 1977). Again the increase is dose-dependant and 
is maximum after 48-72h of treatment with BrdUrd at 25ug/ml 
(Baker et al., 1979). At this concentration BrdUrd inhibits cell 
growth but this can be prevented by adding deoxycytidine (which 
prevents the cytotoxic effects of BrdUrd) without affecting the 
stimulation of IFN production. However the increase in IFN 
production is reduced by the addition of thymidine which also 
reduces the incorporation of BrdUrd into cellular DNA. The effect 
of BrdUrd on IFN synthesis therefore correlates with its incorporation 
into DNA. 
These agents have a varied effect on IFN production in other 
cell-types. For example butyrate increases IFN production in 
monkey V3 cells but not in human diploid fibroblasts 
(Johnston, 1980; 
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Baker et al., 1980). Similarly BrdUrd increases IFN in human 
diploid fibroblasts but not in SV-40 transformed human fibroblasts. 
These results indicated that the effects of butyrate and BrdUrd on 
cellular function and chromatin structure in these cells were not 
sufficient to affect IFN production. 
The significance of all these effects of BrdUrd and butyrate in 
relation to the control of IFN production is not known. However, 
recently it was found that the increase in IFN production caused by butyrate 
was accompanied by increased synthesis of IFNmRNA (Morser et al., 1980). 
Therefore it appeared that for butyrate at least, the effect on IFN 
production was occurring at the level of mRNA transcription or 
processing. 
The aims of this investigation 
There is still a great deal of information to be obtained before 
the control of IFN gene expression can be descibed in detail. Many 
aspects of IFN production in virus induced Namalwa cells, and cultured 
cells in general, remain poorly defined. With the intention of 
characterising IFN gene expression in Sendai induced Namalwa cells, the 
following aspects were considered. 
The control of IIN production in poly(rI). polr(rC) induced 
human fibroblasts has been suggested to occur both at the transcriptional 
and post-transcriptional level, on the basis of data obtained using 
metabolic inhibiters ( see section 1.2 ). Similar data on the control 
of IFN production in Namalvra cells is not available. One section of 
this thesis investigates the role of IFNmRNA stability in control of 
IFN production in Namalwa cells and examines the relevance of the 
post-transcriptional repressor model described in section 1.2. 
It has generally been assumed that IFN synthesis is controlled by 
the availability offunctional IFNmRNA in the cytoplasm. However, 
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the relationship between amounts of IBJmRNA present in the cells and 
the amount of IMF produced has received little attention in the 
literature. This relationship is considered here in order to 
determine how IFIJ synthesis is quantitatively controlled. 
In addition, IFN gene expression in Namalwa cells has been 
investigated by characterising the IFNmBNAs which are present after 
Sendai virus induction. The IFNmRNAs have been studied both by 
translation in Xenonus oocytes and by hybridization with cloned 
IRTcDNA probes. 
Finally, the quantitative and qualitative effects of butyrate 
and BrdUrd treatments on IFNmBNA and IFN synthesis are described. 
The effects of these treatments on IFN gene expression are compared 
with their effects on gene expression in general by characterising 
the changes they cause in the synthesis of other proteins in Namalwa 
cells. 
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SECTION 2. MATERIALS AND LtETHODS. 
a) Reagents and materials. 
All general reagents were obtained either from BDH Chemicals 
Limited, Poole, England; Fisons Scientific Apparatus, Loughborough, 
England; Sigma Chemical Company, London. The named reagents and rnatnrials 
below were obtained from the following suppliers: 
a- Aderman and Company Limited, Central Avenue, East Mosely, 
Surrey, England. 
BCL - Boehringer Corporation (London) Limited, England. 
BRL - Bethesda Research Laboratories Incorporated, Cambridge, 
England. 
b- Collaborative Research Incorporated, ". 9altham, USA. 
o- Eastman-Kodak Company, Rochester, USA. 
d -Fluorochem Limited, Dinting Vale Trading Estate, Dinting 
Lane, Glossop, England. 
e- Lancaster Synthesis Limited, Eastgate, White Lund, 
Morecambe, igland. 
f- Phaxmacia Fine Chemicals, Uppsala, Sweden. 
Reagents and materials, listed in alphabetical order, with supplier 
as indicated above. 
acrylamide -c 
Actinomycin D- Sigma 
N, N'- methylene-bis acrylamide -c 
bovine serum albumen - Sigma 
5'-bromodeoxniridine - Sigma 
butyrate - BDH 
Caesium chloride - BRL 
chloramphenicol - Sigma 
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cycloheximide - Signa 
DE 52, Vlhatman - Fisons 
DNA polymerase 1, (from E. coli) - BRL 
ficoll, Whatman - Fisons 
GF-C, glass fibre filters, Whatman - Fisons 
guanidinium isothiocyanate -d 
methylmercury hydroxide -e 
nitrocellulose, 0.45um, Schleicher and Schull -a 
oligo (dT) cellulose -b 
polyvinylpyrrolidone - Sigma 
PPO - BDH 
proteinase K- BCL 
puromycin - Sigma 
RNaseA -BCL 
Maze T1 - BCL 
tetracyclin - Sigma 
Radioactively labelled compounds were obtained from The Radiochemical 
Centre, Amersham, Ehg1and. 
deoxyguanosine 5'-[a-32p] triphosphate"2,000-3,000 Ci/m1ýol 
deorcytidine 5'-[a-32p] triphosphate. 29000-3,000 Ci/ml-To1 
: L-[35S]methionine. >6000i/mdol 
[5,3H]uridine. 27Ci/mMol 
Media 
Medium RPI 1640 , GIM, foetal calf serum and newborn calf serum 
were all obtained from Flow Laboratories, Irvine, Scotland. 
Medium RPMI 1640 was buffered, with 20mbi Hepes to pH6.9. G11EM 
was buffered with bicarbonate. All media were supplemented with 60ug/ml 
penicillin and 100u&/m1 strptonnycin ( Glaxo ) before use. 
Buffers and solutions. 
Bath-X medium (for oocyte incubation ) was made up in two parts 
and stored as a 25X concentrated stock at -200. 
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Barth-X 
ssC 
25X (A) I1aC1 2.2I, 1 
KC1 2 5el 
Na bicarbonate 600mM 
tris-HC1 pH7.35 375mM 
25X (B) Ca(N03)2 8.25WA 
CaC12 10.25rM 
1O4 20 . 5m M 
20X 
Denhardts solution 
NaC1 3M 
Na citrate 0.311 
Fico11 0.02% 
polyvinylpyrrolidone 0.02`, ) 
bovine serum albumen 0.025' 
Borate buffer ( for methylmercury-a, 
lox borate 61.8g 
Na tetraborate 
Na2SO4 28.4g 
EDTA 7.4g 
; arose gels ) 
38-1c 
made up to 21, pH8.2 
with NaOH 
Glycine-OH buffer ( for agarose gel electrophoresis of DNA } 
NaOH, III 15ml 
glycine 15g per 1 
Cells and viruses. 
The Namalwa cells used in these experiments were provided by 
Wellcome Research Laboratories, Beckenham, England. A separate stock 
of Namalwa cells (see below ) were obtained from Dr"P. Swetly, Ernst 
Boehringer Institute, Vienna, Austria, for comparison with the stocks 
used in these experiments. 
ItIDBK ( Malin Darby Bovine Kidney cells ) and EBTr ( Bovine tracheal 
cells ) were a gift from Dr. J. Vilcek, New York Medical Centre, NY, USA. 
HFF cells (Human Foreskin Fibroblasts ) were a gift from Dr-T. 
Merigan, Stanford University, Ca, USA. 
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Sendai virus seed stock ( for growth of inducing virus stocks) 
was provided by Wellcome Research Laboratories, Beckenham, England. 
Purified normal Sendai virus was a gift from Dr. M. Johnston, Wellcome 
Research Laboratories. 
Characterisation of Namalwa cells. 
The characteristics of the Namalwa cells used in these experiments 
were compared with those of Naraalwa cells obtained from an independant 
source (see above), in order to confirm their identity. 
A karjotype analysis was carried out on both cell lines using 
unbandeci, Giemsa stained chromosomes. Modal numbers of 46 for the 
Wellcome stock, and 45 for the stock from Dr. P. Swetly were obtained 
from 15 spreads, by camera lucida ( Dr. J. Brown, personal communication )" 
No gross differences were observed, and this result agrees with previously 
published variation between sub-populations of Namalwa cells ( Shade 
et al", 1980 ). 
A direct HLA typing was also carried out on both stocks of 
Namalwa. The results showed that the cells behaved identically, both 
being A3, B7, BW21, and DR4 ( L. Kennedy, Dr. L. Jones and Dr. J. P.: orser, 
personal communication ). This result was confirmed by adsorption of 
sera specific for the polymorphic determinants with 3x 108cells/ml, 
and testing in a cytotoxicity assay using fluorescein diacetate and 
ethidium bromide. These results therefore confirmed that the cells used 
in these experiments were in fact Namalwa cells. 
Characterisation of Namalwa cell IFN" 
The IFN produced by the Nainalwa cells used in these experiments 
was characterised by Rob King and Trevor Whittall " Namalwa cells 
have 
been reported to produce both IFN-cC and 111 1-/3 , from 
10-15; f, of the 
MIT activity being neutralized by antisera raised to IFN-f3 
(see section 
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1.2 ). However neutralization of the IFN produced by the Namalwa cells 
used in these 2rperiments indicated that a much lower proportion of 
111; -/3 was- being produced. Because of the difficulties associated 
with detecting small proportions of IRT /2 ( antisera are raised to 
In-T-/3 preparations which are contaminated with trace amounts of IFN- 
and are therefore cross reactive to a small extent ), an antibody 
affinity column containing the monoclonal antibody NK2 was used to 
reduce the high IMI-o(background. NK2 binds to the majority of ITN-Q-( 
species (see below) therefore any IFI1 -/3 present would be enriched in 
the unbound fraction from the colw. 
Approximately 75% of the IFi1 from Wellcome Namalrra cells was 
retained by the column. The unbound fraction was neutralized by 
anti-IFN- oc serum ( IPN- of species not retained by NTK2) , however no 
neutralization was detected using anti-IFT1 j serum ( see Table 2 ). 
IPN--< has a high cross-species activity (see sectionl. 2), While IFld-/3 QctWity 
is virtually undetectable on cells of another species. The ratio of 
activity of the unbound fraction in bovine compared to human cells 
was higher than the starting material (data not shorn), again suggesting 
that it was not IN-/q . Therefore the Namalwa cells used in these experiments 
did not produce detectable IFId-/3 activity. 
By comnarison, the Namalwa cells provided by Dr. P. Slvetly produced 
Im activity which was readily detected as a mixture of both Im- oK and 
IIN-/3 ' Therefore the failure to detect IFN-13 in the Im produced by 
Wellcome Namalwa cells was not due to the methods used in analysis- 
( see Table 2) 
Characterisation of IFNcDNAs. 
Information relating to the IFNcDNAs used to characterise IFIdmRNA 
in section 3.3 was provided by Dr. P. Boseley, Dr. P. Slocombe and Dr-A. 
Easton. The nucleotide sequence of the cDPJA inserts contained in the 
Table 2. Characterisation of Namalwa IFN. 
IFN 
(1og1punits/ml) 0% neutralized 
Namalwa-A ITIT 5.40 
unbound 4.70 
unbound+anti-IM- « serum 2.80 99 
unbound+anti-Iflr, 3 serum 4.75 0 
Namaltiva-B In 4.50 
unbound 3.70 
unbound+anti-IFTN- a serum 2.20 97 
unbound+anti-IPI /3 serum 2.45 44 
The IFN activity produced by Namalwa cells was charactrrised 
using affinity chromatography and neutralization with anti-IFN 
sera as described in the text. Namalwa-A are the cells provided 
by 'Wellcome Research Laboratories. Namalwa-B were provided by 
Dr"P. Swetly. Unbound refers to the fraction of IFTN not 
bound by an NK2-sepharose (monoclonal antibody affinity)column. 
(% neutralized refers to the reduction in activity of unbound 
fraction ) 
4 
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hybrid plasmids N5H8 and D4P. 165 have been obtained and compared with 
published data for the I RT- oc and IFIN-p genes. N5H8 was found to contain 
a complete M-«2 coding and. 3' untranslated sequence together with 
part of the protein signal sequence coding region (Slocombe et al., 1982). 
Fig-3- shows a comparison of the cDNA sequence contained in N5H8 with 
the published sequence of Goeddell et al. (1980) for 1111-oc 2 (or LeIFN A). 
Identical areas are indicated by lines (with arrows in the direction 
of reading) beneath the IFN-a2 sequence, and differences in nucleotides 
are noted. The N5H8-P.: sn fragment also contains an-proximately 24.0 base 
Pairs of plasmid DNA, therefore the size of the IFr1-o(2 cDITA probe derived 
from N5H8 is approximately 1.185Kb. 
D4P. 165 was found to contain a complete M -P cD21A sequence, however 
the 5' regions of the insert contained rearranged sequence derived from 
the non-coding strand. 11ig. 4a. shows sequenced regions of the cDITA 
and the nature of the rearrangement which has probably arisen from 
a strand switch during the preparation of the cDPIA. 
Fig. ¢a. The rearranged IFtd /3 cDNA derived from D4P. 165. 
5' 3' 
IFN70DNA ' 
leader tignol coding region 3'untranslated 
' 
D4P. 165 
Sequenced regions are indicated by hatched areas. The region of 
sequence from the non-coding strand is joined to the 5' end of 
the coding strand as indicated. Arrows show the direction of reading. 
Fig-4b. shows a comparison of the sequenced regions of the cDNA 
contained in D4P. 165 with the published sequence of IFTI 
/3 cDPNA 
(Derynck et al., 1980). Sequenced regions are indicated by lines (with 
Fig-3. The nucleotide sequence of the IFN-o(2cDNA probe. 
S' S1 SIC 
Nt alr Iw IhR ba alr low IOU val ala TGAGCCTAAACCTTAGGCTCACCCATTTCAACCAGTCTAGCAGCATCTGCAACATCTACA AT6 GC! TON 
I ITT GCT TTA CTG GIG GCC 
st GGC GTA GAT GT T GCA TAG GCT GCT AGA ter, 
S20 523 1 10 
lru leu vat lru rrr eyr lye *or set eye rrr vat 1 CYS ASP LEO PRO CL$ TO HIS SCR LEO GL? SEA ARC CTC CTG G G CTC AGC TGC AMG TCA AGC TGC TCT GTG 
III TGT GAT CTG CCT CAA ACC CAC AGC CTG GGT AGG AGG 
100 III 
20 30 
ARC THR LEU MET LEU LEU ALA CLN ME? ARG LYS TLC SEA LCV PN SIR CYS LEV LYS ASP ARC MIS ASP PHI CLY 
AGG ACC TTG ATG CTC CTG GCA CAG AIG AGG AAA AIC TCT CIT TIC TCC 1GC TTG AAG GAC AGA CAT CAC ITT GGA 
Ir 
- 
40 
G 
50 60 
PHI PRO GLN CLU CLU POE CLY ASH CLN POE GUI LYS ALA CLU TMR ILE PRO VAL LEU NIS GLU MET ILE CLN CLN 
ITT CCC CAG GAG JAG ITT GGC AAC CAG TIC CAA AAG GCT GAA ACC ATC CCT GTC CIC CAI GAG ATG ATC CAG CAG 
ISO Soo 
70 so 
ILE PHE ASH LEU PHE SEA TNR LYS ASP SER SER ALA ALA TAP ASP CLU Tilt LEO LEV ASP LYS ? HE TYR TOR CLU 
ATC TTC AAT CTC TTC AGC ACA AAG GAC ICA TCT GST GCT TGG GAT GAG ACC CTC CIA SAC AAA TIC TAC ACT GAA 
90 100 110 
LEU TYR CLN GLN LEU ASH ASP LEU CLU ALA CYS VAL ILE CLN CLY VAL CLY VAL TOR GLU THR PRO LEU MET LYS 
CTC TAC CAG CAG CTG AAT GAC CTG GAA GCC TGT GIG ATA CAG GGG GIG GGG GIG ACA GAG ACT CCC CTG ATG AAG 
400 os, 
120 130 
CLU ASP SEA ILE LEU ALA VAL ARC LYS TYR PNC GLN ARC ILE THR LEV TYR LEV LYS CLU LYS LYS TYR SER PRO 
GAG GAC TCC ATT CTG GCT GIG AGG AAA TAC TIC CAA AGA ATC ACT CTC TAT CTG AAA GAG AAG AAA TAC AGC CCT 
soo 
140 150 160 
CYS ALA TRP CLU VAL VAL ARC ALA CLU TLC MET ARC SER PHI SIR LEV SCR Tilt ASR LEV CLN VLU SEX LEU ARG 
TG1 GCC TGG JAG GTT GIC AGA GCA GAA ATC ATG AGA TCT ITT TCT TTG TCA ACA AAC TTG CAA GAA AGT TTA AGA 
SSO 005 
165 
SLR LYS CLU STOP 
AGT AAG GAA TGA AAACTGGTTCAACAT&GAAATGATTTTCATTAATTCGTATGCCAGCTCACCTTTTTATGATCTGCCATTTC_AAAGACTCATGT 
Ose ioo 
TTCTGCTATGACCATGACACGATTTAAATCTTTTTCAAAIGTTTTTAGGAGTATTAATCAACATTGTATTCAGCTCTTAAGGCACTAGICCCTTACAGAG 
750 too 
GACCATGCTGACTGATCCAITATCTATTTAAATATTTTTAAAATATTATTTATTTAACTATTTATAAAACAACTTATTTTTGTTCATAITACGTCATGTG 
$50 too 
r CACCTTTGCACAGTGGTTAATGIAATAAAATATGTTCTTjGTATTTGGTAA 
ISO 
1 --40-(A) 37 
The sequence of the cDNA contained in plasmid 115H8 is 
compared with the published sequence of IFN-a 2cDNA 
( reproduced from Goeddell et a1., 1980 ). Identical 
regions are indicated by lines beneath the published 
sequence-Data provided by Dr. P. Boseley, Dr. P. Slocombe 
and Dr. A. Easton. 
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arrows in the direction of reading )beneath the published IFN-13 sequence. 
The D4P. 165-MMMIsp fragment contained approximately 240 base pairs of 
plasmid DINA, therefore the si? e of the IFN 
/3 cDNA probe used in 
section 3.3 was approximately 1.214Kb. 
/ 
x6. 
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b) Methods. 
Cell culture. 
Namalwa cells were groom in suspension culture at 370 in medium 
RPNQ 1640 supplemented with 10% newborn calf serum, either in 2.5 1 
roller bottles or medical flats for small volume cultures. The cells 
were passaged routinely every 2days or as soon as the cell density 
exceeded 106 cells/ml. 
The cells used for assay of IFN activity were cultured in 150cm2 
plastic tissue culture bottles or 11 flow bottles in the following 
media. EBTr, b)BK and HFP were groom in GMEM supplemented with 10% 
newborn calf serum. GM 2767 were grown in G1, Mj supplemented with 10al. 4 
foetal calf serum. 
Butyrate and BrdUrd treatment of cells. 
Unless otherwise stated, cells were incubated at a cell density 
of 106 cells/ml in maintenance medium containing 0.8 mlMi butyrate or at 
5x105: cells/ml in maintenance medium containing 25 ug/ml BrdUrd for 48h 
before induction ( Balser et al., 1979; 1980 )" 
RPM; tb4o §Ue6l, vºe+red , atth 2% newborn calc Cer(M. 
Induction of IFN synthesis. 
Treated and untreated cells were resuspended in fresh maintenance 
medium at a cell density of 2x106cells/ml and induced using 100 
haemagglutinating units of Sendai virus per 106 cells ( Baker et al., 
1979 )" Chicken egg grown virus was routinely used as this contained 
DI particles and was found to be an efficient inducer ( Johnston, 1981 ). 
IFN was harvested at the times indicated in each experiment by pelleting 
the cells at 2,500xg for 10 mins. The supernatant was adjusted to pH2 
using HOi in order to inactivate remaining virus before assaying IFN 
activity. 
Intracellular IFS levels were estimated by measuring the activity 
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in supernatants prepared by lysing cells in HCl and pelleting cell debris 
as described by Morser et al. , 1980. 
IRI assay. 
IFN activity eras assayed by the inhibition of virus nucleic acid 
synthesis method ( Atherton and Burke, 1975 )" Briefly, IFN samples were 
added to cells and incubated for 12-18h. Cells were then challenged 
with SFV and the replication of virus measured by the incorporation of 
3H-uridine into viral nucleic acid in the presence of Actinomycin D. 
I unit of IF is defined as the amount of IFN causing a 50% reduction 
in viral nucleic acid synthesis. All IFtt titres are expressed in international 
units based on the human leukocyte interferon standard. ( 69/19 ). The 
sensitivity of the various cell lines used to assay IM is different. 
In the assays used 1 international unit was found to be equivalent to 
10units in EBTr cells, 4 units in 14IDBK cells, 0.5 units in HFF cells and 
10 units in GM 2767 cells. 
`lmmunoradiometric assay of IFN was performed using the monoclonal 
antibody NK2 ( Secher and Burke, 1980 ). The procedure used was that 
described by Secher -(1981) , and the reagents were 
kindly provided by 
Dr. D. Secher. Briefly, the IFN present in cell supernatants was adsorbed 
to a sheep anti-IM-oc serum immobilised on polystyrene beads. 
1251-labelled 
Nß: 2 monoclonal antibody was then bound to the adsorbed IFN and counted. 
The assay was linear for samples ranging from 200-10,000 units/ml. 
Affinity chromatography, using the monoclonal antibody, NK2, bound 
to $epharose was performed as described by Secher and Burke 1980), except 
that washing with ethanediol was not used. Using these procedures approximately 
75% of the IFN-ol protein in Namalwa IFN is bound by the affinity column 
( Allen et a1., 1982 ). 
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Preparation of RIA. 
Total cellular MIA was extracted using the guanidinium isothiocyanate 
technique ( Morser et al., 1979 )" Cells were nelleted, washed twice in 
cold PBS and lysed in 4M guanidinium isothiocyanate, 1M 2-mercaptoethanol, 
20mrd sodium acetate pH5.0. The lysate was then layered over a 5.711 CsC1 
cushion and centrifuged overnight at 137,000 Y. g. The RNA pellet was 
dissolved in 5mM tris-HC1 pH7.5 and extracted 3 times with water-saturated 
butanol: chloroform ( 1: 4 ) than ethanol precipitated. 7e RNA was washed 
3 times with 80% ethanol before use. 
Cytoplasmic RNA was prepared by phenol: chloroform extraction of 
post-mitochondrial supernatants as follows. Cells were pelleted and washed 
twice with cold PBS. Cells were then swollen in a hypotonic buffer 
containing 10mM M. 5mM Mg acetate, 20mM tris-HC1 pH7.5 at 40 for 5min. 
The cells were then lysed using 0.5ö Nonidet P-40 in a Dounce homogenizer 
( 10 strokes ). The homogenate was centrifuged at 10,000 xg for 10mtn and the 
supernatant was treated with O. 5iý SDS and 100ug/ml proteinase K at room 
temperature for 15min. NaCl was then added to 300mMS and the supernatant 
extracted 3-4 times with phenol: chloroform (1: 1) and 3 times with 
chloroform. The RNA was then precipitated with 2.5 volumes of ethanol. 
The precipitated RNA was washed 3 times with 80% ethanol before use- 
RNA was measured by determining the A260 of solutions in 5mM tris-HCl. 
Samples were stored at -200 under ethanol. 
Selection of poly(A)+ RNA. 
Poly(A)+ RNA was selected by oligo(dT)cellulose chromatography. 
Total or cytoplasmic RUA at a concentration of 1mg/ml or less was 
loaded 
onto an oligo(dT) cellulose column in 10mM tris-HC1 pH7.5,350mM Licl, 
17LI EDTA, 0.1% SDS, 0-40- The column was then washed thoroughly with 
several bed volumes of the loading buffer, at 4°, then the bound RNA 
was eluted with 10mM tris-HC1 pH7.5,1mM EDTA, G. 1% SDS at 37°. The 
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bound RITA was reloaded onto the column and eluted for a second time, 
using the above conditions, then ethanol precipitated. 
Preparation of polysomes. 
Polysomes were prepared by the method described by Morser and 
Shuttleworth 1981). Briefly, post-mitochondrial supernatants -prepared 
as for cytoplasmic RNA extraction except that 0.25 volumes of 1.25M 
sucrose, 460mM KC1 were added to the homogenate before centrifugation. 
The supernatant was treated with 0.1% sodium deoxycholate then 
centrifuged through a discontinuous sucrose gradient consisting of 
equal volumes of 114 and 1.8M sucrose in 100mM KCl, 5mM Mg acetate, 
20mM4 tris-HC1 pH 7.5. Centrifugation was for 3h at 140,000 x g. Ifi'A 
was extracted from the polysome pellet by dissolving the pellet in 
guanidinium isothiocyanate and centrifugation through CsCl as described 
above. 
Mlcrdinjection of oocytes. 
Total and poly(A)+ RNA was iaicroinjected into oocytes from mature 
Xenopus laevis frogs as described by Colman and Morser (1979, for the 
purpose of estimating the relative amounts of IFNmRNA present. Briefly, 
each RNA sample was assayed by microinjecting batches of 10oocytes with 
30nl of RNA solution ( at 1-5 mg/ml in distilled water 
) per oocyte. 
After 24 h incubation at 21° in 300u1 of Barth-X solution, the IFN 
secreted by the oocytes wag assayed. 
The amount of IFN secreted by the oocytes was found to be directly 
proportional to the amount of IFNmRNA injected over the range of RNA 
concentrations used in the assay. Fig-5. shows the amount of IFN secreted 
by oocytes which had been microinjected with various concentrations of 
total RNA extracted from induced cells. Total RNA from non-induced cells 
was used to maintain a constant input of RNA. 
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Fig-5. Calibration of the oocyte translation assay for IFNmR2; A. 
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Methylmercury-agarose 
, Mel electrophoresis. 
Poly(A)+RNA was fractionated by electrophoresis through vertical 
methyllnercury-agarose gels" 10-20ug of RNA was first denatured in 20mM 
methylmercury hydroxide for 10min at room temperature. 1.5% agarose gels 
containing 5mM methylmercury hydroxide were prepared in borate buffer. 
Samples were loaded onto gels- in borate buffer containing Y lo Ficoll and 
0.005%brotnophenol blue, and electrophoresed at 50V for 12-15h. All 
operations were performed in a fume hood ( methylmercury is highly toxic_ ). 
After electrophoresis the gels were soaked for 30min in either 
0.51.1 ammonium acetate before transferring the RNA to nitrocellulose filters, 
or 100mM 2-mercaptoethanol, 10mMtris-HM pH7.5 before extracting ! MA for 
translation in oocytes (see below ). 
RNA was extracted from the gels by manually slicing tracks into 
2mm segments. The excised gel slices were then homogenized, using a sterile 
glass rod, in 5 volumes of 5mM tris-HCF1 pH7.5 containing 5u&/m1 yeast RNA 
carrier. The RNA was then allowed to diffuse out of the agarose at 40 
overnight. After pelleting the agarose the RNA solution was extracted 
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trice with 'rater-saturated butanol: chloroform ( 1: 4 ) and then ethanol 
precipitated. The RNA pellet was washed three times with 8(' ethanol 
before use. 
The size of RNA fractionated by agarose gel electrophoresis was 
estimated using 
32P-labelled X-Hind III/ Eco Ri restriction fragments 
( kindly provided by Dr. P. Turner ). These were electronhoreserl in adjacent 
tracks, blotted onto nitrocellulose and visualised by autoradiograrhy. 
Preisaration of IPVcDTTh probes. 
IFtü-a 2 and IN-13 cDNAs were prepared from the recombinant nlasmids 
N5H8 and D¢P. 165 respectively. Both plasmids were derived from pAT153 
by insertion of IM-JcDNA into the plasmid tetracyclin resistance gene 
( Slocombe et al., 1982 ; Dr. P. Boseley, Dr"P. Slocombe, and Dr. A. Easton 
personal communication ). 
a) preparation of plasmid DNA 
E. coli (HP101) containing the plasmids 115HB or D4P. 165 rarere grov^n 
using standard procedures, in L-broth containing 10Dug/ml Ap ici tb i _, 
to a density of 0.8 ( at 590nm ). Plasmid DNA was amplified overnight 
in the presence of 100ug/ml chloramphenicol. Cleared lysates were then 
prepared from cell pellets by the following procedure. Cells were 
resuspended in 25j sucrose, 50m1ti! tris-HC1 pH8.09 and treated with 1.6mg/ml 
lysozyme for 5min on ice. The cells were then treated with 60mi, 1 EDTA 
pH8.0 for 5min on ice and an equal volume df 0.1%Triton-X 100,62mM 
EDTA, 5mM tris-HC1 pH 8.0 added. The cells were shaken vigorously. 
After centrifugation at 20,000 rpm, 1h, 40, the supernatant was extracted 
with phenol: chloroform (1: 1) several times and dialysed extensively 
against 10mTJ tris-HC1 p118.0,1mi2 EDTA. DNA was then ethanol precipitated. 
Pre cipitated DNA was washed with 80; ethanol, resuspended in 10mM 
tris-HC] pH7.5,1mM EDTA, 300mM NaCl and digested with Ti RNase and 
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RT, 1ase A( Sul and 50u1/10ml respectively ) for 1h at 37°. After phenol: 
chloroform extraction the DNA was then reprecinitated. 
DNA was then resuspended in 0.1 x SSC, added to 20ml of 0.1 x SSC 
containing 26g of CsCl and 0.6m&/ml ethidium bromide and centrifuged 
at 509000rpm, for 18h at 230 in a Beckman VTi 50 rotor using a Beckman 
18 centrifuge. Banded plasmid DNA was collected and extracted 7 times 
with isoamyl alcohol to remove ethidium bromide. The DNA was then ethanol 
precipitated. 
b)Preparation of cDNA inserts. 
IFNcDNA was purified from plasmid DNA by restriction enzyme digestion 
and agarose gel electrophoresis. Plasmid DNA was digested with Map 1 
and the cDNA frgment_fractionated by electrophoresis through 1.5% 
ßgarose gels prepared Ind run in glycine-OH buffer. Gels were stained 
with ethidium bromide and the appropriate band excised. DNA was extracted 
from the agarose ( by homogenisation and diffusion overnight, into 
10mM Iris-HCL pH 7.5,1mld EDTA ) and purified by DE52 chromatography. 
c) 
32: 
-labelling of cDNA probes. 
IFNcDNAs were labelled by nick-translation with ;. coli DNA 
deoxy- 
polymerase 1, using 
32P-labelledjnucleotide triphosphates. Labelled DNA 
was separated from unincorporated deoxynucleotide triphosphates by 
sephadex G-50 chromatography and used without further purification. 
The specific activity of these probes was usually in the order of 
2xlO8cpm/ug of input DNA. 
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Dot-blot hybridization with RITA. 
Poly(A)+ and total RIBA was analysed by dot-blot hybridization 
essentially as described by Thomas, 1980.5ug of poly(A)+ or 20ug 
of total RNA dissolved in 5mM tris-HC1 pH7.5, were loaded onto 
nitrocellulose filter discs which had been soaked in 10 x SSC and dried. 
The filters were then baked at 800 in a vacuum oven, then prehybridized 
at 37°for at least 5h in 50;: deionized formamide, 3x SSC, Ix Denhardts 
solution, 20mM sodium phosphate pH 6.5 and 50uilml denatured salmon 
sperm DNA. Hybridization was performed in the same solution for 48h 
using approximately 107cpm of denatured nick-translated IFNcDPNA probe. 
In some hybridizations using IFN-o' 2cDNA the temperature of hybridization 
was reduced to 200 for the reasons indicated in section 3. 
Following hybridization the filters were washed for 1h at room 
temperature in 3x SSC then for 15min at 600 in 0.1 :: SSC then counted 
by Cerenkov emmission. 
Gel-transfer hybridization. 
MIA was transferred from methylmercury-agarose gels by blotting 
onto nitrocellulose filters. After soaking in 0.5M ammonium acetate 
the RNA was transferred to nitrocellulose filtar sheets essentially 
as described by Southern, using 10 x SSC. Transfer ( or retention)of 
RNA was found to be increased by soaking the gels in 20 x SSC before 
blotting. Following trensfer of RNA the filters were dried, baked and 
hybridized as for dot-blots ( see above ). 
Hybridized filters were autoradiographed using a Dupont Cronex 
intensifying screen at -70° for 1-5days. 
Labelling of cells with 
3H-uridine 
and 
35s-methionine. 
Incorporation of 
3H-uridine 
and 
35S-methionine into TCA-insoluble 
material was followed using the method of Baker et al. 
11980). Briefly, 
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duplicate 0.5ml cultures were incubated for Ih in maintenance medium 
containing either 1OuCi/m1 
3H-uridine 
or 20uCi/ml 
35S-methionine. 
5m1 of cold 10% TCA was added and the precipitate collected by 
filtration through GF-C glass fibre filters. Filters were washed twice 
with cold 10% TCA and once with cold ethanol then dried and counted 
in PPO-toluene scintillant. 
Labelling of cells for analysis on polyacrylamide gels was 
carried out as described in Shuttleworih et al., (1982). Cells were 
labelled at a density of 107cells/ml in GIMI lacking methionine 
to which 600uCi/ml 
35S-methionine 
had been added. Labelled proteins 
were prepared for electrophoresis as described in Shuttleworth et al., (1982). 
SDS-polyacrylamide gel electrophoresiR. 
q 
One-dimensional SDS-polyacrlamide gel electrophoresis of 
35S-methionine labelled proteins was performed as described in 
Shuttleworth et al. (1982). 10-20%exponential gradient polyacrylamide 
gels were run with a 2cm stacking gel using the discontinuous buffer 
system of Laemmli (1970). After electrophoresis gels were fixed in 
several changes of 45", nethanolq 10; % acetic acid andthen dried and 
autoradiographed. 
Molecular weight marker proteins were run in adjacent tracks 
and visualised by staining with Coomasie brilliant blue. The markers 
and their molecular weights were; cytochrome C, 12,000; carbonic 
lanhydrase, 30,000; phosphorylase b, 95,000; fumarase, 49,000; transferrin, 
77,000. 
Two-dimensional-polyacrylamide gel electrophoresis. 
IEF and NEPHGE first-dimension gels were were prepared and run 
according to the methods of O'Farrell(1975) and O'Farrell et al. 
(1977) 
respectively. IEP gels were electrophoresed for 7200 Vh and were 
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found to have ý, pI gradient of 4.5-6.3. NEPHGE gels were electrophoresed 
for 1600 Vh . The first-dimension gels were equlibrated for 1h then 
frozen at -70°. Exponential gradient - SDS-polyacrylamide gels were used 
for electrophoresis in the second dimension. These were run as described 
above except that 5cm stacker gel was used. 
Second-dimension gels were fixed, dried and autoradiogranhed 
as described above. 
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SECTION 3 RESULTS 
Section 3.1' The control of IFNmRNA stability in Namalwa cells 
a) Introduction 
Current thinking relating to the control of IFN production 
maintains that the rapid shut-off of IFN synthesis in poly(rl). 
poly(rC) induced fibroblasts involves the selective inactivation 
of IFNmRNA by a specific repressor mechanism which is initiated 
at, or shortly after, the induction of IFN synthesis (see section 
1.2). The evidence supporting this repressor hypothesis is 
indirect and based entirely on the phenomenon of superinduction 
in poly(rl). poly(rC) induced fibroblasts. The time course of 
IFN production in Namaiwa cells in many ways resembles that 
described for fibroblasts (see section 1.2). In particular the 
rapid shut-off of IFN synthesis in Namalwa cells shortly after 
induction as in fibroblasts is accompanied by a rapid decline 
in the amounts of functional IFNmRNA present in the cells. 
Although IFNmRNA has a very short half-life in Namalwa cells, 
it is translated and therefore stable for several days after 
microinjection into oocytes (Morser et al., 1979). This suggests 
that IFNmRNA stability is controlled in Namalwa cells, however 
since virus-induced IFN production cannot be superinduced in these 
cells, - no evidence has been obtained to support the involvement 
of a post-transcriptional repressor in the shut-off of IFN 
production. 
The experiments described in this section investigate the 
control of IFNmRNA stability and its role in the regulation of 
IFN synthesis in Namalwa cells. 
b) The effect of reduced incubation temperature on IFN production 
During experiments on the secretion of IFN by Namalwa cells 
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(Morser and Colman, 1980) it was found that by reducing the 
temperature of incubation from 370 to 280 after induction, the 
overall yield of IFN at 24h after induction was paradoxically 
increased. This provided a potentially useful approach to 
studying the control of IFN synthesis, and the discovery prompted 
a series of experiments in which I collaborated with Dr Morser, 
with the assistance of Jane Oliver, the results of which have 
now been published (Morser and Shuttleworth, 1981). 
In order to determine the optimum temperature causing 
increased yield of IPN at 24h, cells were induced and incubated 
at 370 before shifting to various temperatures at 7h after 
induction. Fig. 6 shows that the largest increase was caused 
when cells were shifted to 28°. Fig. 7 shows that the maximum 
effect was achieved when the temperature was reduced to 28 0 at 
7h after induction, however increased yields resulted from a shift 
to 28° at any time during the first 10h of IFN synthesis, with the 
exception of lh after induction. The small increase caused by 
incubating cells at 28° from the time of induction was reproducible, 
and in fact yields were still increased when the temperature 
was reduced up to 3h before induction. The increase in IFN 
yield at 24h caused by reducing incubation temperature to 28 
° at 
7h after induction was on average 5-fold (mean of 16 experiments) 
and was observed in all but one experiment. 
In these and subsequent experiments the cells were routinely 
treated with butyrate before induction. Table 3 shows that the 
increase in IFN yield caused by reducing incubation temperature 
was not affected by butyrate treatment, and likewise the increase 
in IFN yield caused by butyrate was not affected by the reduced 
temperature. Therefore butyrate treatment provided a useful way 
. of increasing the amounts of IFN 
(and IFNmRNA) available for study. 
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Fig-6. The effect of incubation temperature on IFN yield. Cells 
were induced at 370 and the temperature of incubation changed 
7h later. The yield of IFN was assayed at 24h after induction. 
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Fig-7. The effect on IFN yield of reducing the incubation tem-nerature 
at different times. Cells were induced and incubated at 370 and 
their incubation temperature reduced to 2.80 at vzrious times 
after induction. IFN yield was assayed at 24h after induction. 
Control value was obtained from cells incubated at 370 throughout. 
( Average of. Uuplicate samples from a representative experiment. ) 
Table 3. The effect of reduced incubation temperature on IFN yields in 
butyrate-treated and untreated cells. 
incubation IFN yield increase in IFN yield (x-fold) 
butyrate temperature (log10u/ml) butyrate 2 8° 
treatment (°C) EBTr IRA EBTr IRA EBTr IRA 
+ 37/28 5.55 4.75 11 14 25 22 
- 37/28 4.50 3.61 -- 22 16 
+ 37 4.15 3. 40 10 10 -- 
- 37 3.15 2. 40 - --- 
Butyrate-treated and untreated cells were induced and incubated at 37°. 
At 7h after induction the incubation temperature of half of the cells 
was reduced to 28°. The 11W yield at 24h was determined by assay in 
bovine (EBTr) cells and by an immunoradiometric assay (IRA) using the 
monoclonal antibody NK2. IFN titres are expressed in international units 
together with the relative increase in IFN yield caused by butyrate and 
by the reduced incubation temperature. (Results from single samples 
assayed in duplicate. ) 
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Several explanations could account for the effect of reduced 
incubation temperature on IFN yield. An effect on the intracellular 
degradation or secretion of, IFN could be discounted since it was 
shown that the proportion of newly synthesized IFN being secreted 
(that is the ratio of intracellular to extracellular IFN) was not 
altered at 28° (Morser and Colman, 1980). Similarly the stability 
of secreted IFN was no different at 370 or 28°, therefore the 
increased yield was not due to decreased degradation of extra- 
cellular IFN (data not shown). Two remaining possibilities were 
investigated; firstly that the increased yield was not caused by 
increased synthesis of IPN but by a change in composition and 
specific activity of the IFNs produced. Secondly, that the 
regulation of IFN synthesis was altered at 28°, increasing the 
rate or production period of IFN synthesis. 
i) Characterisation of the IFN produced at 28° 
Several biological properties can be used to characterise IFN 
mixtures (see section 1.2), these include comparison of activities 
in heterologous and homologous cells and neutralization by 
monospecific antisera to IFN-o(. and IFN 13 . No differences could 
be detected in the biological properties of IFN produced at 28° 
and 370 (data not shown), therefore there was no significant change 
in the composition of IFN produced at the lower temperature. 
The Namalwa cells used in these experiments do not produce 
any detectable IFN -/3 activity (see section 2), consequently the 
increase in IFN yield at 28° Must be caused by increased IFN-ac 
synthesis. In order to confirm this, the amounts of IFN- a protein 
produced at 280 and 370 were compared by measuring the IFN in an 
immunoradiometric assay using the monoclonal antibody NK2. which 
is specific for a number of IFN- « species 
(which represent approximately 
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70% of the IFN- 04activity produced by the cells, see section 2). 
Table 3 shows the effect of reduced temperature on IFN yield in 
untreated and butyrate-treated cells. Using a bioassay in EBTr 
cells, the increase in IFN activity was 22-fold for untreated 
and 25-fold for butyrate-treated cells, while the immunoradiometric 
assay detected a 16-fold and 22-fold increase in IFN respectively. 
Therefore at 28° the increased yield of IFN was explained by 
increased synthesis of IFN and was not due to changes in the 
specific activity of IFN. (The difference in IFN 
Eitre 
measured by 
bioassay and immunoradiometric assay is considered in section 2 
and does not alter the interpretation of these data). 
(ii) The kinetics of IFN production at 28° 
Incubation of cells at 28° would be expected to reduce both 
the rate of general protein'synthesis and IFN synthesis in which case IFN 
synthesis would have to continue for longer in order to result 
in equal or increased yields. To investigate this possibility, 
the rate of IFN synthesis and accumulation in the medium was 
measured using cells shifted to 28° at 7h after induction. It 
was already known that the proportion of newly synthesised IFN 
being secreted was not affected by the reduced temperature (Morser 
and Colman, 1980), so the rate of IFN synthesis was estimated by 
measuring the IFN secreted by cells which had been pelleted and 
resuspended in fresh medium. Although this procedure could have 
disturbed the normal rate of synthesis and secretion, it still 
allowed comparison of cells at 28° and 37°. Fig. 8a shows the 
amounts of IFN secreted over a lh period at various times after 
induction. The rate of synthesis in cells at 37° continued to 
increase up to 13-14h after induction, then declined rapidly. 
By comparison, the rate of IFN synthesis in cells shifted to 28°, 
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Fig-8. IFN production in cells incubated at 37° and 28°. Cells were 
induced and incubated at 370 for 7h. a) The rate of IFN synthesis 
and b) the cumulative yield of IFN were measured in cells 
incubated at 370 ( ) or at 28° (c) from 7h after induction. 
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although initially slower than at 37°, continued to increase until 
18h after induction exceeding the rate at 37°" Fig. 8b shows that 
the accumulation of IFN in the medium of cells at 37 
° had apparently 
ceased by 13-14h whereas with cells at 280 the accumulation was 
slower but continued for longer, resulting in a higher yield of 
IFN. The shut-off of IFN synthesis was therefore delayed in 
cells incubated at 28°. 
The effect of the reduced incubation temperature on macromolecular 
synthesis was investigated by measuring the incorporation of 
355- 
methionine and 
3H-uridine 
into TCA-insoluble material in cells 
shifted to 28° at 7h after induction. Fig. 9 shows that at 28° 
incorporation of methionine declined to 40% and uridine to 30% 
of the 370 control. Therefore the initial reduction in the rate 
of IFN synthesis at 28° (Fig. 8a) was consistent with a reduction 
in the rate of general macromolecular synthesis. However, the 
elevated rate of IFN synthesis at 28° at later time points 
(Fig' 8a) was clearly paradoxical in the face of results showing 
a depressed rate of general protein synthesis. 
c) The control of amounts of IFNmRNA in cells at 28° and 37° 
One explanation for the delay in shut-off and the increase 
in rate of IFN synthesis in cells incubated at 28° was that the 
control of amounts of IFNmRNA was affected in these cells. To 
investigate this possibility, the relative amounts of IFNmRNA 
present in cells incubated at 280 and 370 were compared at various 
times after induction. Total RNA was extracted from the cells, 
microinjected into Xenopus oocytes and the 
activity was measured. Fig. 10b shows the 
activity from 10h after induction in cells 
also section 3.2). In cells shifted to 28' 
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Fig-9. Rates of incorporation of 
35S-methionine 
and 
3H-uridine 
in 
cells incubated at 37° and 28°. Cells were induced and incubated 
at 37° for 7h. The incorporation of 
35S-methionine 
and 
3H-uridine 
into TCA-insoluble material ( during a 1h labelling period ) 
was measured in cells incubated at 370 or at 280 from 7h after 
induction. A, methionine incorporation at 370; A, methionine 
incorporation at 28°;  , uridine incorporation at 370; o , uridine 
incorporation at 280. ( Single samples from a representAtive 
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Fig-10. The cumulative yield of IFPT and relative amounts of IFPTmRNA 
in cells incubated at 370 and 280. Cells were induced and 
incubated at 370 for 7h. a) The cumulative yield of IFPJ was 
measured in cells incubated at 370 ( ) or at 280 (a) from 
7h after induction. b) MIA was extracted from these cells and 
the relativd amount of IFTTmRNA determined by microinjection into 
Xenopus oocytes. The IFN translated from RNA from cells 
incubated at 37° (0) or at 28° (O) was then assayed. ( Single 
samples from a repr: sentative experiment) 
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were initially comparable to those in cells at 
later times more IFNmRNA was present in cells 
temperature, and the maximum amount of IFNmRNA 
exceeded that found in cells at 37. Fig. 10a 0 
37°. However at 
at the lower 
in cells at 28° 
shows the 
accumulation of IFN in the medium of cells at both temperatures 
(from the same experiment) confirming that IFN synthesis continued 
for longer and resulted in a higher yield at 280. 
The RNA samples used in Fig. 10b were also assayed for the 
presence of IFN-a mRNA by dot-blot hybridization with an IFN-. 2 cDNA 
probe (see section 3.3, Fig. 22). The results of the hybridization 
analysis confirmed the conclusions made from translation of 
IFNmRNA in oocytes, showing that the relative amounts of IFNmRNA 
in cells incubated at 28° exceeded those in cells at 370 and that 
the decline of IPNmRNA was delayed in cells at 28°. In addition, 
as the loss of hybridizable IFNmRNA accompanied the loss of 
functional IFNmRNA (Figs. 10 and 22) the inactivation of IFNmRNA 
was caused by its degradation. 
Arguably, the IFNmRNA detected by oocyte translation or by 
hybridization need not necessarily be involved in translation 
of IFN in the cell. It has been suggested that IFNmRNA can be 
detected in cells after IFN synthesis has apparently ceased 
(Berger et al., 1980). The data in Figs. 8 and 10 disagree with 
this view. IFN synthesis, measured by its rate of secretion, 
continued as long as IFNmRNA was present in the cells at both 
280 and 370. However, by measuring cummulative yield, as Berger 
et al. did, the small amount of IFN accumulating from this late 
IFN synthesis would not easily be detected on a logarithmic 
scale. In order to establish whether the IFNmRNA detected 
in 
cells late after induction was still associated with polysomes 
and capable of being translated, polysomes were prepared 
from cells, 
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their RNA extracted and microinjected into oocytes. Table 4 shows 
that not only was IFNmRNA still associated with polysomes at 
14 and 16 hours after induction, but also that more IFNmRNA was 
associated with polysomes from cells incubated at 28 
0 than cells 
at 37°. These results were therefore consistent with the finding 
that IFN synthesis continued for longer at 28°. 
It remained to establish the reason why amounts of IFNmRNA, 
. and hence rates of IFN synthesis at 280, exceeded those at 370 
The most obvious explanation, that this was the result of continued 
transcription of IFNmRNA at 28°, was eliminated by inhibiting 
RNA synthesis by the addition of actinomycin D before reducing 
the incubation temperature. Table 5 shows clearly that when 
actinomycin D was added and the incubation temperature reduced to 
28° at 3.5h after induction, an increase in IFN yield still occurred. 
In fact the increase in IFN yield at 28 0 was greater in the presence 
of inhibitor. The reduced incubation temperature must therefore 
be affecting the stability of IFNmRNA synthesised before the temperature 
shift. This suggested that IFNmRNA which would normally be degraded 
in cells at 37 0 persists in cells at 28°. As a consequence this 
increased accumulation of IFNmRNA and delay in its degradation 
could explain the prolonged period of synthesis and increased yield 
of IFN in cells incubated at 28°. This does not eliminate the 
possible involvement of continued IFNmRNA synthesis in causing 
increased yield at 280, but only showed that it was not necessary. 
d) The mechanism of IFNmRNA inactivation 
The fact that IFNmRNA can be translated for several days after 
microinjection into oocytes suggests that its rapid degradation 
shortly after the induction of IFN production in Namalwa cells 
is 
caused by an active process which is absent in Xenopus oocytes. 
Table 4. The amount of IFI1mRNA present on polysomes during the 
shut-off of IRT synthesis. 
hours after incubation 1111 yield from 
induction temperature (°C) polysomal RNA (units/ml ) 
14 37 
14 37/28 
40 
125 
16 37 16 
16 37/28 25 
RNA was extracted from polysomes prepared from cells incubated at 370 
throughout or at 280 from 7h after induction. The RNA was microinjected 
into oocytes and the IFIJ produced was assayed. ( Single samples from a 
representative experiment. ) 
Table 5. The effect of actinomycin D on the enhancement of IFN yield 
caused by reduced incubation temperature. 
incubation IFN yield (log1Cunits/ml) 
temperature (°C) no inhibitor + actinomycin D 
37 5.0 3.8 
37/28 5.4 4.6 
cells were induced and 
actinomycin D (1ug/n1 
at 24h was compared in 
reduced to 280 at 3.5h 
of actinomycin D. (Aver, 
experiment ) 
incubated at 37°. At 3.5h after induction 
was added to half of the cells. The IFN yield 
cells incubated at 37° throuout and cells 
after induction, in the presence and absence 
age of duplicate samples from a representative 
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In poly (rl). poly(rC) fibroblasts this process has been attributed 
to a post-transcriptional repressor molecule which, because of 
the requirement for both transcription and translation, has been 
suggested to be a protein. The following preliminary experiments 
were designed to test whether a similar repressor mechanism exists 
in Namalwa cells which could be reconstructed in a heterologous 
system, namely Xenopus oocytes. 
The induction and accumulation of the hypothetical repressor 
has been used to explain both the inactivation of IFNmRNA and the 
hyporesponsive or refractory state (see section 1.2). Because 
the repressor is assumed to be induced at the same time as IFN, two 
questions were asked. Firstly, could the mRNA coding for such a 
protein be translated and shown to affect the stability and hence the 
translation of IFNmRNA in oocytes, and if so, do the amounts of 
this mRNA alter during the induction and shut-off of IFN synthesis? 
In the experimental-approach used, total RNA lacking any detectable 
IFNmRNA activity was extracted from either non-induced cells or 
cells in the refractory state 18h after induction and injected 
together with RNA containing IFNmRNA extracted at 7h after induction. 
Table 6 shows that the amount of IFN translated by the oocytes was 
not affected by either of the RNA samples from cells not producing 
IFN. In another experiment, similar RNA samples extracted from 
and 
cells beforeel8h after induction, were injected into oocytes 24h 
before injecting RNA containing IFNmRNA. Table 7 shows that again 
no effect on translation of IFN could be detected. 
These negative results can be interpreted in several ways. 
Either the repressor does not exist, since neither RNA or protein 
translated from this RNA had the predicted effect on IFNmRNA 
translation, or it was possible that the oocyte did not provide 
the necessary environment for the mechanism to operate. Alternatively 
the mRNA or protein could be labile and rapidly lost 
from the oocytes. 
Table 6. The effect of coinjection of RNA from non-induced and 
11 
refactory cells on the translation of IRTmRNA by Xenopus oocytes. 
A 
IFN yield 
RNA sample (Iog10units/10o0cytes) 
non-induced 0 
7h 0.40 
18h 0 
7h + non-induced 0.35 
7h +1 8h 0.40 
Total RNA was extracted from cells before induction, 7h after induction 
and 18h after induction. These samples were then microinjected into 
Xenopus oocytes either individually or in the combinations indicated, 
and the yield of IFN translated during the following 24h was assayed- 
( Results from one experiment, singles samples ) 
Table 7. The effect of preinjection of RNA from non-induced and 
r 
refactory cells on the translation of IFNmRNA by Xenopus oocytes. 
BNA sample RNA sample IFN yield at 48h 
injected at Oh injected at 24h (log10units/10oocytes) 
water 7h - 2.65 
non-induced 7h 2.65 
18h 7h 2.65 
Oocytes were microinjected with either water, total RNA ectracted from 
non-induced cells or total RNA extracted from cells at 18h after 
induction. After incubating for 24h the oocytes were then microinjected 
with total RNA from cells at 7h after induction and the yield of IFN 
translated during a further 24h incubation was assayed. ( Results from 
one experiment, single samples ) 
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e) Discussion 
The purpose of these experiments was to consider the control 
of IFNmRNA stability and its role in. regulating IFN synthesis in 
Namalwa cells. The results presented clearly confirm that inactivation 
and degradation of IFNmRNA occurs during the shut-off of IFN 
synthesis. When the incubation temperature is reduced, IFN synthesis 
continues for longer and the degradation of IFNmRNA is delayed. 
However, interpretation of the effects of reduced incubation 
temperature on IFN production is difficult without data comparing 
the rates of IFNinilNA synthesis and degradation at 28° and 37°. The 
best way to obtain such measurements is by pulse-labelling nascent 
RNA and hybridization with specific IFNcDNA probes (see section 1.1). 
This approach was explored, however since IFNmRNA represents such a 
small proportion of total RNA (see section 3.3), labelling of intact 
cells with RNA precursors failed to incorporate sufficient radioactivity 
for these measurements to be made. Alternative strategies are 
discussed in section 4. 
Bearing in mind that reduced incubation temperature most 
probably affects both the rates of macromolecular synthesis and 
degradation, the effect of incubating cells at 28° on amounts of 
iFNmRNA, IFN yield and period of IFN synthesis can be interpreted 
in several ways. The reduced incubation temperature could have a 
non-specific effect, reducing the rate at which all mRNA's are 
degraded, thus explaining the persistance of IFNmRNA. Balanced 
by this however, the reduced rate of RNA and protein synthesis 
at 28° would be unlikely to result in the observed effects of 
reduced temperature on amounts of IFNmRNA, rates of IFN synthesis 
and IFN yield, all of which eventually exceed the values attained 
by cells at 37°" Alternatively, the reduced temperature could 
differentially affect a mechanism controlling IFNmRNA stability, 
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for example, by reducing the rate of synthesis of a hypothetical 
repressor molecule. Several observations favour the latter 
interpretation. i) The timing of the temperature shift was 
restricted to the first 10h of IFN production for increased IFN 
yields to occur. If the effect of reduced temperature was general, 
then an increase should have occurred when cells were shifted to 
28° at any time during the period of IFN production. ii) The 
amounts of IFNmRNA and rates of IFN synthesis in cells at 28° 
continued to rise above those at 370, indictating that either 
IFNmRNA synthesis was continuing for longer, or that its 
degradation was inhibited at 28°. iii) Continued transcription 
and IFNmRNA synthesis was not however necessary to cause increased 
IFN yields at 28°. 
Using the post-transcriptional repressor model as a working 
hypothesis, these results can be explained as follows. Perhaps 
the simplest scenario suggested by the effects of metabolic inhibitors 
on poly(rl). poly(rC) induced fibroblasts is one in which IFN synthesis 
precedes repressor synthesis, although both are induced at (or 
around) the same time. Once IFNmRNA synthesis slows down, the 
rising repressor levels begin to increase the rate of degradation 
of IFNmRNA, causing a decline in its amounts (see section 1.2). 
When the accumulation of repressor is prevented, by inhibiting 
protein and RNA synthesis, IFNmRNA persists resulting in increased 
IFN yields. By analogy, I would propose that by reducing the 
incubation temperature of Namalwa cells, repressor synthesis is 
reduced. As a consequence any IFNmRNA produced before or after 
temperature shift would be stabilised. Therefore increased IFNmRNA 
synthesis would not be required to explain the increased amounts of 
IFNmRNA present in cells at 28°, although continued synthesis would 
, obviously contribute to this. By iCh after 
induction the rate of 
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IFNmRNA synthesis has probably declined and sufficient repressor 
could be accumulated, preventing any such effect occurring. This 
explanation is strengthened by the fact that reduced incubatipn 
temperature has a similar effect on IFN production in poly(rl). poly(rC) 
induced fibroblasts (Havell and Vilcek, 1973) however it remains 
speculative. 
In conclusion the shut-off of IFN synthesis in Namalwa cells 
is accompanied and probably caused by the degradation of IFNmRNA. 
However, the possibility that degradation of IFNmRNA is a consequence 
of the shut-off of IFN synthesis cannot be eliminated. The data obtained 
by comparing amounts of IFNmRNA, rates of IFN synthesis and IFN 
yield in Namalwa cells incubated at 370 and 28° are consistent with 
the hypothesis that IFNmRNA is degraded by a mechanism (possibly 
a repressor) which is selectively inhibited by reducing the 
incubation temperature. These results and the phenomenon of 
superinduction are open to other interpretations which are discussed 
in seotion 4. 
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Section 3.2 Control of IFNmRNA levels and IFN Yields: the effects 
of butyrate and BrdUrd 
6 
a) Introduction 
The previous section has considered how control of IFNmRNA 
stability may be involved in regulating the shut-off of IFN 
production in Namalwa cells. However, despite the fact that the 
period of IFN production is tightly controlled and does not vary 
significantly from one occas ion to another, IFN yield can vary by 
over two orders of magnitude, even when cell culture, induction and 
assay conditions are strictly controlled and standardised. One 
obvious possibility is that rates of transcription or processing of 
IFNmRNA are controlled. However, the relationship between the 
amount of IFNmRNA present in the cells and IFN yield has received 
little attention. In order to investigate its cause and possible 
significance, the natural variation in IFN yield could be exploited 
by looking for similar variation in relative amounts of IFNmRNA. 
An alternative approach would be to investigate the increase in IFN 
yields caused by treating Namalwa. cells with butyrate or Brdürd 
before induction. These agents do not alter the time course of IFN 
production (Baker et al., 1979; 1980), and butyrate has already been 
shown to increase IFN yield by increasing the rate of IFNmRNA synthesis 
(Morser et al., 1980). 
This section describes the effect of butyrate and BrdUrd treatments 
on the amounts of IFNmRNA synthesised by the cells and considers 
how these treatments cause increased yields of IFN. These results 
have now been published (Shuttleworth et al., 1982). 
b) IPNmRNA levels in butyrate- and BrdUrd-treated cells 
Treatment of Namalwa cells with 0.8 mM butyrate or 25, "g/ml 
BrdUrd for 48 h before induction reproducibly increased the yield of 
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IFN produced 24 h after induction. The effect of these treatments 
on the relative amounts of IFNmRNA synthesised by the cells was 
investigated by extracting total RNA from treated and untreated cells 
at 8h after induction. The RNA was microinjected into Xenopus oocytes 
and the IFN activity translated was used as a measurement of the 
relative amount of IFNmRNA present in the cells. Fig. lla shows the 
yields of IFN produced by these cells at 8h after induction (results 
from 16 experiments) from which it can be seen that both treatments 
caused an increase in IFN yield. Although the yield varied (for 
untreated cells, 2.35-5.10; for butyrate-treated cells, 3.95-6.10; 
for BrdUrd-treated cells, 2.95-4.95 Log10 units/106cells) treatment 
caused an increase in every experiment. The size of this increase, 
calculated from the increase in each experiment, varied from 8-300 
fold and averaged 77-fold for butyrate-treated cells. For BrdUrd- 
treated cells the increase varied from 3-35 fold and averaged 11-fold. 
Fig. llb shows that both treatments also caused an increase in the 
relative amounts of IFNmRNA in the cells (from the same 16 experiments), 
The average increase, calculated from tie increase in/each experiment, 
was 26-fold for butyrate-treated and 3-fold for BrdUrd-treated cells. 
The increase in IFN yield was therefore 3-4 fold greater than the 
increase in amounts of IFNmRNA. In every experiment, butyrate-treated 
cells produced more IFN and IFNmRNA than did BrdUrd-treated cells, both 
producing more than untreated cells. Therefore the increased 
production of IFN was always accompanied by, but not due solely to, 
an increase in amounts of IFNmRNA. 
Considering the range of values obtained for IFN yield and 
IFNmRNA from treated and untreated cells, it was necessary to 
evaluate the significance of the increases caused 
by butyrate and 
BrdUrd treatment. There are several sources of error which could 
contribute to this variation, apart from differences in cell culture 
treatment butyrate BrdUrd none 
mean 4.90 4.05 3.25 
6- 
" 
5- N " " 
" 
0 
IFN 
4 N = " 
units/ 
(Log *m" 
io 
106ceIIs) 
3- N 
2- 
(a) 
Fig-11a. The effect of butyrate and BrdUrd on IFl1 yield. Cells were 
incubated in 0.8 mM butyrate, 25 ug/ml BrdUrd or maintenance 
medium for 48h, then induced. At 8h after induction the cumulative 
Ifll yield was measured. The range and mean of values obtained 
from 16 experiments are shown. 
treatment butyrate BrdUrd none 
mean 2.40 1.90 1.45 
3-0- 
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Fig lib. The effect of butyrate and BrdUrd on IFNnRNA levels. I MA 
was extracted from the cells used in Fig 11a, and microinjected 
into oocytes. The IMI translated was used to determine the 
amounts of IPImRNA present. The range and mean of values 
obtained from 11 experiments are shown. 
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conditions, media and handling (which were minimised by strict 
experimental protocols). For example, the IFN assay itself was 
subject to variation for the same sample assayed on different 
occas ions (interassay variation), differed by up to 2-fold 
(i. e. ± 0.3 Log10 Units). This variation was corrected for by 
including an internal standard with each assay. Intra-assay 
variation was found to be considerably lower. Similarly, it 
was necessary to include an internal standard IFNmRNA preparation 
in oocyte microinjection assays, since the efficiency of translation 
of RNA samples was found to vary by up to 4-fold (i. e. 
t 0.6 Log10 Units) 
when using different batches of oocytes. In order to test the 
significance of the increases in IFN yield and amounts of IFNmRNA 
caused by treatment, a one-way analysis of variance test was applied 
to the data in Figs. lla and lib with the null hypothesis being that 
the distribution of values for treated cells could be accounted for 
by the variance of data from untreated cells, the probability of 
obtaining these results by chance was less than 0.1% (i. e. P<0.001). 
Therefore treatment was significantly affecting both IFN yield and 
amounts of IFNmRNA. 
c) Characterisation of IFN produced by treated cells 
Bearing in mind the points rained in sections 1.2 and 3.1 
regarding the specific activity of IFN-tCspecies, it was necessary to 
confirm that the increase in IFN yields caused by butyrate and BrdUrd 
was due to increased IFN synthesis and not a change in the composition 
of the IFN produced. To do this, the IFN produced by butyrate- 
treated, BrdUrd-treated and untreated cells was measured 
by bioassay 
in bovine EBTr cells, human cells and also by the immunoradiometric 
assay using the NX2 monoclonal antibody to IFN- C< " 
Table 8 shows 
that a similar increase was measured in both IFN activity and antigenic 
Table 8. Characterisation of the IFri produced by treated and untreated cells. 
IR1 (1og, 0units/lo 
6cells) 
treatment EBTr HFF IRA 
butyrate 4.40 (38) 4.60 (19) 3.10 (22) 
BrdUrd 3.60 ( 6) 3.75 (3) 2.60 ( 7) 
none 2.80 3.30 1.75 
Cells were treated for 48h with either 0.8mM butyrate or 25ug/ml BrdUrd 
or maintainance medium. At8h after induction the cumulative IFN yield 
was assayed using EBTr cells, HFF cells or by an. imlTrunoradiometric 
assay ( IRA ). Titres are all expressed in international units. Figures 
in parentheses indicate the relative enhancement in IFN yield from 
treated cells. 
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mass produced by treated cells (see also section 3.1P table 3). These 
Namalwa cells do not produce active IFN-/3 (see section 2 and 3.3) 
therefore these results indicated that butyrate and BrdUrd treatment 
caused a genuine increase in IFN-« synthesis. Similarly, when the 
IFN translated in oocytes from RNA extracted from butyrate-treated 
and untreated cells was measured by bioassay and by the immunoradiometric 
assay, the relative increase in IFN activity corresponded with a 
similar increase in antigenic mass (data not shown). Furthermore 
the relative increase in amounts of IFNmRNA in RNA from butyrate- 
and BrdUrd-treated cells was measured by hybridization with IFNcDNA 
probes and found to be similar to the increase measured by oocyte 
translation (see section 3.3). This eliminated the possibility that 
the IFNmRNA from treated cells was for some reason translated less 
efficiently in oocytes than IFNmRNA from untreated cells, an effect 
which would result in the underestimation of amounts of IFNmRITA in 
treated cells. Therefore the increase in IFNmRNA content of treated 
cells was not sufficient to account for the increase in IFN yield. 
d) Are the effects of treatment on IFATmRNA levels and IFN . yields 
causally related? 
If the increase in IFN yields was caused, at least in part, by 
the effect of treatment on the rate of IFNmRNA synthesis, then 
changes in conditions of treatment should result in parallel effects 
on both the amounts of IFNmRNA and IFN yields. It had previously 
been shown that by altering the concentration of butyrate, the 
effect on the increase in IFN yield and amounts of IFNmRNA correlated 
exactly, the optimum concentration being around 1mM 
(Morser et al., 
1980). Figs. 12a and 12b show that likewise, when the cells were 
treated for 48 h with various concentrations of BrdUrd, the increases 
in IFN yield and IFNmRNA at 8h after induction were similarly 
(a) 
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Fig-12. The effect of varying the concentration of BrdUrd on IFN 
yields and IFNmRNNA levels. Cells were treated for 48h with 
various concentrations of BrdUrd, then induced. a) The cumulative 
IFN yield at 8h after induction was assayed. b) The amount 
of IPM. translated by oocytes microinjected with total RNA extracted 
from the cells at 8h after induction. 
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affected. Both IFN yield and amounts of IFNmRNA increased rapidly 
when the concentration was raised from 0-10ug/ml, then gradually 
declined as the concentration was increased further. 
The same observations were made using cells which had been 
treated for different times before induction. Cells were suspended 
in maintenance medium and either 0.8mM butyrate or 25ug/ml BrdUrd 
added at various times from 4-48h before induction. IFN yield and 
amounts of IFNmRNA were measured at 8h after induction. Figs. 13a 
and 13b show that increases in both yield of IFN and amounts of 
IFNmRNA were detected after only 4h of treatment with either agent, 
and the effects increased reaching a maximum after 48h of treatment. 
Again, on all occassions the increase in IFN yields exceeded the 
increase in amounts of IFNmRNA, therefore thetreatments cannot be 
affecting the rate of IFNmRNA synthesis alone. 
Since it was possible that butyrate and BrdUrd affect IFN 
synthesis at different points, the following experiment was designed 
to test whether combined treatment had an additive effect on IFN 
yield. Simultaneous treatment would be unlikely to have any such 
effect because the inhibition of DNA synthesis by butyrate (Adolf 
and Swetley, 1979) would prevent the incorporation of BrdUrd which is 
required to increase IFN yield (Baker et al., 1979). Various 
regimens of sequential treatment were used and as Table 9 shows, no 
additive effects on IFN yield or amounts of IFNmRNA were detected. 
Therefore, the mechanisms by which these agents affect IFN synthesis 
are either mutually exclusive, mediated by common pathways or 
restricted by another rate limiting process. Surprisingly though, 
these conditions of treatment resulted in increases in IFN yields 
which were equivalent to the increases in amounts of IFNmRNA. 
It 
would appear that cells which had been held in maintenance medium 
for 48h before treatment were altered such that butyrate or BrdUrd 
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Fig. 13. The effect of varying times of treatment on IFN yield and 
amounts of IFNmRNA. The cells were treated for various times 
with either butyrate (") or BrdUrd (A) then induced. 
(a) The cumulative IFN yield at Ch after induction. 
(b) The amount ofIRI secreted by oocytes microinjected with 
total RNA extracted from cells at after induction. 
(single samples from a representative experiment ) 
Table 9. The effect of sequential treatment with butyrate and BrdUrd 
on IFN yield and IFT1mRNA levels. 
treatment IFN IFNmRNA 
0-48h 48-96h (1og10units/10 cells) (1og10units/lOoocytes ) 
BrdUrd butyrate 4. 20 (12) 2.20 (11) 
BrdUrd none 3. 70 ( 4) 1.60 ( 3) 
butyrate none 3. 50 ( 3) 1.65 ( 3) 
none butyrate 4. 40 (20) 2.40 (18) 
none BrdUrd 3. 80 ( 5) 1.65 ( 3) 
none none 3. 10 1.15 
Cells were treated with 0.8 mM butyrate, 25ug, /ml BrdUrd or maintenance 
medium for the times indicated, then induced. At 8h after induction 
the cumulative IFN yield was measured. Total RNA was extracted and 
microinjected into oocytes and the amount of IFN translated used to 
determine therelative amounts of IFNmRNA present in the Dells. Figures 
in parentheses indicate the relative increases in treated cells. 
( single samples from a representative experiment 
) 
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treatment no longer caused an increase in IFN yield which was 
disproportionateto the increase in amounts of IFNmRNA. 
e) The time course of IFNmRNA and IFN synthesis 
The time course of IFN production has been reported to be 
unaffected by butyrate or BrdUrd treatment (Baker et al., 1979; 1980), 
therefore it was unlikely that the difference between the increase 
in relative amounts of IFNmRNA and the increase in IFN yields in 
treated and untreated cells was caused by a more rapid decline in 
the amounts of IFNmRNA in treated cells so that by the time at which 
IFN yield was measured (8h after induction) IFNmRNA levels were low. 
However this possibility was tested by comparing the amounts of IFNmRNA 
and cumulative IFN yield at various times after induction in butyrate- 
treated, BrdUrd-treated and untreated cells. Pig. 14a confirms that 
the treatments did not alter the time course of IFN production, and 
the increase in IFN yield was seen at all times for both treatments. 
Total RNA was extracted from the cells at these times and translated 
in oocytes. Fig. 14b shows that both treatments caused an increase 
in the amounts of IFNmRNA at all times after induction. Amounts of 
IFNmRNA accumulated to a maximum at 9h after induction, then declined 
with a half-life of approximately 2.7h in both treated and untreated 
cells. (In fact the decline in IFNmRNA levels had an average half- 
life of 2.7h in 18 other experiments with treated and untreated cells. 
) 
Therefore treatment increased the rate of IFNmRNA synthesis and 
inactivation, but at no time did the increase in amounts of IFNhRNA 
completely account for the increase in IFN yield. 
f) Intracellular IFN and its rate of secretion 
Extracellular yields of IFN need not necessarily reflect the 
amount of IFN synthesised by the cells. If, for example, treatment 
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Fig-14. The time course of accumulatio_- of IFi1 and IFtdmRNA in treated 
and untreated cells. Cells were incubated with butyrate ("), 
BrdUrd (A) or maintenance medium- (0) then induced. 
(a) The cumulative IR T yield was assayed at various times after 
induction. 
(b) RNA was extracted from the cells at various times after induction 
and microinjected into oocytes. The IFIT translated was assayed in 
order to determine the amounts of ITNmRNA. 
( single samples from a representative experiment 
) 
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reduced the intracellular accumulation or degradation of IFN9 or 
increased its rate of secretion, then this could cause a disproportionate 
increase in extracellular yield compared to the increase in amounts 
of IFNmRNA. For this reason the intracellular levels of IFN, its 
rate of secretion and extracellular accumulation were compared in 
treated and untreated cells. 
Cells were treated for 48h with butyrate or BrdUrd, induced, then 
after 8h they were pelleted and the supernatant used to determine 
cumulative extracellular yield of IFN. The cells were washed and 
resuspended in fresh medium for lh, and the amount of IFN secreted 
was measured. Intracellular IFN was estimated in washed cells at the 
same time. Table 10 shows the effect of butyrate and BrdUrd on each 
of these parameters, and clearly intracellular levels, rate of secretion 
and extracellular yield are equally increased. Therefore, the 
extracellular yield of IFN accurately reflected the relative amounts 
of IFN synthesised, and treatment was not altering the post-trans- 
latiopal movements of IFN. 
g) The effect of treatment on translation of IFNmRNA 
Having confirmed that the increase in IFN synthesis in butyrate 
and BrdUrd treated cells was greater than the increase in IFNmRNA, 
the most likely explanation was. that treatment caused an increase 
in the efficiency of IFNmRNA translation. The effect was not 
caused by an increase in the rate of general protein synthesis, 
since as Fig. 15 shows, the rate of incorporation of 
35S-methionine 
into TCA-insoluble material following induction was if anything 
lower in treated cells. In butyrate-treated cells 
35S-methionine 
incorporation was approximately 96% of that in untreated cells, 
therefore the 60% inhibition of protein synthesis caused 
by 48h 
treatment with butyrate (Baker et al., 1980) was rapidly reversed 
Table 10. Intracellular IFN, its rate of secretion and extracellular 
accumulation in treated and untreated cells. 
IFN (log10units/106cells) 
cumulative 
treatment extracellular 8h secreted 8-9h intracellular 8h 
butyrate 4.40 (38) 4.10 (16) 2.40 (18) 
BrdUrd 3.60 ( 6) 3.60 ( 5) 1.85 ( 5) 
none 2.80 2.90 1.15 
Cells were treated for 48h with either 0.8mM butyrate or 25u/m1 Brdürd 
or maintenance medium. At 8h after induction the cumulative IFN yield 
and intracellular levels of IFN were measured, together with the 
amount of IFN secreted from 8-9h after induction. Figures in parentheses 
indicate the relative enhancement of IFN in treated cells. 
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Fig-15. The incorporation of 
35S-methionine in treated cells. Cells 
were treated with butyrate ( ) or BrdUrd (O) then induced. 
The incorporation of 
35S-methionine into TCA-insoluble material 
at various times after induction is expressed as a percentage 
of the incorporation into untreated, induced cells at each time 
point. 
(average from 3 experiments ) 
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after removal from butyrate and induction. In BrdUrd-treated cells 
35S-methionine incorporation was approximately 80% of that in 
untreated cells. 
Increased efficiency of translation of IFNmRNA could occur as 
a result of reduced competition from other mRNA species in treated 
cells. For example, the inhibition of RNA synthesis by treatment 
with butyrate before induction could alter the mRNA population by 
depleting short half-life mRNAs. However, treatment had no effect 
on the distribution of free and ribosome bound IFNmRNA, approximately 
80% of the IFNmRNA being associated with polysomes prepared from 
treated and untreated cells. Table 11 shows the amounts of IFNmRNA 
in RNA associated with polysomes which were extracted from butyrate- 
treated, BrdUrd-treated and untreated cells at 8h after induction. 
The increase in amounts of IFNmRNA caused by treatment was similar 
in both polysome associated and total RNA, therefore the proportion 
of IFNmRNA available for translation was similar in treated and 
untreated cells. This is consistent with the observation that 
butyrate and BrdUrd produce very few detectable effects on the rates at 
translation of other proteins (see section 3.4)) which suggests that 
the treatments do not significantly alter the amounts or rates of 
translation of other mRNAs. By exclusion, butyrate and BrdUrd must 
therefore increase the rate of elongation, termination or processing 
of IFN or increase the number of ribosomes on each IFNmRNA. 
hý The relationship between amounts of IFNmRNA and IFN yield 
To consider the original question of how the amounts of IFNmRNA 
present in induced Namalwa cells relate to IFN yield, the data shown 
in Figs. lla and llb together with other relevant data were analysed 
using a computer programme (Royal Society statistical package, 
OLIM) 
to plot amounts of IFNmRNA against IFN yield. 
When the data were 
Table 11. The amount of IFNmRNA present in total RNA and polysomal 
F1IA extracted from treated and untreated cells. 
IFN (units/lOoocytes ) 
treatment total RNA polysomal MIA 
butyrate 112 100 
BrdUrd 63 50 
none 25 35 
Cells were treated with 0.8 mLI butyrate, 25ug/ml BrdUrd or maintenance 
medium then induced. At 8h after induction total RNA and polysomal RNA 
was prepared and microin jected into oocytes. The IFN translated was 
used to determine the relative amount of IFNmRINA present in each sample. 
( single samples ) 
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plotted collectively, the line of best fit produced a slope of 
1.215 ± 0.267 with the deviance of points from the line being 22.65. 
Interestingly, the line intercepted the y (IFN yield) axis at around 
2.0. It was rarely possible to detect IFNmRNA by translation in 
oocytes of RNA extracted from cells producing less than 2.0 Log10 
units/106 cells of IFN, therefore this probably represented the 
lower limits of the oocyte translation assay. When the y intercept 
was fixed at 2.0 and the data for treated and untreated cells plotted 
separately, the deviance of points from the lines and standard 
deviation of the slopes were considerably reduced. Fig. 16 shows 
this interpretation of the data. The line of best fit for data from 
untreated cells had a slope of 1.06 ± 0.149, with the deviance of 
points from the line being 4.5. The slope would indicate that in 
untreated cells, the increase in IFN yield was directly proportional 
to the increase in amounts of IFNmRNA. For treated cells, the line 
of best fit gave a steeper slope of 1.547 ± 0.064 with the deviance 
of points being 7.5. This was consistent with the observation that 
in treated cells the increase in IFN yield was not directly proportional 
to the increase in amounts of IFNmRNA, and favours the interpretation 
that butyrate and BrdUrd increase the efficiency of IFNmRNA translation. 
j) Discussion 
These results have shown, together with those of Morser et al., 
1980, that butyrate and BrdUrd both caused a dose-dependant increase 
in the amounts of IFNmRNA and IFN yield induced in Namalwa cells. 
The 
treatments did not cause any changes in the time course of accumulation 
or decay of IFNmRNA, consistent with the fact that the time course of 
IFN production was the same in treated and untreated cells. Therefore 
the increase in amounts of IFNmRNA must result from an increased rate 
of synthesis. The most likely explanation would be increased 
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Fig-16. The relationship between IRT yield and amounts of IFNMPd A 
in butyrate-treated (0), BrdUrd-treated (Q) and untreated 
cells (" ). Data were plotted as described in the text. 
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transcription of the IFN genes, however these data cannot distinguish 
this from increased processing or export of transcripts from the 
nucleus. As in section 3.19 accurate measurements of rates of 
transcription and degradation, using pulse-labelled nascent RNA, 
would help to determine the effects of butyrate and BrdUrd on 
transcription and degradation of IFNmRNA. 
An alternative explanation for the effect of butyrate on amounts 
of IFNmRNA and IFN yield would be that treatment increases the 
number of cells responding to IFN induction. However, data kindly 
provided by Dr D Barlow indicated that this does not occur. Using 
a single-cell assay designed to measure the number of cells 
producing IFN in a population of cells induced by NDV, it was found 
that 40% of both butyrate-treated and untreated Namalwa cells were 
making sufficient IFN to be detected in the assay. Therefore 
butyrate did not increase the amounts of IFNmRNA and IFN produced by 
the cells population by increasing the number of cells responding 
to induction. 
In untreated cells there was a direct relationship between 
amounts of IFNmRNA and IFN yield, as might be expected. However, 
the data from treated cells have been interpreted to suggest that 
butyrate and BrdUrd not only increased the rate of synthesis of 
IFNmRNA, but also the rate of its translation, so that the amounts 
of IFNmRNA are only indirectly related to IFN yield. The reasons 
for this effect on translation are not known, but several observations 
indicate that it is a non-specific effect of butyrate and BrdUrd 
treatment which is unrelated to the increase in amounts of IFNmRNA. 
i) The difference of 3-4 fold between the increases in IFNmRNA and 
IFN yield was the same for both treatments and not dose-dependant. 
ii) It would appear that the condition of the cells 
before treatment 
was critical. Firstly, when the cells were held 
in maintenance medium 
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for 48 h before butyrate or BrdUrd treatment the increase in amounts 
of IFNmRNA equalled the increase in IFN yield. Secondly, in previous 
studies on the effects of butyrate on IFNmRNA and IFN synthesis 
(Morser et al., 1980), both were increased to the same extent. The 
only difference between the experiments reported here and those by 
Morser et al., 1980 would appear to be the passage conditions they 
used to grow cells before treatment. Cells were grown to a density 
of 2x 106 cells/ml or more, whereas in this study cell density never 
exceeded 106 cells/ml and cells were routinely passaged 2 days before 
each experiment. Namalwa cell cultures exceeding 2x 106 cells/ml 
are no longer growing exponentially, and similarly growth is 
arrested if cells are held in maintenance medium. This suggested 
that the metabolic status of cells was important in determining 
whether or not butyrate and BrdUrd treatment caused increased 
efficiency of translation of IFNmRNA. No further investigations 
were carried out since this was not a specific effect of butyrate 
or BrdUrd. 
In conclusion, IFN synthesis is directly proportional to the 
amounts of IFNmRNA present in untreated, induced cells. Butyrate 
and BrdUrd treatments increase the rate of IFN synthesis by 
increasing the rate of IFNmRNA synthesis. The treatment conditions 
also caused an increase in the efficiency of IFNmRNA translation 
which contributed to the enhanced yields of IFN. The value of 
butyrate and BrdUrd as tools for studying the control of IFN synthesis 
is discussed in section 4. 
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Section 3.3 Analysis of Namalwa IFNmRNA 
a) Introduction 
The data in the previous two sections, describing the control 
of IFNmRNA synthesis and its stability in Sendai virus induced 
Namalwa cells, were obtained entirely by translation of the mRNA 
in oocytes. While this method was sufficient to determine the 
relative amounts of functional IFNmRNA, and hence the capacity of 
the cells to produce IFN, it has several important limitations. 
Firstly, the oocyte translation method considered all IFNmRNAs 
collectively and the proportions of IFN- a and IFN 13 mRNA were not 
distinguished. The Namalwa cells used in these experiments did 
not produce detectable IFN ß activity (see section 2) although 
this cell line has been reported to produce both IFN- c and IFN /3 mRNA 
and protein (see section 1.2). Therefore it was important to know 
whether IFN -/3 mRNA was induced in these cells and if so, to determine 
the reason for the failure to produce IFN activity. Secondly, the 
measurement of IFNmRNA by translation in oocytes is indirect, being 
dependant on both the translational activity of the mRNA and the 
specific activity of the translated protein. Consequently, changes 
in the functional amounts of IFNmRNA, either during the period of 
IFN production or after treatment of the cells with butyrate and 
BrdUrd, are not necessarily equivalent to changes in physical amounts 
of IFNmRNA. In addition information was required about changes in 
the composition of IFNmRNA, for example do butyrate and BrdUrd 
alter the relative proportions of IFN- a to IFN /3 mRNA and likewise 
do they cause increased synthesis of the multiple IFN- mRNA species 
individually or collectively? This information is important for 
understanding the control of IFN synthesis and also the action of 
butyrate and BrdUrd. 
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Hybridization of induced RNA with cloned IFNcDNA probes provides 
an alternative and complimentary method of identifying and quantitating 
IFNmRNA. The method allows-each class of IFNmRNA to be characterised 
specifically since the lack of sequence homology between IFN- a and 
IFN 13 prevents cross-hybridization and in addition it is dependant 
on the physical amounts of mRNA present. In this section the IFNmRNA 
induced in Namalwa cells is investigated by hybridization with IFN- a 
and IFN 13 cDNA probes. The data are used in conjunction with 
measurements of IFNmRNA activity in oocytes to describe in more 
detail the expression of IFNmRNA in these cells 
Unless otherwise stated, RNA from butyrate-treated cells was 
used because butyrate treatment increased the amounts of IFNmRNA 
available for investigation. This approach was based on the 
assumption, which will be validated in part g, that treatment did 
not alter the characteristics of the IFNmRNA induced. 
b) Characterisation of the Namalwa IFNmRNA 
The distinction between IFN- « and IFN -/3 mRNA classes by oocyte 
translation relies on measurement of the neutralisation of translated 
IFN activity by antisera raised to each class of IFN. Using this 
approach no IFN ß activity, and hence no IFN-ý3 mRNA, could be 
distinguished by microinjection of oocytes with either total or 
pöly(A)+ RNA from induced Namalwa cells. (data not shown). Because 
of the problems caused by cross-reactivity of the antisera mentioned 
in section 2, this result did not eliminate the possible presence 
of small quantities of active IFN-/3 mRNA which could be masked by 
the translation of predominantly IFN-oc. 
In contrast, dot-blot hybridisation of RNA from Namalwa cells 
with 
32P-labelled IFN- a2 and IFN 13 cDNA indicated that both classes 
of IFNmRNA were readily detectable after (But not before) induction 
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with Sendai virus. The size of the RNA hybridizing with these 
probes was estimated by fractionating poly(A)+RNA from induced, 
butyrate-treated cells under fully denaturing conditions by 
electrophoresis through 1.59'agarose, 10mm methylmercury gels. The 
RNA was then transferred by blotting, to nitrocellulose filters 
and hybridized with 
32P-labelled IFN- d2 cDNA in order to locate 
the IFN-ocmRNA species present. Only an IFN-c<2 cDNA probe was 
used, therefore the stringency of the hybridization was reduced 
to allow for the lack of sequence homology, and ensure that all 
IFN-a mRNA species were detected (see section 1.2). Fig. 17, 
track 1 shows that the IFN- a mRNA species were represented by a 
heterogeneously sized population of molecules. Two broad bands 
could be distinguished around 1.25Kb and 1.4Kb in size. The 
and 1 35 -003 kb 
1 average 
size of these bands (from 6 determinations) was 1.20± 0.03Kb. 
When the stringency of hybridization was increased the same size 
distribution was observed, although this reduced the degree of 
hybridization (judged by the intensity of the signal). Therefore 
the reduced stringency was not introducing artifactual results and 
Fig. 17, track 1 represented specific hybridization with IFN-« mRNA. 
The size of the IFN-/3 mRNA present in the poly(A)+RNA from 
induced cells was determined using the same filter. The IFN- '2 
cDNA probe was melted off and the filter rehybridized with labelled 
normal 
IFN /j cDNA using stringency conditions. Fig. 17, track 2 shows 
that a single band of IFN-13 mRNA was detected with a size of 
1.1Kb. The average size if this band was 1.05± 0.03Kb 
(from 6 
determinations) which was clearly distinct from the size of 
IFN- a mRNAs. 
Therefore since these sizes corresponded closely with 
the expected 
sizes of IFNmRNA species (see part h), it was concluded that both 
IFN- a and IFN -/3 mRNA were present in these Namalwa cells. 
Fig. 17. Blot-transfer hybridization analysis of R TA from induced 
cells. 20ug of poly(A)+ RNA prepared from cells at 7h after 
induction were electrophoresed through an agarose-me'thyl- 
mercury gel and transferred to a nitrocellulose filter. The 
immobilised B NA was first hybridized with 
32P-labelled 
IFN-a cDDTA (track 1 ). The probe was then melted off and the 
RNA rehybridized with 
32P-labelled IFN 13 cDNA (track 2 ). 
Kb 12 
2.00- 1.91- 
1.58- 
1.35- 
0-91- 
0-81- 
Fig. 17 
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c) The relative abundance of IFN-o<and IFN-/3 mRNA 
Comparison of the amounts of probe hybridizing with dot-blots 
of RNA from induced cells suggested that comparable amounts of IFN-61 
and IFN - mRNA were present. It was therefore unlikely that low 
levels of IFN 13 mRNA were the reason for the failure to detect 
translation of IFN 13 activity in the Namalwa cells or in oocytes. 
However, a direct comparison of the amounts of probe hybridizing 
to RNA was not sufficient to confirm the relative proportions 
of IFN- a and IFN-/3 mRNA. For example, possible differences in 
hybridization efficiency could not be discounted. In order to estimate 
the relative abundance of each IFNmRNA as a percentage of the total 
poly(A)f population in untreated cells, the dot-blot hybridizations 
were calibrated using unlabelled cDNA bound to nitrocellulose filter 
discs. Filters were loaded with 0-5ng of denatured double-stranded 
DNA containing the IFN- a2 or IFN-/3 cDNA in a total of 5ug of carrier 
salmon sperm DNA. (Since double-stranded probe was to be used the 
double-stranded nature of the unlabelled DNA on the filters could be 
ignored). The DNA on the filters was hybridized with the appropriate 
labelled cDNA probe (using an approximate 10-fold excess of labelled 
complementary DNA), washed and then counted by Cerenkov emmision to 
quantitate the amount of probe hybridized. Fig. 18 shows that 
there was a linear relationship between DNA loaded and counts 
hybridized for both the IFN- ocand IFN-/3 calibration. In order to 
estimate the abundance of IFN- a and IFN-/3 mRNA filters carrying 
0-5ug of poly(A)+RNA from untreated induced cells 
(in a total of 
5ug, made up with carrier yeast RNA) were included in the hybridization 
together with the filters used to calibrate the assay. By comparing 
the amount of each probe which hybridized with the RNA in Fig. 19 
and the calibration curves in Fig. 18, the relative proportions 
of IFN- * and IFN /3 mRNA were calculated as follows. 5ug of poly(A)+RNA 
Fig. 18. Dot-blot calibration. From 0-5 ng of (a) IFN-c< 2cDITA and 
(b) IFN -/3 cDNA were dot-blotted onto nitrocellulose filters 
with 5ug of carrier DNA. The filters were then hybridized with 
their respective 
32P-labelled 
cDNAs, and then counted by 
Cerenkov emmission. 
(duplicate samples from a single experiment ) 
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Fig-19. Dot-blot calibration. From 0-5ug of poly(A)+ . TJA from 
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contained the equivalent of 0.5ng of IFN-occDNA and 1.2ng of IFN ,g cDNA. 
These values were corrected for the difference in size between the 
DNA fragments containing the"cDNAs and their respective mRNAs. The 
size of the Msp fragment containing the IFN-0(2 cDNA was 1.18Kb 
(see section 2) whereas the average size of IFN-ofmRNA was 1.27Kb 
(Fig. 17, trackl), therefore ing of DNA was equivalent to 1.08ng 
of mRNA. Similarly, the IFN /3 cDNA was contained in a 1.21Kb fragment 
(see section 2) while IFN-/3mRNA was 1.05Kb in size (See Fig. 17, 
track 2) therefore ing of DNA was equivalent to 0.86ng of mRNA. 
From this it was estimated that IF]-a mRNA represented 0.01% and 
IFN /3 mRNA 0.02% of the poly(A)+RNA in this sample from untreated 
cells. On a molar basis the IFNmRNA was therefore composed of 
approximately 29% IFN-a and 71% IFN-fimRNA. Almost identical results 
were obtained when the calibration was repeated using different 
preparations of cDNA. Similar values were indicated by dot-blot 
hybridizations using over 20 other RNA samples. 
These results indicated that sufficient IFN 13 mRNA should be present 
in induced cells for its translation to be detected, since by comparison, 
the translation of IFN-ocmRNA was readily detected. This suggested that 
the IFN /3 mRNA was in some way defective. Two explanations for the 
failure to detect IFN-713 activity in either induced cell cultures or 
oocytes microinjected with RNA from induced cells were i) the IFN 13 xRNA 
is not translated or translated with a very low efficiency relative 
to IFN- a mRNA or ii) the IFN /3 mRNA codes for an inactive protein. 
Although the method used only provides an approximation of the 
relative abundance of each class of IFNmRNA, the values obtained 
for IFN-ocmRNA compare well with other data which are discussed 
later in section h. 
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dý The activity of fractionated IFNmRNA 
The characterisation of Namalwa IFNmRNA was extended by 
investigating the translational activity of the agarose gel 
fractionated RNA detected by hybridization with IFNcDNA probes. 
The reasons for this comparison were threefold; i) to determine 
whether the size distribution of IFN-a mRNA which hybridizes with 
IFN-occDNA (See Fig. 17, track 1) also represents functional 
mRNA, ii) to confirm that no IFN -ý3 activity is translated from the 
IFN-/3 mRNA detected by hybridization with IFN-13 cDNA (in the absence 
of IFN- a activity which could"maýk small amounts of IFN-/3) and iii) 
to ensure that no functional IFNmRNA (such as the large IFN-(mRNAs 
reported by Sagar et al., 1981) is produced other than the mRNAs 
identified by hybridization with IFNcDNA probes. To obtain the 
information, poly(A)+RNA from induced, butyrate-treated cells was 
fractionated by methylmercury agarose gel electrophoresis as in 
Fig. 17. The-gel was then cut into 2mm slices and the RNA eluted. 
An aliquot of the RNA from each gel slice was microinjected into 
oocytes in order to determine the position of active IFNmRNA. Fig. 
20A shows the IFN activity translated from this RNA assayed in both 
bovine and human cells. For comparison, further aliquots of the 
same RNA samples were also analysed by dot-blot hybridization with 
either IFN- a 2cDNA or IFN-/3cDNA probes, and Fig. 20B shows the 
location of gel slices containing IFN- o and IFN /3 mRNA. From this it 
was apparent that active IFNmRNA was only detected in gel slices contain- 
ing RNA 1.35Kb in size, which coincided with the region of the gel 
containing hybridizable IFN- a mRNA. No activity was detected 
by 
translation of RNA from other regions of the gel including 
RNA 
around 1.1Kb in size which hybridized with IFN-/3cDNA. 
Bovine cells are only sensitive to IFN- a, 
hence if any IFN -/3 
activity were present it would only be detected 
by assay in human 
Fig-20. Characterisation of fractionated IFNmIUTA by oocyte translation 
and dot-blot hybridization. 20ug of noly(A)+ RNA was electrophoresed 
through an agarose nethylmercury gel. 
(A) RIBA was extracted from excised gel slices and microinjected 
into oocytes. The translated IRT-ryas assayed in both bovine 
. 
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cells and would result in a different profile of activity compared 
to assay in bovine cells. However, the distribution of functional 
IFNmRNA was identical when the translated IFN activity was assayed 
in either cell type. Furthermore, none of this IFN activity was 
neutralised by anti-IFN -P serum. The IFN assay using human GM2767 
cells, as it was performed in this experiment, was capable of 
detecting as little as 0.4 units of IFN per ml. In the experiment 
shown in Fig. 20 this would mean that if active IFN 13 were present 
it represented less than 0.25% of the total IFN activity translated 
by the RNA el u ted from the gel. No active IFN /3 mRNA could be 
detected by a similar analysis of RNA from untreated cells either 
(data not shown), therefore these results were not due to an effect 
of butyrate treatment. 
The RNA extracted from agarose gel slices contained only partially 
purified IFNmRNA, since other RNAs of similar size would comigrate 
to the same position on the gel. To eliminate the possibility that 
these 
IRNAs 
interfered with translation of IFN /3 mRNA, a control 
experiment was set up to purify the IFNmRNAs. Poly (A)+RNA from 
induced , butyrate-treated cells was hybridized with either IFN- a 2cDNA 
or IFN-/3 cDNA which had been immobilised on nitrocellulose filters. 
The hybridized RNA was then eluted and translated by microinjection 
into oocytes. Table 12 shows data kindly provided by Dr Morser which 
demonstrates that the RNA released from IFN- a 2cDNA translated to 
produce IFN activity which was characterised as IFN-a by its high 
ratio of activity in bovine compared to human cells. This activity 
was also neutralised by anti-IFN- a serum (data not shown). The 
RNA released from IFN /3 cDNA did not translate to give any IFN 
activity. As a check, RNA from NDV-induced MG63 cells 
(which produce 
both IFN- « and IFN -/3 ) was also hybridized with both 
IFNCDNAS and 
clearly both UN- a and IFN 13 mRNA could be detected in RNA released 
Table 12. Hybrid-release translation of IFniRNA from induced Namalwa 
and Y. G63 cells. 
IFN (log10units/ml ) 
RNA cDNA EBTr HFF 
Namalwa 
C4 
2.1 1.2 
MG63 1.1 < 0.3 
Namalwa < 0.3 < 0.3 
MG63 
13 
< 0.3 1.6 
Poly(A)+ Fü1A from induced Namalwa and MG63 cells was hybridized with 
either IIN-c<2 or IFN ßcDNA which had been immobilised on nitro- 
cellulose filters. Hybridized RNA was removed from the filters and 
microinjected into oocyte,. The Ifd translated was assayed in both 
bovine (EBTr) and human (HFP) cells. (single samples from a representative 
experiment ) 
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from the respective cDNAs. 
Together these results indicated that the IFN -A mRNA induced 
in these Namalwa cells was not functional. In addition, the size 
distribution of functional IFN-o mRNA was identical with that of 
the IFN- a mRNA detected by hybridization. This did not mean that 
all of the hybridizable IFN- a mRNA was functional, but it did 
confirm that no IFNmRNA could be detected other than that which 
hybridized with IFN- a2 and IFN-/3 cDNA probes. 
eý The distribution of IFNmRNA 
In order to obtain more information about the non-functional 
IFN-/3 mRNA its cytoplasmic distribution was compared with that of 
IFN- a mRNA. Measurements of functional IFNmRNA by translation in 
oocytes indicated that it was present exclusively in the poly(A)+ 
fraction of cytoplasmic RNA, and that approximately 80% was 
associated with polysomes (and presumably involved in translation), 
(see section 3.2). Non-functional IFNmRNA could be present in the 
poly(A) RNA and possibly not be associated with polysomes. Therefore 
the physical distribution of IFN-o<and IFN /3 mRNA was compared by 
preparing polysome-associated and non-polysome-associated RNA from 
butyrate-treated, induced cells. Poly(A)+ and poly(A) RNA was 
selected from each fraction and hybridized with either IFN- a or 
IFN-/3 cDNA probes. Table 13a shows that neither IFN- °(or IFN 
sequences could be detected by hybridization with poly(A) RNA, 
therefore this fraction does not contain either active or inactive 
IFNmRNA. Hybridization with their respective probes showed that 
approximately 66% of the IFN-oc mRNA and 76% of the IFN -/3 mRNA was 
in the poly(A)+RNA associated with polysomes.. Therefore not only 
was the relative distribution of each class of IFNmRNA similar, 
but it corresponded closely with the value of 80% obtained by 
Table 13. The distribution of IFN-a and IFN -p mRNA in induced cells 
in the presence and absence of puromycin. 
(a) cDNA hybridized 
IFN- cc ITN- 
(f) RNA sample cpm (%) cpm. 
polysomal pellet poly(A)+ 2880 (66) 1069 
(76) 
free cytoplasmic poly(A)+ 1434 330 
polysomal pellet poly(A) 00 
free cytoplasmic poly(A) 00 
(b) 
pellet poly(A)+ 446 (24) 136 (10) 
free cytoplasmic poly(A)+ 1377 288 
pellet poly(A) 00 
free cytoplasmic poly(A)- 00 
(a) 5ug of both poly(A)+ and poly(A)- RNA prepared from polysome 
associated and free cytoplasmic RNA were dot-blotted onto nitro- 
cellulose filters and hybridized with IFN-at 2cDNA. The probe was 
then melted off and the RNA rehybridized with IFN19 cDNA. The 
amount of probe hybridized was estimated by Cerenkov emission. 
(b) Samples were prepared and analysed as in (a) except that the RNA 
was prepared from cells which had been treated with purormrcin 
( 100 ug/ml ) for 5 min. 
(average of duplicate samples from a representative experiment 
) 
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measuring polysome associated IFNmRNA activity. It was possible 
that some of the mRNA pelleting with the polysomes was in fact 
associated with RNP particles, since the method of preparation 
depended on sedimentation of post-nuclear supernatants through 
a discontinuous sucrose gradient designed to optimize polysome 
yield (see section 2). To overcome this criticism a portion of the 
cells used to prepare polysomes was treated with puromycin 100ug/ml 
before preparing polysomes. This treatment disrupts the polysome 
complex by causing premature termination of polypeptide synthesis 
and detachment of the mRNA from ribosomes. Consequently, any 
RNA pelleting in the polysome preparation should not in fact be 
associated with polysomes but more likely RNP.. Table 13b shows 
the distribution of IFN-< and IFN -/3 mRNA in this control experiment. 
Clearly the amounts of each IFNmRNA in the pellet were significantly 
reduced, following puromycin treatment of the cells. The small 
amounts remaining could be accounted for either by RNP or by small 
quantities of polysomes which remained, since the period of puromycin 
treatment was not sufficient to ensure complete dissociation. A 
longer exposure to puromycin would have meant that the RNA extracted 
in this experiment could no longer be compared with RNA extracted from 
polysomes, for example it could not be assumed that the stability 
of the mRNA or the integrity of its poly(A) tract would remain 
unaltered once removed from ribosomes. Nonetheless this result 
showed that most of the IFNmRNA pelleted during the preparation of 
polysomes was in fact associated with polysomes and not RNP. 
The IFN ,3 mRNA was therefore a poly(A)+mRNA which was 
specifically associated with polysomes to the same extent as the 
functional IFN- a mRNA. Consequently the absence of translated IFN 
13 
activity was not due to a defect in the efficiency of IFN 
/3 mRNA 
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ribosome binding. 
f) The Coordinate control of IFN- a and IFN-ß mRNA synthesis 
and degradation 
Having established the time course of accumulation and decay of 
functional IFNmRNA in Section 3.2, it remained to determine firstly, 
whether physical amounts of IFNmRNA were regulated in the same way, 
and secondly, whether IFN-ccand IFN-, mRNAs were coordinately 
controlled. For this purpose, total RNA extracted from butyrate- 
treated cells at various times after induction, was dot-blotted 
onto nitrocellulose filters then hybridized with either 
32P-labelled 
IFN- ( 2cDNA or IFN 13 cDNA. (The RNA samples were in fact aliquots 
of the RNA used in Section 3.2, Fig. 14b) Fig. 21 shows that the time 
course of accumulation and degradation of IFN-otand IFN-/3mRNAs was 
identical. The amounts of both mRNAs reached a maximum at 9 hours 
after induction then declined as in Fig. 14b. Therefore both 
IFN-ocand IFN - mRNAs are induced and regulated coordinately. 
The accumulation and decay of functional IFNmRNA therefore 
corresponds with similar changes in the physical amounts of IFNmRNA 
in the cells, indicating that the shut-off of IFN synthesis is 
accompanied by the degradation and not merely inactivation of its 
mRNA. However, the decline in amounts of functional IFNmRNA 
(Fig. lob) 
slightly preceded the loss of hybridizable IFNmRNA 
(Fig. 21) as might 
be expected if the mRNA became non-functional while remaining 
sufficiently intact to be detected by the probe. The amounts of 
full-length IFNmRNA could have been measured by hybridization to 
fractionated RNA, in order to confirm this possibility, 
however the 
data in Fig. 16 were sufficient to conclude that degradation of 
IFNmRNA occurred on a similar time scale as 
its loss of translational 
activity. 
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It was shown in section 3.1 that by reducing the incubation 
temperature of cells to 28° at 7h after induction, IFNmRNA stability 
was increased thereby delaying the shut-off of IFN synthesis and 
increasing the overall yield of IFN. The conclusions relating to 
the effect of temperature on IFNmRNA stability (measured by oocyte 
translation of RNA extracted from cells at various times after 
induction) were confirmed by dot-blot hybridization of aliquots of 
the same RNA samples used in Fig. 10b with IFN-o(2cDNA probe. Fig. 22 
clearly shows that the disappearance of IFN- a mRNA is delayed in 
cells incubated at 28°, and confirms that the shut-off of IFN 
synthesis and decay of functional IFNmRNA (see Fig. 10b) is accompanied 
by the degradation and loss of IFNmRNA from the cells. 
g) The effects of butyrate and BrdUrd on IFNmRNA synthesis 
In section 3.2 treatment of cells with butyrate or BrdUrd 
before induction was shown to increase the synthesis of translatable 
IFNmRNA. Although the characteristics of the IFN produced by cells 
were not affected by these treatments it was still necessary to 
compare the characteristics of the IFNmRNA produced by treated and 
untreated cells and to confirm that increased physical amounts of 
IFNmRNA were synthesised. This information was required to describe 
more fully the effects of butyrate and BrdUrd on IFN synthesis. For 
these reasons the size distribution and differences in the physical 
and functional amounts of IFNmRNA were compared in treated and 
untreated cells. 
Po1y(A)+RNA from induced, butyrate-treated, BrdUrd-treated and 
untreated cells was electrophoresed through an agarose methyl-mercury 
gel, transferred to nitrocellulose filter and then 
hybridized with 
IFN- a 2cDNA as in Fig. 17. Fig. 23 shows that the 
IFN- a mRNA 
detected has the same heterogeneous size distribution 
in RNA from 
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Fi g. 22. The effect of reduced incubation temperature on IFNmRNA levels 
during the shut-off of IFmm, synthesis. Total RIBA was extracted from 
cells incubated at 37° ( ) or at 28° from 7h after induction (O ). 
20ug of the RNA was dot-blotted onto nitrocellulose and hybridized 
with 
32P-labelled Ili-c< 2cDNA. 
( average of duplicate samples from a single experiment 
) 
Fig-23. Blot-trenfer hybridization analysis of Irld-c(mRNA from 
induced, treated and untreated cells. 20ug of poly(A)+ Ri; A 
extracted at 7h after induction from (1) butyrate-tree. ted, 
(2) untreated and (3) BrdUrd-treated cells was electrophoresed 
through an agarose-methylmercury gel and transferred to a 
nitrocellulose filter. The immobilised RNA was then hybridized 
with 
32P-labelled 
IR1-o(cDNA. (4) shows a shorter autoratiio- 
graph exposure of (3). 
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both treated and untreated cells, with two broad bands being 
resolved around 1.2 Kb and 1.35 Kb in size. No hybridization was 
detected with RNA larger than approximately 1.5 Kb. Fig. 23, track 
4 shows a shorter autoradiograph exposure of track 3, confirming that 
the RNA was identical in size. The hybridization with smaller RNA 
in track 3 was most probably due to degraded IFN-ocmRNA, and was 
not unexpected since the mRNA is rapidly turned over (see section 
3.1). 
Fig. 24 shows densitometric scans of the autoradiograph shown 
in Fig. 23 tracks 1-3. By measuring the area beneath each peak, 
the increase in hybridization was found to be 18-fold for RNA from 
butyrate-treated cells and 3-fold for RNA from BrdUrd-treated cells 
relative to RNA from untreated cells. 
Identical samples to those used in Fig. 23 were electrophoresed 
on the same gel, and the gel tracks were cut into 2mm slices. An 
aliquot of the RNA extracted from each gel slice was microinjected 
into oöcytes and the translation products assayed for IFN- a activity 
in bovine cells. Fig. 25 shows that the profile of IFN-O(mRNA 
activity was identical for treated and untreated cells, with a single 
peak occurring around 1.35 Kb in size. No IFN activity was detected 
elsewhere on the gel by assay in human or bovine cells and none of 
the IFN activity was neutralised by anti-IFN /3 serum, as in Fig. 20a, 
therefore no active IFN-r3 mRNA could be detected. The increase in 
active IFN- a mRNA, calculated by integrating each peak, was 10-fold 
for butyrate-treatment and 4-fold for BrdUrd treatment which closely 
compared with the values obtained for the unfractionated 
RNA (10-fold 
for butyrate and 1.5-fold for BrdUrd treatment). Therefore the increase 
in amounts of active IFNmRNA in butyrate and BrdUrd-treated cells 
could be accounted for by RNA of this size, and 
it was unlikely 
that IFNmRNA of another size had gone undetected 
(for example, due to 
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Fig. 24. Densitometric scans of the autorad. iograph shovm in Fig. 23. 
(A) RNA from butyrate-treated cells, (B) RNA from BrdUrd-treated 
cells and (C) RNA from untreated cells. 
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inefficient elution from the gel or inactivation). 
Another aliquot of the same RNA samples used for microinjection 
into oocytes was analysed by dot-blot hybridization in order to 
correlate the location of active and hybridizable IFNmRNA. Fig. 25 
shows the amount of IFN-« 2cDNA hybridizing to each sample, and 
clearly the size distribution of IFN-ocmRNA was identical for both 
treated and untreated cells. The increase in amounts of hybridizable 
IFN- a mRNA (measured by integrating each peak) was 16-fold for RNA 
from butyrate-treated cells and 4-fold for RNA from BrdUrd-treated cells. 
Although the dot-blot analysis did not distinguish the two bands of 
hybridization seen in Fig. 17a (as might be expected, since gel 
slicing provides poor resolution), it indicated that the physical 
distribution of IFN-c mRNA coincided with the distribution of active 
IFN-cCmRNA. This does not indicate that all of the IFN-o(mRNA detected 
by hybridization is active, since neither technique measures absolute 
amounts of mRNA. 
Together these results suggested that butyrate and BrdUrd 
treatments caused a proportionate increase in all of the IFN-ccmRNA 
species transcribed in untreated cells, and did not cause the 
transcription of new IFNmRNA species. In addition, the increase 
in amounts of functional IFN- c mRNA in RNA from treated cells was 
accompanied by a similar increase in physical amounts of IFN- o( mRNA 
confirming that butyrate and BrdUrd do indeed cause-increased 
synthesis of the mRNA rather than changes in its translational 
activity or the specific activity of the IFN it codes for. 
A similar investigation of the IFN -p mRNA could not 
be performed 
since it did not code for active IFN-13 " However, similar poly(A)+RNA 
samples from butyrate-treated, BrdUrd-treated and untreated cells were 
electrophoresed through an agarose gel, transferred 
to nitrocellulose 
filter and hybridized with labelled IFN 
/3 cDNA as in Fig. 17. Fig. 26 
Fig. 26. Blot-transfer hybridization analysis of IM -/3 mRNA from 
induced, treated and untreated cells. 20ug of poly(A)}RNA 
extracted at 7h after induction from (1) butyrate-treated, 
(2) untreated and (3) BrdUrd-treated cells was electrophoresed 
through an agarose-methylmercury gel and transferred to a 
nitrocellulose filter. The immobilised RITA was then hybridized 
with 
32P-labelled IFN 13 cDNA. 
Kb 123 
2"oo- 1.91- 
1.58- 
1.35- 
0.91- 
0-81- 
Fig. 26 
101 
shows that the IFN-/3 mRNA was the same size and also present in 
increased amounts in the RNA from treated cells. The increase in 
amounts of IFN-/3 9 estimated from densitometric. scans of the 
autoradiograph was 17-fold in RNA from butyrate-treated and 2-fold 
in RNA from BrdUrd-treated cells. These values were virtually 
identical to those for IFN-ocmRNA shown in Fig. 18, therefore 
butyrate and BrdUrd treatments coordinately increased the synthesis 
of both IFN-c< and IFN ,3 mRNA. 
h) Discussion 
These results have shown that Sendai virus induced the synthesis 
of IFN-oamRNA and also a non-functional IFN /3 mRNA in the Namalwa 
cells used in these experiments. The size of the RNA hybridizing 
with IFN- «2 cDNA probe ranged from 1.2 Kb to 1.35 Kb. Such size 
heterogeneity can be accounted for by inspection of cloned IFN-o< 
cDNA and genomic"DNA sequence data (Nagata et al., 1980; Goeddell 
et al., 1981). The minimum predicted size for IFN-e(1 and IFN- cic2, 
two of the species suggested to be expressed by Namalwa cells (see 
section 1.2), is approximately 1.08 Kb (based on a DNA sequence 
consisting of 70 bp of 5' leader sequence, 564-567 bp of coding 
region, 242 bp of 3' untranslated sequence and an estimated poly(A) 
tract 200 residues long). IFN- °C3 is also thought to be expressed 
by Namalwa cells since its predicted amino acid sequence closely 
matches the NH2-terminal sequence of the major constituent of 
Namalwa IFN (Zoon et al., 1980). IFN- a3 has a 342 bp 3' untranslated 
region therefore the predicted size of its mRNA in 1.18 Kb. 
Similarly, IFN-. 8mRNA, with a 441 bases of 3' untranslated region, 
would be even larger with a size of 1.28 Kb. 'In addition the 3' 
flanking regions of IFN-ac genes have multiple possible sites for 
polyadenylation. When the IFN-ocl gene is expressed after transfer 
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to mouse L-cells the majority of transcripts are polyadenylated at 
the first site, however two other sites are utilised resulting 
in a small proportion of transcripts which are 300 bases longer 
( S. Nagata, personal communication), that is up to 1.38 Kb in 
size. Admittedly, the identity of the IFN-« species expressed in 
Namalwa cells has not been confirmed however, these are possible 
explanations for the heterogeneity of IFN-°cmRNA. 
The non-functional IFN-/3 mRNA induced in these Namalwa cells, 
was discrete, only RNA 1.05 Kb in size hybridized with the IFN /3cDNA 
probe, which is the reported size of the single IFN f3 mRNA . 
in fibroblasts (Raj and Pitha, 1981). SI mapping has shown that 
the IFN-/3 induced in Namalwa cells is indistinguishable from 
fibroblast IFN-/3 mRNA (Gross et al., 1982), therefore both are 
probably transcribed from the same unique gene. The IFN /3 mRNA 
induced in the Namalwa cells used in the experiments described here, 
although not functional, comigrated with functional IFN-f3 mRNA from 
induced MG 63 cells (data not shown) suggesting that it was a full- 
length transcript. Therefore it was unlikely that its failure to 
code for active IFN /3 was due to a large deletion or premature 
termination of transcription. The characteristics of this IFN -/3 mRNA 
are discussed further below. 
The size distribution of IFN-c(mRNAs in the fractionated 
poly(A)+RNA from these cells was identical when determined either 
by 
oocyte translation or by hybridization with IFN-a cDNA probe. Therefore 
its heterogeneity represents functional mRNA and not incomplete 
or partially degraded transcripts. Furthermore the larger 1.9 
Kb 
IFN-otand IFN ß transcripts reported by Sagar et al., 1981 were not 
detected by either method. Therefore the only IFNmRNA species 
produced by these Namalwa cells were of the size predicted 
from 
the IFN- t and IFN-13gene sequences. 
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The value obtained for the relative abundance of IFN-ocmRNA 
agrees with information obtained from cDNA cloning and the 
355- 
methionine labelling of IFN- a produced by these cells. IFN-c(mRNA 
was estimated to represent 0.01% of the poly(A)+RNA population in 
induced, untreated cells. By comparison only 2 IFN- a cDNA clones 
were identified in 2000 cDNA clones prepared from size fractionated 
poly(A)+RNA from induced, butyrate-treated cells (Slocombe et al., 
1982), suggesting a relative abundance of 0.1% for the IFN-cfmRNA 
in this sample. Furthermore, the relative rate of synthesis of 
IFN-a protein was estimated to be 0.2-0.6% of total protein synthesis 
in induced butyrate-treated cells (see section 3.4). The difference 
between the values obtained from untreated and butyrate-treated cells 
is consistent with, and can be explained by the effect of butyrate 
on IFN and IFNmRNA synthesis. The following calculations were 
performed to test whether the estimated abundance of IFN-o( mRNA 
could account for the IFN activity produced by the cells from which 
the RNA was extracted. 
An average of lOpg of total RNA/cell was obtained during the 
course of these experiments. An average of 2% of this was recovered 
following oligo dT chromatography, giving a value of 0.2 pg of 
poly(A)+ selected RNA/cell. If 0.01% of this poly(A)+RNA was 
IFN- d mRNA, then there were 2x 10-5 pg of IFN-o(mRNA/cell. 
The average molecular weight of IFN-o(mRNA 
(Average size 1.27 Kb) 
was 4.19x 105, therefore 4.19x 10-17 pg of IFN-ocmRNA were equivalent 
to 6x 1023 molecules. This gives a value of 
(2x 10 5) x (6 x 1023) 
(4.19x1017) 
or 28 molecules of IFN-o(mRNA/cell 
The cells from which this RNA was extracted produced 
102.2 units 
of IFN/106 cells/h. Taking the specific activity of 
IFN- a to be 
104 
approximately 2x 10 
8 
units/mg (Zoon et al., 1979) the cells 
produced (102.2) =5x 10-12.8 mg of IFN- a /ce11/h. 
10 x (2x10 ) 
The molecular weight ofIFN-Cis 1.9 x 104 (see section 1.2), 
therefore 1.9 x 107 mg of IFN-ocare equivalent to 6x 1023 molecules. 
This gave a value of (5 x 10-12'8) x (6 x 1023) . 1.6 x 104.2 
1.9x107 
molecules of IFN- a /cell/h or 412 molecules of IFN- °/cell/min 
If there are 28 molecules of IFN-ocmRNA/cell, then 15 molecules of 
IFN- are produced/IFN- o' mRNA molecule/min, this was equivalent to 
2475 amino acids/min (166 amino acids/molecule see section 1.2) 
Assuming the rate of elongation in eukaryotic cells ranges from 
120-480 amino acids/min (Palmiter, 1975) this rate of protein synthesis 
would require 5-20 ribosomes to be associated with each IFN- o< mRNA. 
Despite the number of assumptions and approximations made in this 
calculation, the value it gives for the size of the polysomes 
involved in IFN synthesis although rather high, is quite sensible. 
By measuring the IFN activity of nascent polypeptides associated with 
sucrose gradient fractionated polysomes, IFN was found to be associated 
with polysomes up to 8 ribosomes in size, (data not shown) therefore 
all of the available data are consistent with the conclusion that 
IFN-acmRNA iS'a low abundance mRNA representing approximately 0.01% 
of the poly(A)+RNA synthesised by these cells. The importance'of this, 
with regard to the limits it places on the study of IFNmRNA synthesis 
and degradation are discussed in section 3.1. 
The IFN j mRNA induced in these cells was defective since it 
did not translate to give active IFN -/, 3, thus explaining 
the cells 
failure to produce detectable IFN 13 activity. None of 
the 
characteristics which were investigated identified the reasons 
for 
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this lack of IFN-/3 mRNA function. Thus IFNm. NX. of the predicted size, 
hybridizing specifically with IFN /3 cDNA, was induced and regulated 
coordinately with IFN-ocmRNA. This RNA was present in similar 
amounts, and specifically associated with polysomes to the same 
extent as functional IFN-ocmRNA. The failure of this mRNA to translate 
active IFN-/3 could be explained by small deletions, insertions, 
substitutions or inversions in this IFN -13 gene which would not 
necessarily affect expression of the gene or the regulation and 
function of the mRNA up to ribosome binding. Such mutations could 
cause faults in polypeptide synthesis or termination or the translation 
of an inactive protein. An unsuccessful attempt was made to identify 
the possible presence of an inactive translation product of 
this IFN-13 mRNA using immunoprecipitation of 
35S-methionine-labelled 
cell and microinjected oocyte proteins with anti-IFN-/3 serum. To 
have been successful this would have required that the inactive 
IFN 13 was still recognised by anti-serum to active IFN-13. However, 
insufficient radioactivity was incorporated into IFN- oc proteins which 
served as a positive control, therefore no conclusions could be drawn. 
One of the most significant conclusions of this section is 
that apart from the detection of inactive IFN-/3, the results obtained 
by oocyte translation of IFNmRNA have been confirmed by hybridization 
with IFNcDNA. Hence the observations made in sections 3.1 and 3.2 
relating to the control of IFNmRNA synthesis and degradation and the 
relative amounts of IFNmRNA in butyrate-treated, BrdUrd-treated and 
untreated cells have been substantiated. Therefore it can be stated 
that non-induced Namalwa cells do not contain detectable amounts of 
IFNmRNA. Infection with Sendai virus induces the coordinate synthesis 
and regulation of UN- a and IFN /3mRNA. Treatment of the cells 
with butyrate or Brdürd before IFN induction causes the synthesis 
of increased amounts of IFN- « and IFN 13 mRNA which appear identical 
106 
in size distribution to the IFNmRNAs induced in untreated cells. This 
is consistent with, but does not prove that these treatments cause 
a coordinate increase in synthesis of all the IFN-c<mRNA species 
and IFN /3 mRNA, suggesting that butyrate and BrdUrd affect the 
regulation of all the IFNs expressed in these cells. 
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Section 3.4 A comparison of the proteins synthesised by butyrate - 
and BrdUrd-treated Namalwa cells 
a) Introduction 
0 
Treatment of Namalwa cells with butyrate or BrdUrd has been 
shown to substantially increase IFN synthesis by up to 300-fold 
and 35-fold respectively (see section 3.2). Subsequent experiments 
have logically been directed towards characterising the effects of 
these treatments specifically on the control of IFNmRNA and IFN 
synthesis. However as an alternative line of investigation it would 
be useful to examine the effects of butyrate and BrdUrd on the expression 
of other proteins in Namalwa cells. This would establish firstly the 
extent to which these agents affect the rate of synthesis of other 
protein, and secondly, whether they induce any changes which are 
comparable to, or could account for the increased rate of IFN 
synthesis. This section compares the proteins synthesised by 
butyrate-treated, BrdUrd-treated and untreated Namalwa cells. 
Using polyacrylamide gel electrophoresis to resolve 
35S-methionine 
labelled proteins, the pattern of proteins synthesised and changes 
in their rates of synthesis have been assessed. The results of 
these experiments have now been published (Shuttleworth et al., 1982) 
b) One-dimensional SDS-polyacrylamide gel analysis 
In order to obtain information which could be related to the effects 
on IFN synthesis it was decided to investigate the proteins 
synthesised by Namalwa cells after 48h treatment with butyrate or 
BrdUrd, both before and 7h after induction by Sendai virus. Any 
changes which arise before or during the induction and synthesis 
of IFN could then be assessed. 
Cells were treated for 48h with butyrate or BrdUrd then labelled 
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for 30 min with 
35S-methionine. The labelled proteins were compared 
by one-dimensional SDS-polyacrylamide gel electrophoresis using a 
10-20% exponential gradient-of polyacrylamide. From Fig. 27 it 
can be seen that the proteins synthesised by BrdUrd-treated and 
untreated cells were -indistinguishable (Fig. 27, tracks 2 and 3). 
However, butyrate treatment affected the rate of incorporation 
of label into several proteins, which have been indicated by arrows 
(Fig. 27, track 1). The increase in one band migrating with an 
apparent molecular weight of 35,000 (indicated by large arrow), 
which for convenience will be referred to as butyrate enhanced 
protein BEP35, was consistently seen, whereas a decrease in 
intensity of three bands in the molecular weight range of 12,000- 
18,000 (indicated by small arrows) occurred only occasionally. 
Fig. 28 shows a similar analysis of protein from treated 
and untreated cells at 7h after induction of IFN synthesis. The 
preparation of Sendai virus normally used to induce IFN synthesis 
contains a high proportion of DI particles (see section 1.3) and 
will therefore be referred to as DI Sendai virus. Although DI 
Sendai virus is an efficient inducer of IFN9 it does not replicate 
in Namalwa cells (Baker et al., 1980). Consequently the synthesis 
of virus polypeptides was almost undetectable (Fig. 28, tracks 1-3). 
Therefore a purified preparation of normal Sendai virus was used to 
infect cells in order to observe the effect of treatment on the 
synthesis of virus structural peptides. Synthesis of the L, P, HN, Fo 
and NP virus polypeptides and C. a virus-specific cellular protein 
(see section 1.3) were unaffected by the treatments 
(Fig. 28, tracks 
4-6). Likewise the synthesis of an unidentified virus-specific 
cellular protein (indicated by dotted bar) was not affected. This 
protein has not been detected by others, but it was also induced 
in normal Sendai virus infected chick embryo fibroblasts and was 
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Fig. 27. One-dimensional SDS-rolyacrylamide gel analysis of proteins 
from 'seated and untreated cells. Cells were incubated for 48h in 
0.8ml,: butyrate, 25ug/ml BrdUrd or maint ünance medium then labelled 
with 
35S-methionine 
for 30min. Proteins from butyrate-treated 
(trac',: 1) , BrdUrd-treated 
(track 2) and untreated cells (track 3) 
were compared by electrophoresis through one-dimensional. SDS-noly- 
acrylamide gels. The large arrow indicates i rerroducible change 
and the small arrows non-reproducible changes in the rates of 
synthesis of r, roteins from butyrate-treated cells. 
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Fig. 28. One-dimensional SDS-polyacrylamide gel analysis of proteins 
from Sendai virus-infected, treated and untreated cells-Cells were 
incubated for 48h in 0. ßm4 butyrate, 25ug/ml BrdUrd or mnintainance 
medium then infected with either DI Sendai virus (tr,, --cksl-3) or 
normal Sendai virus ( track 4-6). After 7h incubation the cells 
were labelled for 30min with 
35S-methionine. Cellular and virus 
protein synthesis was compared in butyrate-treated (tracks 1,4), 
BrdUrd-treated (tracks 2,5 ) and untreated cells (tracks 3,6 
). 
Track 7 shows untreated, uninfected control cells. The large arrow 
indicates a reproducible change and the small arrows indicate 
non-reproducible changes in the rates of synthesis of proteins 
from butyrate-treated cells. The letters refer to virus structural 
and virus-specific cellular proteins. 
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therefore not unique to Namalwa cells. The Sendai M polypeptide 
was not detected because it was not synthesised in sufficient 
quantity. The butyrate-induced changes in cellular protein 
synthesis were still detectable in infected cells (Fig. 28, 
tracks 1 and 4 indicated by arrows) and remained the only effects of 
treatment observable on one-dimensional gel separation of cell- 
associated proteins. 
Glucocorticoids have been reported to enhance IFN production Rdolýomd 
by Namalwa cells (Swetly, 1979b). However one-dimensional gel 
n 
analysis of proteins from prednisolone-treated cells failed to 
show any enhancement of BEP35 (data not shown). Therefore as 
neither BrdUrd or prednisolone affected the synthesis of BEP35 it 
was unlikely that this protein was associated with a common mechanism 
of enhancement of IFN synthesis. 
When non-infected, butyrate-treated cells were homogenised using 
(\lonidet P-40 and centrifuged to remove nuclei and intact cells, 
BEP35, was found to be located predominantly in the post nuclear 
'supernatant (data not shown). Therefore BEP35 was not associated with 
chromatin, unlike some of the proteins reported to be induced or 
enhanced by butyrate in other cells (D'Anna et al., 1980). 
The effects of treatment were characterised further by pulse- 
chase labelling of cells. Treated and untreated cells were labelled 
for 30min and followed by a 2h chase. The labelled proteins were 
separated by one-dimensional SDS polyacrylamide gels as in pigs. 27 
and 28. Fig. 29 shows that apart from BEP35 no other changes in 
protein synthesis were apparent. By -comparing the intensity of 
the 
band from pulse labelled (track 1) and pulse-chase labelled cells 
(track 2) it was clear that BEP35 was rapidly turned over, in fact 
after a 4h chase no enhancement was observed (data not shown). 
The proteins secreted by treated and untreated cells were 
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Fi ;. 2j. One-dim. nsioncl SDS-cooly , crylamide gel an alysis of pulse- 
labelled Proteins from treated and untreated cells. Cells were 
incubated for 48h in 0.8m. iI butyrate, 25ug/ml BrdUrd or maintainance 
mediuri . 
t:. en either , ulse-labelled for 30min with 
35S-methionine 
or pulse-labelled for30min with 
35S-mehtioni. 
ne followed by a 
2h chase with unlabelled nethioi. ine. r l. se-labelled (tracks 1,3,5 ) 
and pulse-chase labelled (tracks 2,4,6 ) samples from butyrate- 
treated (tracks 1,2 ), ", rd Urd -treated 
(tracks 7,4 ) and untreated 
cells (track's 5,6 ) were compared by electrophoresis through one- 
dimensional SDS-polyacryla üde gels 
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compared by one-dimensional gel analysis of the pulse-chase medium 
obtained from the labelling of cells used in Fig. 29. Fig. 30 
shows that two broad bands, ' migrating with apparent molecular 
weights of 20,000 and 22,000 were enhanced in proteins secreted 
by butyrate-treated cells (track 1) and to a lesser extent by 
BrdUrd-treated cells (track 2). These corresponded closely in size 
to the reported molecular weights of IFN species produced by Namalwa 
cells (Allen and Fantes, 1980). Such an increase would be expected 
in view of the effects of treatment on IFN synthesis, and should be 
within the limits of detection (see discussion). However this by no 
means confirmed that these two bands were IFN. Only one other 
change was detected reproducibly, this was an increase in synthesis 
of a protein with a relative molecular weight of 11,000. On the gel 
shown, one protein with a molecular weight of approximately 45,000 
appeared to show increased labelling in treated cells (Fig. 30 
tracks 1 and 2). This protein most likely represents contamination 
of th'e sample by actin, a major cellular protein. No such change 
in labelling of this protein was observed in cell-associated samples 
(Figs. 27 and 28), therefore this suggested that the variation 
was caused by differences in contamination of the secreted proteins 
by cellular proteins. 
c) Two-dimensional gel electrophoresis 
One-dimensional gel electrophoresis is limited in its capacity 
to resolve individual proteins, therefore two-dimensional analyses 
were performed using either isoelectric focussing 
(IEF) or non- 
equilibrium PH gradient gel electrophoresis 
(NEPHGE) for the first 
dimension.. - With the combination of ampholines 
used, the IEF gels 
were capable of resolving protein within a pI range of 
4.5-6.3- 
More basic proteins would be separated by the 
NEPHGE gels. 
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the ? pul^. e-chase labelled cells in ?. g"29 were used to compare 
the r, ro'; eins secreted by butyrate-treated ( track 1), BrdUrd- 
treated ( track 2) ind untreated cells 
(track 3 ). The arrows 
indicate proteins showing increased incorporation of 
label in 
treated cells. 
Exponential gradient SDS-polyacrylamide gels were used for the 
second dimension because of their increased range of resolution and 
also to aid interpretation as they could be compared directly with the 
one-dimensional gels. Cells were treated with butyrate or BrdUrd 
and labelled with 
35S-methionine 
as above, except a lh period of 
labelling was used to increase incorporation. Fig. 31 A-C shows 
proteins from butyrate-and BrdUrd-treated and untreated cells 
before induction, separated using a NEPHGE first dimension. 
With the autoradiograph exposure used (14 days) approximately 
250 proteins could be detected by this system. Only two proteins 
were found to be affected reproducibly by treatment, these showed 
increased synthesis in butyrate-treated cells (Fig. 31A, indicated 
by large plus signs). One of these had a molecular weight of 
35,000 and probably corresponds to BEP35. On this particular 
gel an additional 8 polypeptides showed increased label incorporation 
(Fig. 31A, indicated by small plus signs), but this was not observed 
on other occasions. No reproducible changes were detected on gels 
of protein from BrdUrd-treated cells, although on this gel 12 
polypeptides show reduced intensity (Fig. 31B, indicated by small 
minus signs). 
The increase in incorporation of label into BEP35 caused by 
butyrate was quantitated by excising that section of the gel and 
comparing the radioactivity it contained with the same gel from 
untreated cells. The increase varied from 3-4 fold. As this 
was the most significant of the changes detected it showed that 
butyrate and BrdUrd treatment had relatively little effect on 
the synthesis of proteins other than IFN. 
Aliquots of the samples separated on NEPHGE gels were separated 
using a IEF first dimension. Fig. 31, D-F shows that again 
very few changes were apparent. With a 14 day autoradiograph 
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exposure 300 proteins were detected using this system. Butyrate 
treatment consistently increased the incorporation of label into 
only one protein with a molecular weight of approximately 42,000 
(Fig. 31D, indicated by large plus sign). On this gel a group of 
4 other proteins were not visible and one protein showed reduced 
incorporation of label (indicated by small minus sign) but this 
was not observed reproducibly. The pattern of proteins synthesised 
by BrdUrd-treated cells was indistinguishable from untreated cells 
(Fig. 31, EandF) One protein showed differences in migration in 
the IEF dimension, its pI varying from 4.65-4.75, but this 
fluctuation was independant of treatment and may reflect modification 
during sample preparation. The 42,000 molecular weight proteins 
enhanced by butyrate and observed on the IEF and NEPHGE gels 
(Fig. 31A and D, indicated by large plus signs) are probably the 
same protein. However, BEP35 was not detected on the IEF gels, 
probably because it is a basic protein, since its position on 
NEPHGE, gels suggests it has a pI greater than 7.0. 
Fig. 32, A-C shows proteins from treated and untreated cells 
at 7h after induction using DI Sendai virus, separated by an 
IEF first dimension. Again butyrate consistently enhanced only 
one protein (Fig. 32A, indicated by large plus sign). On the gel 
shown a group of 4 other proteins showed increased synthesis 
(indicated by small plus signs). BrdUrd treatment resulted in no 
reproducible changes although on the gel shown one protein had 
increased synthesis (Fig. 32B, indicated by small plus sign). 
The 
position of Sendai virus structural polypeptides were 
determined by 
electrophoresing proteins from normal Sendai virus infected cells. 
Only the HN, P and Po polypeptides were identified on 
the basis of 
molecular weight alone (Fig. 32E) and none of these were apparent 
in samples from DI Sendai virus infected cells. 
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Similar observations were made from analysis of samples from 
infected cells when resolved using NEPHGE first dimensions (data 
not shown), therefore it was concluded that butyrate and BrdUrd 
have a very limited effect on the synthesis of proteins in induced 
and non-induced Namalwa cells. At most only 12 proteins of the 300 
investigated had altered rates of synthesis, of these only 2 proteins 
were reproducibly affected in butyrate-treated cells and none in 
BrdUrd-treated cells. 
dý Discussion 
This analysis of 
35S-methionine labelled proteins has shown 
that butyrate and BrdUrd treatment of Namalwa cells causes only 
minor changes in the relative rates of synthesis of only a few 
proteins when examined either before or after induction with 
Sendai virus. Most of these changes were not reproducible, only 
occurring on single occasions, and these probably reflect slight 
variations in the cells or artifacts arising from the running 
and processing of gels. Only two proteins were reproducibly 
affected by treatment, both showed increased incorporation of 
label following butyrate treatment. The most significant effect 
was the 3-4fold increase in BEP35 synthesis. Considering the 
magnitude of these effects they are clearly distinct from the 
reproducible increases in IFN synthesis caused by butyrate and 
BrdUrd. 
Core histone acetylation induced by butyrate has been shown to 
give rise to chromatin with increased DN ase I sensitivity, a 
property characteristic of actively transcribed chromosomal loci 
(see section 1.1). As histone hyperacetylation has been demonstrated 
in butyrate-treated Namalwa cells (Baker et al. 1980) it is 
surprising that the consequences, in terms of expression of proteins, 
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are so slight. Likewise incorporation of BrdUrd into cellular 
DNA is also reported to alter DNA-protein interactions (see section 
1.1) and might be expected to perturb the pattern of protein synthesis. 
Similar studies on butyrate-treated hepatoma cells also failed to 
detect large changes in protein synthesis (Rubenstein et al., 1979). 
In contrast considerable de novo changes in RNA and protein synthesis 
were reported in butyrate-induced erythroleukemic cells (Reeves and 
Cserjesi, 1979). IFN production by both erythroleukemic and Namalwa 
is similarly affected by both butyrate and DMSO (Swetly. 1976; 
Glazier et al., 1977). The nature of any response to butyrate 
treatment will obviously differ depending on a cells phenotype and 
the genes it is expressing or capable of expressing. 
Two-dimensional gel electrophoretic analysis using detection of 
proteins by staining or autoradiography is limited to relatively 
abundant proteins. Proteins detectable by their biological activity 
at normal cellular concentrations, such as IFN, are not always 
present in sufficient quantity t be detected by staining or 
autoradiography. It was estimated that a protein containing less 
than 0.002% of the radioactivity in a sample loaded onto IEF or 
NEPHGE gels would be below the limits of detection by the 
conventional autoradiography used here. This was determined by 
counting the radioactivity associated with one of the faintest 
spots on a typical autoradiograph and comparing this with the total 
amount of radioactivity recovered from the gel. By using the 
NK2 monoclonal antibody to IFN-« it was possible to estimate the 
proportion of radioactivity associated with IFN-« in pulse-chase 
supernatants. From 2-6% of the TCA-insoluble radioactivity in such 
supernatants from butyrate-treated cells was retained by an NK2- 
Sepharose column. It was therefore possible that labelled IFN could 
be detected by polyacrylamide gel analysis of secreted proteins as 
in 
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Fig. 30. Only 10% of the total TCA-insoluble radioactivity incorporated 
into cells during a lh pulse was secreted, therefore IFN- a synthesis 
represents approximately 0.2-0.6% of total protein synthesis 
in butyrate-treated cells. Measurements of IFN activity showed that 
only 2% of the IFN synthesised by cells during a lh period 
remained associated with the cells (see section 3.2) therefore as an 
approximation only 0.004-0.012% of the radioactivity incorporated 
into cell-associated proteins in the pulse-labelled samples used for 
two-dimensional gel analysis would be IFN. In this case it was 
unlikely that IFN could have been detected by the IEF or NEPHGE gel 
analysis used here, since the amount of radioactivity associated 
with each of the several IFN- o( proteins would be below the limits 
of detection. Consequently, other low abundance proteins could 
be equally affected by treatment but not detected by this survey. 
Greater sensitivity of detection could have been obtained using 
fluorography or longer autoradiograph exposures, however very few 
additional proteins were detected when longer exposures were used. 
Unless butyrate or BrdUrd preferentially affect the expression of 
low abundance proteins, the 300 proteins detected here are a 
sufficiently large sample. 
By infecting cells with normal Sendai virus it was clear that 
the treatments did not affect the synthesis of virus polypeptides 
which confirms the conclusions of Baker et al., 1980 that the 
increase in IFN synthesis is not caused by effects on the replication 
of the inducing virus. 
In conclusion, while butyrate and BrdUrd have a marked affect 
on the synthesis of IFN, the synthesis of the majority of proteins 
expressed by Namalwa cells remains unaltered. No changes were 
detected which were comparable to, or could account for, the 
enhancement of IFN synthesis. These results suggest that whereas 
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butyrate and BrdUrd may have a general effect on the organisation 
and transcriptional capacity of chromatin, the pattern of proteins 
expressed is not necessarily disrupted. 
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SECTION 4. GENERAL DISCUSSION- 
a) Post-transcriptional control of IFN synthesis? 
The results presented in section 3 clearly show that IFNmRNA 
is inactivated and degraded during the shut-off of IFN production in 
Namalwa cells. It is most likely that this event, together with the 
cessation of INN gene transcription, is responsible for the shut-off 
of IFN production. The inactivation of IFNmRNA in Namalwa cells can 
be delayed by incubating the cells at reduced incubation temperaturva, 
and it is proposed that this effect is caused by inhibition of the 
synthesis of an RNA or protein which is involved in the degradation 
df IFNmRNA. By analogy with the effect of metabolic inhibitors on 
poly(rI). poly(rC) induced fibroblasts, the effect of reduced incubation 
temprrature on IFNmRNA inactivation and IFN production in Namalwa cells 
is consistent with the post-transcriptional repressor model (see 
section 1.2). This proposes that the inactivation of IFNmRNA by a 
specific repressor molecule, induced at or shortly after the induction 
of IFt+, is responsible for controlling If( production. To date, the 
only evidence for such a repressor is the variation in IFNmRNA stability 
in cells perturbed by metabolic inhibiters. 
It is conceivable that such a repressor protA% is induced. 
Poly(rI). poly(rC) treatment of fibroblasts not only induces IFN synthesis 
but also a number of other mRNAs and proteins ( Raj and Pitha, 1980a; 
1980b ). Similarly, it has been found that three regions of DTNA, linked 
were 
to but unrelated to the IFN-13 gene, ^coordinately 
induced by poly(rI). 
poly(rC) in fibroblasts ( Gross et al., 1981). However it was found 
that the mH27As derived from these rtgions were differentially expressed 
in poly(rI). poly(rC) induced fibroblasts and virus induced Namalwa 
cells. One of the mRlTAs was not found in Namalwa cells, therefore it 
was unlikely to be involved in controlling IWI1R A stability. At -resent 
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the function of these mRNAs and proteins remains unknown. 
One possible candidate for the repressor molecule, a latent 
endonuclease which is activated as a consequence of the effect of 
IFN itself, does not appear to be involved in controlling IFNmRNA 
stability. IFN increases the synthesis of an enzyme called 2'-5' 
oligoadenylate synthetase which when activated by double-stranded 
RNA ( such as viral nucleic acid ) produces the oligonucleotide 
2'-5' oligoadenylate ( reviewed by Lengyel, 1981 ). The only 1a own 
function of 2'-5' oligoadenylate is to activate the latent endonuc' 
RNase L. Thus it would be possible for IIN secreted by induced cells 
to activate the RNase L and cause the degradation of IFNmRNA. However, 
thestability of IFNmRNA was found to be unaffected by varying levels 
of 2'-5' oligoadenylate synthetase, and further more the level of 
enzyme remained unchanged during normal induction of IF1J synthesis 
in fibroblasts ( Sehgal land Gupta, 1980 ). Therefore RNase L is unlikely 
to be involved. 
There are alternative exnla nations for the inactivation of 
IFNmRNA other than those involving a specific post-transcriptional 
control mechanism. There is very little evidence to indicate that 
the inactivation of MO NA is specific ( see section 1.2 ). IFrmRNA 
could belong to a class of mRPNAs which are rapidly turned over by 
constitutive mechanisms. Hence the observation that the inactivation 
of I TinRNA is not accompanied by changes in the stability of total 
3H-uridine labelled mRNA ( Sehgal and Gupta, 1980 ) would not be 
remarkable-Consequently the idea that IFlhrRNA is controlled is open 
to question. Indeed there is no evidence to suggest that IFIJmRNA 
stability changes during the period of IFTI production, as would be 
required if IFIT synthesis was controlled post-transcriptionally. The 
effects df metabolic inhibitors and low temperature on IFNmRNA stability 
could equally be explained by the inhibition of a constitutive 
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process ( with short half-life components ) which is involved in 
determining the stability of a class of mRNAs to which IRImflNA 
belongs. The rapid decline in IFNmRNA would then be explained solely 
by the control of transcription. 
In order to confirm how IFN production is controlled, following 
the initial events of induction, measurements of the rate of transcription 
of the IFET genes, and the rate of degradation of IfimR11A, are required. 
Preliminary attempts to determine the rate of transcription in 
induced Namalwa cells ( see section 3.1 ) by pulse-labelling intact 
cells with 
3H-uridine 
were unsuccessful since insufficient rad. ioactivit, 
was incorporated into IIII gene transcripts. However it should be 
possible to determine the rate of IIII gene transcription by incornoration 
of 
32P-labelled 
nucleotide triphosphates into "run-off" transcripts in 
isolated nuclei and hybridization with cloned IFT1cDPNA ( Derman et al., 
1981 ). The rate of IFNmRITA degradation could likewise be determined 
by following the decay of MIA hybridizing with IFAIcDITA during a chase 
of 
3H-uridine labelled cells. These measurements would indicate at 
, chat level (s) IFTT gene expression is controlled. 
An alternative approach to the question of post-transcriptional 
control would be to look for changes in IFITrn ITA stability by following 
the decay of functional IFITm1U A in the presence of inhibiters of 
RNA synthesis. In a prelir. 1nary experiment in which cordycerin was 
added to Namalwa cells at 8h after induction, the levels of IIITmI 'TA 
in the cells during the following 2h ( measured by translation in 
oocytes ) declined with a half-life of approximately 30mins ( data 
not shovm ). This was significantly shorter than the normal half- 
life of 2.7h ( see section 3.2 ) indicating that transcription was 
still occuring after 8h while IPNmRNA levels were declining. By comparing 
th e stability of IWnRTJA at various times after induction it shoulr 
be possible to determine whether its stability is controlled during 
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the shut-off of IFN synthesis. The obvious criticism of this approach 
would be that inhibition of RNAsynthesis would interfere with other 
nan-specific regulatory processes such as those suggested above. 
Nonethgless any change in IFNmRNA stability would be informative 
since it would most likely be a consequence of IFN induction. 
To conclude, although the data in section 3.1 are consistent 
with the post-transcriptional repressor hypothesis, they do not 
prove that IFTJmRNA stablity is controlled during the shut-off 
of IFIT production in Nazalwa cells. 
b) IFN gene expression in Sendai induced Namaiwa cells. 
IFIT- a and IFN-/3 gene expression are shoim to be coordinately 
induced and regulated in Sendai virus induced Nnmaiwa cells ( see 
section 3.3 ). This observation is not unexpected, since both classes 
of IRT are induced by the same inducer. However, as the IM: - ce and 
IF1T-! G genes are differentially expressed in different cell-tyres 
and with different inducers, it was conceivable that the two classes 
of MT gene were independantly controlled and hence could have shown 
different kinetics of induction end regulation. 
The conclusion that the IFN -/3 mM%TA expressed by the NemaJ. wa cells 
used in these experiments doesnot code for an active Ir? d-ý3 protein 
is perhaps more suprising ( see section 3.3 ). Other Namalwa cells 
produce readily detectable amounts of IFI1/3 mRNA and rrotein ( see 
sections 1.2 and 2 ). It waa suggested that the Irßd-f3 gene in the 
Namalwa cells used in these experiments has mutated, and work is 
in progress to characterise the gene from which the IPN /3 mRINA is 
derived, using cloned genomic DNA from these cells. 
Karyotype and serotype analysis have confirmed that the cells 
used in these experiments are Namaliva cells. Therefore the mutated 
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IFN gene must have arisen recently during culture. Whatever the 
reason , the failure 
to express active IFN-13 in these cells has 
possible implications for the function of multiple IFN genes. 
F nctional constraints are known to have an important role in 
regulating the rate at which mutated genes ( or their products ) 
become established in a population. This would suggest that a 
mutation of the IFN-13 gene in cultured cells could only persist 
in the population if it was not essential in culture. In the intact 
organism, the rate of fixation of such a mutation must be much 
slower, as evidenced by the close homology of thr IFN- u: and IFN /3 
genes, and the fact that a large number of these genes appear to 
code for active proteins. This might suggest that each of the 
fictional ITIT proteins has a distinct role in vivo. 
The question of how differential expression of the IPN- ac and 
INN 13 genes is controlled remains. Since expression of both classes 
of IFT gene is induced and regulated coordinately, the mechanism 
determining the relative proportions of each IFN produced must 
involve differential regulation at the transcriptional or post- 
transcriptional level ( or possibly the translational level ). 
Unfortunately no comparison of the relative proportions of IFTJ- "t 
and IFN 13 mRNA and proteins could be made in these Namaliva cells 
because no active IFN-f3 was produced. The relative proportions 
of IfJ-d and IEM-l3 mRNA in these cells were however suprising. On 
a molar basis IFNmRNA was found to be composed of 29% IRI- of and 
71% IFN -/3 " Since the composition of Namalwa IFN ( in cells producing 
active In 13 ) was reported to be approximately 85% IFTJ- a and 15i% 
IN-/3 these IMmRNA values would appear to be inconsistent. However 
it is possible that the differential regulation is affected in the 
Namalvra cells which are not producing active IFtd 
/3. 
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To conclude, a systematic survey, comparing the relative proportions 
Of ITN--C and IlN-/3 mRNA and protein is required in order to determine 
the level at which differential expression of the IFTJ genes occurs. 
Ideally measurements of IFtd protein, using specific antisera or 
monoclonal antibodies should be made, in conjunction with hybridization 
of IFNmENA with cloned IFNcDNA probes in order to elliminate possible 
differences in specific activity of the proteins or translational 
activity ofthe mRNA. The investigation could be extended by comparing 
the expression of the multiple IFN-o( genes, using probes specific- 
for each IFN-o< gene. Such probes could be constructed from the 3' 
untranslated regions of the genes where least homology occurs. This 
information would hopefully enable the design of further exprriment, 
possibly using in vivo or in vitro transcription systems to investigate 
transcriptional control of cloned 1111 genes. 
c) The effect of butyrate and BrdUrd on IFN gene expression. 
Treatment of Nanaliva cells with butyrate or BrdUrd before 
induction by Sendai virus has been shown to increase the synthesis 
of both IFN- a and IFTJ /3 mRNA ( see sections 3.2 and 3.3 ). The 
increase in IFN-amPI'A levels in treated cells partly explains the 
increase in I1T production which has previously been reported ( see 
section 1.3 ). An increase in the efficiency of translation of 
IFNmRNA also contributes to the increased IFN yield, but this was 
apparently caused by culture conditions prior to induction of cells. 
No qualitative differences could be detected in either the IFrnRNA 
or IRR expressed by treated cells. It is most likely that an increase 
in expression of a single ITN-c< species would be detected either by 
changes in the size distribution of IEN- oc mf1 A or biological 
properties of the IFN produced. Jowever these data do not prove 
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conclusively that treatment coordinately increases the synthesis of 
all IFN- -C species expressed by Namalwa cells. 
Further analysis of the effects of butyrate and BrdUrd on IFN 
gene expression will require measurements of the rate of transcription 
of the IFN genes in order to determine the level at which they act. 
Butyrate and BrdUrd could well prove useful in studying the mechanisms 
which control IR gene transcription ( or mRNA processing ) since 
their effect must be mediated by alterations in these events. However 
at present too little is known about the mode of action of butyrate 
and BrdUrd to propose how such experiments could be designed. 
d) Conclusions. 
Sendai. virus induced Namaiwa cells have provided useful 
information about the control of IFN- ac and IFN-13 gene expression 
in cultured humsncells. Although key questions still remain unanswered 
the information provides a basis for further experiments on the control 
of IFN synthesis. Of the remaining problems, the nature of the proximate 
inducer and the mechanisms controlling transcriptihn of the IFN genes 
are probably the most important. However even when these control processes 
are described, this information will have to be related to the in vivo 
situation in order to understand the physiological significance and 
ftinction of this group of genes. Clearly there is a considerable 
distance to go before the IFrd system is fully understood. 
0 
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